Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3029713	s-mkomp-1	g/l (g/l)	11932	27220	0.00%
3029713	s-mkomp-1	— (—)	2625	5385	100.00%	Distribution not available
3029713	s-mkomp-1	g/l_______ (g/l)	853	2606	0.00%
3029713	m-komp-1	g/l (g/l)	135	1094	0.00%	Distribution not available
3029713	m-komp-1	— (—)	61	236	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

629

1208

6.17

322.13

3.8

2.3

1.75

0.99

g/l

2.42

523

1012

Heart failure,strict

2221

6355

2.56

316.49

2.4

2.5

0.71

1.03

g/l

3.37

1910

5391

Finngen Rheumatological endpoints

2917

7436

2.28

316.03

2.3

2.6

0.62

0.87

g/l

3.05

2553

6441

Infections, IBD-co-morbidities

579

614

7.00

315.05

4.1

2.4

1.06

1.21

g/l

0.22

507

533

Unspecified kidney failure

731

1575

5.29

307.65

2.8

2.3

0.78

0.95

g/l

0.47

663

1312

Other anaemias

2932

6984

4.34

307.65

2.8

2.4

1.05

0.92

g/l

0.62

2539

5861

Implicit Sepsis, including avohilmo

3299

9315

2.63

307.65

2.6

2.3

0.77

0.75

g/l

0.11

2851

8010

Influenza and pneumonia

3521

10007

2.23

307.65

3.3

2.1

0.86

0.68

g/l

2.10

3063

8662

Primary_lymphoid and hematopoietic malignant neoplasms

1962

3960

5.77

307.65

9.0

1.5

3.77

0.39

g/l

59.25

1681

3369

Renal failure

3359

7048

4.51

307.65

2.7

2.4

0.84

0.96

g/l

0.75

2983

5876

All chronic kidney diseases

3390

6677

4.41

307.65

2.6

2.4

0.74

0.92

g/l

1.48

3019

5650

Multiple myeloma

565

397

27.63

307.65

19.3

1.5

7.16

0.48

g/l

36.68

492

333

Gout

1449

4007

3.33

307.65

3.3

2.6

0.91

1.12

g/l

0.98

1270

3390

Inflammatory bowel disease treatment related agents

4071

9495

2.45

307.65

2.3

2.5

0.73

0.82

g/l

0.73

3571

8122

Multiple myeloma and malignant plasma cell neoplasms

855

751

19.91

307.65

16.7

1.7

6.92

0.69

g/l

45.10

706

632

Implicit bacterial Sepsis, including avohilmo

2232

6793

2.90

307.65

2.9

2.4

0.87

g/l

0.00

1929

5758

Second line medication for Crohn's disease

2521

8707

3.05

307.65

5.5

1.8

1.16

0.64

g/l

7.36

2193

7545

ILD medications: immunosuppressive drugs

3115

7406

4.05

307.65

4.8

1.8

0.99

0.67

g/l

3.88

2747

6364

Multiple myeloma, including Hilmo

853

644

23.93

307.65

16.7

1.5

6.96

0.43

g/l

50.19

709

548

Fever of other and unknown origin

2385

6439

3.37

307.65

4.1

2.2

1.20

0.84

g/l

2.72

2082

5508

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3400

10358

2.25

307.65

3.2

2.2

0.87

0.70

g/l

1.71

2948

8949

General symptoms and signs

3327

7075

2.42

307.65

2.6

2.2

0.70

0.79

g/l

0.61

2926

6088

Other systemic involvement of connective tissue

1381

4375

3.40

307.65

2.0

2.5

0.54

0.94

g/l

4.66

1214

3697

Other bacterial diseases

3836

9732

2.72

307.65

3.1

2.2

0.92

0.70

g/l

2.37

3367

8320

Heart failure, not strict

3249

8047

2.86

307.65

2.7

2.5

0.60

0.93

g/l

5.49

2813

6898

Examination and observation for other reasons

2299

4292

3.15

307.65

2.5

2.4

0.51

0.79

g/l

3.20

2098

3649

Aplastic and other anaemias

3055

7301

4.21

307.65

2.8

2.4

1.03

0.92

g/l

0.61

2644

6139

Condition for Implicit Sepsis (Organ dysfunction codes)

3249

9268

2.52

307.65

2.6

2.4

0.77

0.73

g/l

0.20

2814

7980

Bacterial Sepsis

2292

6894

2.91

307.65

3.2

2.4

1.04

0.86

g/l

1.01

1975

5850

Dialysis, with operation codes

828

1645

5.74

307.65

4.1

2.2

0.87

0.84

g/l

0.05

752

1398

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

5243

8942

4.22

307.65

2.7

2.3

0.82

0.72

g/l

1.03

4573

7662

ILD medications: prednisolone, methylprednisolone, prednisone

4102

8178

2.89

307.65

2.4

1.8

0.71

0.74

g/l

0.20

3595

6990

Oral corticosteroids

3966

9445

2.55

307.65

2.3

2.5

0.71

0.82

g/l

0.94

3476

8076

Autoimmune diseases excluding thyroid diseases

3545

8732

2.26

307.65

2.2

2.6

0.64

0.86

g/l

2.90

3124

7485

Pneumonia, organism unspecified

3265

9808

2.36

307.65

3.2

2.1

0.89

0.69

g/l

2.05

2817

8473

Bacterial infection, other or unspecified

2701

7659

3.16

307.65

3.5

2.2

0.99

0.82

g/l

1.26

2381

6460

Acute renal failure

1376

3580

4.25

307.65

2.9

2.4

1.00

0.89

g/l

0.30

1219

2989

Other and unspecified polyneuropathies, also in other diseases

1428

3279

5.00

307.65

2.3

2.4

0.56

0.93

g/l

3.64

1266

2782

ILD medications

4299

8199

2.93

307.65

3.2

1.8

0.84

0.74

g/l

0.79

3763

7011

Anaemias

992

539

12.62

307.65

2.5

1.3

0.63

0.11

g/l

5.47

896

484

Osteopathies and chondropathies

2323

8691

2.55

307.65

3.2

2.3

0.92

0.79

g/l

0.73

1910

7498

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3082

8032

2.31

307.65

3.2

2.0

0.84

0.70

g/l

1.19

2687

6949

Systemic connective tissue disorders

1818

5670

3.45

307.65

2.1

2.5

0.50

0.92

g/l

6.99

1599

4772

Tramadol

3012

6550

2.87

307.65

2.6

2.1

0.65

0.78

g/l

1.19

2648

5623

Autoimmune diseases excluding thyroid diseases, strict definition

3419

8435

2.27

307.65

2.2

2.6

0.66

0.87

g/l

2.52

3012

7221

Implicit bacterial Sepsis

2046

6427

2.89

307.65

3.0

2.3

0.91

0.90

g/l

0.03

1766

5431

3082

8032

2.31

307.65

3.2

2.0

0.84

0.70

g/l

1.19

2687

6949

Pain in limb

2958

7907

2.46

307.65

2.4

2.5

0.62

0.89

g/l

3.32

2605

6749

Pneumonias (Asthma/COPD co-morbidities)

3451

10227

2.27

307.65

3.3

2.1

0.84

0.69

g/l

1.44

2998

8838

Malaise and fatigue

2226

5842

3.15

307.65

2.4

2.3

0.80

0.89

g/l

0.47

1918

4985

Other and unspecified anaemias

2919

6937

4.37

307.65

2.8

2.4

1.03

0.93

g/l

0.52

2527

5817

All kidney diseases

4222

9253

3.20

307.65

2.6

2.4

0.67

0.78

g/l

1.18

3706

7940

Renal tubulo-interstitial diseases

4107

9503

3.34

307.65

2.6

2.4

0.75

0.81

g/l

0.40

3578

8146

Bacterial infection, other or unspecified, including avohilmo

2875

7966

3.14

307.65

3.4

2.2

0.99

0.80

g/l

1.47

2541

6735

Implicit Sepsis

3185

9146

2.68

307.65

2.7

2.4

0.83

0.76

g/l

0.41

2746

7837

Glomerular diseases

1063

2740

4.30

307.65

3.0

2.4

0.68

0.86

g/l

0.63

955

2361

Other soft tissue disorders, not elsewhere classified

3150

7982

2.31

307.65

2.5

0.64

0.88

g/l

3.44

2786

6813

Other bacterial diseases, including avohilmo

3842

9360

2.66

307.65

2.9

2.2

0.86

0.70

g/l

1.51

3395

7997

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

565

397

27.63

307.65

19.3

1.5

7.16

0.48

g/l

36.68

492

333

L04AX Other immunosuppressants

2486

8522

3.08

307.65

5.6

1.8

1.18

0.65

g/l

7.30

2162

7385

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1090

670

35.38

307.65

7.9

1.3

5.09

0.10

g/l

96.42

871

575

Liquid cancers, including Hilmo

2421

5217

4.55

307.65

7.6

1.5

3.23

0.35

g/l

62.29

2076

4453

Chronic kidney disease

2449

5222

5.12

307.65

2.5

2.4

0.68

1.02

g/l

3.64

2191

4320

All pneumoniae

3463

10245

2.26

307.65

3.3

2.1

0.84

0.69

g/l

1.49

3013

8855

Polyneuropathies and other disorders of the peripheral nervous system

1536

3716

4.68

307.65

2.6

2.4

0.58

0.92

g/l

3.44

1364

3154

Liquid cancers

2304

4584

5.43

307.65

8.0

1.5

3.36

0.36

g/l

61.55

1977

3910

Metabolic disorders

3244

8538

2.35

307.65

2.5

2.4

0.62

0.87

g/l

3.35

2848

7295

Polyarthropathies

2828

6131

3.10

307.65

2.6

2.5

0.70

0.90

g/l

1.91

2511

5292

First line medication for Crohn's disease

3933

8087

2.71

307.65

3.2

1.7

0.89

0.70

g/l

1.97

3456

6935

Other systemic involvement of connective tissue (FG)

1353

3405

4.22

307.65

2.0

2.7

0.50

0.99

g/l

6.01

1188

2885

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3280

8996

2.55

307.65

2.5

2.4

0.72

0.71

g/l

0.07

2847

7768

Codeine

2789

6688

2.31

306.38

2.3

2.0

0.65

0.76

g/l

0.84

2421

5754

Erysipelas, including avohilmo

2607

8705

2.29

301.67

2.4

2.2

0.77

0.75

g/l

0.12

2291

7397

Oedema, not elsewhere classified

1365

4544

3.09

300.68

2.5

2.3

0.55

0.90

g/l

4.07

1189

3843

Glomerular disorders in diseases classified elsewhere

738

1718

4.85

297.47

3.1

2.3

0.81

0.93

g/l

0.26

661

1476

Abnormal findings on examination of blood, without diagnosis

2034

7675

2.52

297.00

3.0

2.5

1.17

0.84

g/l

2.95

1774

6577

Heart failure and antihypertensive medication

1025

1767

4.00

295.73

2.4

2.7

0.56

1.05

g/l

3.21

891

1526

Other and unspecified iron deficiency

1547

5756

2.84

291.09

2.1

2.5

0.68

0.93

g/l

2.16

1330

4850

Nephropathy related operations

747

1785

4.71

291.00

4.2

2.3

0.89

0.85

g/l

0.07

681

1531

Nutritional anaemias

2077

8481

2.44

287.71

2.2

2.5

0.72

0.97

g/l

2.58

1779

7182

Gout, FINNGEN

1449

5278

2.92

283.04

3.3

2.5

0.91

1.03

g/l

0.50

1270

4446

Iron deficiency anaemia

1826

7368

2.55

278.71

2.2

2.5

0.73

0.95

g/l

1.82

1555

6233

Asthma, unspecified (mode), excluding more controls

1678

4577

2.71

275.18

2.3

2.0

0.75

0.69

g/l

0.22

1477

3956

Disorders of lipoprotein metabolism and other lipidaemias

2814

8106

2.17

274.32

2.5

2.4

0.59

0.92

g/l

5.09

2490

6894

Opioids

2800

6716

2.20

272.32

2.5

2.0

0.76

g/l

0.01

2453

5780

Other heart diseases

1254

2650

3.17

264.71

2.6

2.2

0.58

0.70

g/l

0.53

1108

2334

Explicit Sepsis, including avohilmo

1811

6852

2.50

262.76

3.2

2.4

1.25

0.86

g/l

2.48

1543

5829

Pure hypercholesterolaemia

2621

7884

2.18

258.78

2.4

2.5

0.57

0.94

g/l

7.08

2335

6691

Osteoporosis

1319

4406

2.94

257.61

2.5

2.3

0.96

0.90

g/l

0.17

1030

3714

Septicaemia

1734

6554

2.52

256.01

3.3

2.2

1.28

0.85

g/l

2.62

1475

5510

Explicit Sepsis

1774

6771

2.49

255.42

3.3

2.3

1.26

0.87

g/l

2.40

1512

5752

Care involving dialysis

536

1093

5.63

254.72

2.8

2.3

0.65

0.86

g/l

0.48

485

937

Heart failure, strict

2422

7906

2.22

252.50

2.4

2.6

0.76

0.98

g/l

1.89

2084

6695

Any gastric operation

2038

4248

2.46

251.68

2.3

2.0

0.77

0.69

g/l

0.39

1761

3730

GASTRO-related operations

2038

4248

2.46

251.68

2.3

2.0

0.77

0.69

g/l

0.39

1761

3730

Implicit viral Sepsis, including avohilmo

1327

4927

2.84

250.44

3.0

2.3

0.94

0.83

g/l

0.40

1150

4169

Diseases of arteries, arterioles and capillaries (FINNGEN)

898

1715

3.80

249.04

2.6

2.4

0.54

0.96

g/l

2.49

791

1486

Other diseases of blood and blood-forming organs, wide

1051

3482

3.24

247.55

3.8

2.3

1.34

0.83

g/l

2.71

922

2991

Codeine or tramadol medication

3494

9991

1.94

247.42

2.3

2.4

0.68

0.85

g/l

1.72

3024

8603

Autoimmune diseases related-to ILD

2771

11640

2.04

246.61

2.2

2.5

0.61

0.82

g/l

2.50

2443

9987

Dental caries

1053

3275

3.20

244.17

3.8

2.3

0.99

0.73

g/l

1.20

939

2831

Hypertensive diseases (excluding secondary)

1328

2682

2.96

242.31

2.3

2.2

0.67

0.70

g/l

0.09

1194

2357

Reimbursement for rheumatic diseases

2041

9287

2.26

242.24

1.8

2.6

0.54

0.81

g/l

3.57

1810

7929

Persons encountering health services for specific procedures and health care

3219

9876

1.97

241.14

2.8

2.3

0.82

0.72

g/l

0.77

2851

8478

Asthma, unspecified (mode)

1743

5223

2.48

240.67

2.3

2.1

0.75

0.69

g/l

0.24

1528

4500

Hypertension, essential

2201

5587

2.28

238.61

2.3

2.5

0.65

0.75

g/l

0.51

1952

4791

Exposure to unspecified factor

3234

11652

1.93

237.19

2.4

2.5

0.62

0.83

g/l

2.98

2770

10076

All-cause Heart Failure

2357

7809

2.19

237.15

2.4

2.6

0.79

0.98

g/l

1.38

2027

6609

Pain in joint

1886

4964

2.40

233.18

2.2

2.4

0.61

0.84

g/l

1.71

1656

4249

Covid-19 confirmed case

1563

6547

2.50

229.92

3.2

2.3

1.11

0.85

g/l

1.41

1339

5584

Certain infectious and parasitic diseases

2746

6765

2.08

229.27

2.6

2.0

0.87

0.66

g/l

1.85

2407

5773

Other arthritis (FG)

1147

4138

2.90

228.63

2.5

2.6

0.55

0.86

g/l

3.10

1012

3548

Caries of dentine

943

2954

3.25

225.56

3.7

2.3

0.90

0.73

g/l

0.71

838

2561

Acute tubulo-interstitial nephritis

2063

8123

2.21

225.41

2.4

0.72

0.87

g/l

1.07

1756

6895

Oxycodone

1512

5307

2.54

224.48

4.9

2.2

1.39

0.89

g/l

3.34

1254

4506

Transplanted organ and tissue status

550

1269

4.83

223.25

5.2

2.3

0.83

0.78

g/l

0.08

507

1098

Provisional assignment of new diseases of uncertain etiology

1896

8662

2.25

221.25

3.1

2.3

1.01

0.79

g/l

1.40

1644

7426

Codes for special purposes

1898

8676

2.25

221.12

3.2

2.3

1.01

0.79

g/l

1.36

1645

7439

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

166

38.58

218.10

11.1

1.2

8.88

0.24

g/l

17.35

140

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

427

491

6.50

216.13

2.4

2.6

0.69

1.46

g/l

1.86

380

418

Diverticular disease of intestine

2525

7855

2.06

216.03

2.6

2.5

0.80

0.88

g/l

0.44

2216

6700

Other specific joint derangements/joint disorders

2127

6191

2.19

215.23

2.2

2.5

0.57

0.82

g/l

2.47

1866

5380

Diseases of oesophagus, stomach and duodenum

3247

10389

1.89

215.05

2.2

2.5

0.60

0.83

g/l

3.87

2793

8975

L04AA Selective immunosuppressants

923

3082

3.18

213.33

2.0

2.4

0.40

0.79

g/l

4.30

843

2674

Erysipelas

1987

8076

2.19

212.99

2.4

2.2

0.84

0.79

g/l

0.23

1747

6845

Other septicaemia, including avohilmo

1536

6169

2.44

212.68

2.9

2.2

1.13

0.85

g/l

1.41

1306

5172

Dyspnoea

2936

11344

1.91

211.71

2.6

2.4

0.72

0.81

g/l

0.68

2511

9783

Other septicaemia

1507

6058

2.45

210.66

2.9

2.2

1.13

0.86

g/l

1.35

1280

5069

Hypertensive diseases

2136

5634

2.19

209.87

2.2

2.5

0.61

0.74

g/l

0.85

1894

4832

Medical observation and evaluation for suspected diseases and conditions

1918

4335

2.32

209.10

2.4

0.78

0.80

g/l

0.08

1683

3679

Hypertension

2131

5634

2.18

208.07

2.2

2.5

0.61

0.74

g/l

0.87

1889

4832

Autoimmune diseases

3199

8767

1.89

205.92

2.3

2.6

0.66

0.86

g/l

2.19

2801

7514

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3375

9894

1.85

205.91

2.3

2.5

0.65

0.85

g/l

2.49

3049

8390

Used for control exclusion in common control thyroid runs

2999

8021

1.92

203.29

2.3

2.6

0.63

0.87

g/l

3.26

2626

6877

Asthma, excluding more controls

2001

4687

2.24

202.90

2.2

2.0

0.70

0.67

g/l

0.09

1765

4060

Other specified/unspecified arthritis

1027

3736

2.88

201.83

2.4

2.6

0.56

0.86

g/l

2.68

903

3214

Ulcer of lower limb, not elsewhere classified

798

2559

3.40

200.25

2.5

2.3

0.50

0.92

g/l

3.05

707

2161

Low back pain

2364

8040

2.03

200.17

2.8

2.3

0.81

0.76

g/l

0.27

2057

6905

Non-Hodgkin lymphoma, all, including Hilmo

687

2006

3.74

200.11

3.1

1.5

1.53

0.35

g/l

9.26

597

1723

Gout, idiopatic and unspecified

1194

4771

2.67

197.30

2.2

2.6

0.50

1.00

g/l

7.42

1060

4044

Malignant immunoproliferative diseases

179

148

22.55

195.00

10.2

2.4

7.57

0.80

g/l

13.53

153

132

L04AD Calcineurin inhibitors

524

1295

4.43

193.55

2.6

0.36

1.01

g/l

4.06

491

1139

Complications of surgical and medical care, not elsewhere classified

3109

11567

1.83

193.43

2.5

0.78

0.80

g/l

0.11

2691

9949

Continuous positive airway pressure

743

1872

3.49

192.23

2.4

2.5

0.73

0.86

g/l

0.33

662

1621

Coagulation defects, purpura and other haemorrhagic conditions

851

2892

3.13

191.08

2.6

2.4

0.67

0.87

g/l

0.90

746

2477

Polymyalgia rheumatica

753

2412

3.43

189.90

2.0

2.4

0.60

1.05

g/l

2.88

648

2014

Other heart diseases, wide

2483

7785

1.97

188.87

2.4

0.61

0.75

g/l

1.28

2180

6778

Cardiovascular diseases (excluding rheumatic etc)

1322

2991

2.58

187.90

2.3

2.1

0.56

0.62

g/l

0.24

1200

2648

Other disorders of skin and subcutaneous tissue

2475

11165

1.92

185.56

2.4

2.5

0.68

0.87

g/l

2.01

2153

9540

Abnormalities of breathing

2460

7278

1.97

185.41

2.4

0.70

0.76

g/l

0.36

2126

6326

Diseases of arteries, arterioles and capillaries

2421

9362

1.96

184.99

2.3

2.6

0.60

0.97

g/l

6.45

2099

7947

Pain, not elsewhere classified

947

3456

2.85

184.16

2.9

2.2

0.71

0.86

g/l

0.61

842

2959

Asthma (only as main-diagnosis), excluding more controls

1829

4687

2.20

182.46

2.3

2.0

0.63

0.67

g/l

0.18

1612

4060

Cerebrovascular diseases (FINNGEN)

894

2120

3.06

181.57

2.3

2.4

0.52

0.84

g/l

1.90

788

1843

Persons encountering health services in other circumstances, wide

3379

9935

1.78

181.49

2.4

2.5

0.69

0.85

g/l

1.71

3002

8417

Headache

1763

6453

2.16

180.73

2.3

2.2

0.57

0.77

g/l

2.07

1552

5556

Asthma

2115

5345

2.08

180.01

2.3

2.0

0.71

0.68

g/l

0.13

1869

4614

Gout, unspecified

990

3789

2.80

179.01

2.2

2.5

0.54

0.93

g/l

3.81

886

3219

Symptoms and signs involving the skin and subcutaneous tissue

2319

11705

1.92

176.85

2.5

2.4

0.69

0.81

g/l

0.88

2042

10042

Asthma (mode)

2083

5389

2.07

175.82

2.3

2.0

0.67

0.68

g/l

0.01

1838

4653

Gout, strict definition

913

3389

2.90

175.79

2.2

2.6

0.50

1.02

g/l

6.06

810

2886

Pain in throat and chest

2346

7242

1.96

174.25

2.4

0.62

0.77

g/l

1.33

2061

6290

Syncope and collapse

1452

5453

2.29

173.26

2.5

2.3

0.72

0.94

g/l

1.44

1221

4640

Disturbances of skin sensation

958

3639

2.75

172.87

2.1

2.4

0.47

0.79

g/l

2.98

865

3158

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2327

10882

1.92

172.86

2.6

2.5

0.98

0.83

g/l

0.85

2018

9281

Other diseases of intestines

2876

8916

1.83

172.24

2.4

0.72

0.79

g/l

0.42

2516

7688

Rheumatoid arthritis

1145

4156

2.54

171.89

2.0

2.7

0.64

0.94

g/l

2.22

1014

3542

Disorders of thyroid, IBD co-morbidities

440

631

4.93

170.87

2.2

2.5

0.37

1.18

g/l

3.29

385

544

Spondylopathies

2450

7732

1.92

170.69

2.8

2.3

0.86

0.80

g/l

0.29

2126

6607

Disorders of mineral metabolism

456

1122

4.48

169.94

3.8

2.4

0.96

1.06

g/l

0.13

373

964

Viral Sepsis

887

3287

2.85

169.27

3.4

2.2

1.04

0.77

g/l

0.97

762

2784

Symptoms and signs involving the urinary system

2502

10351

1.87

169.11

2.4

2.5

0.88

0.84

g/l

0.21

2154

8850

Implicit viral Sepsis

885

3283

2.85

168.55

3.4

2.2

1.04

0.77

g/l

0.97

760

2780

Disorders of calcium metabolism

393

871

5.08

168.51

4.2

2.5

1.09

1.15

g/l

0.06

321

748

Other disorders of fluid, electrolyte and acid-base balance

1216

4933

2.42

166.27

2.6

2.5

0.77

1.04

g/l

1.30

1020

4128

Preparatory care for dialysis

323

622

6.19

165.54

2.5

2.8

0.40

1.32

g/l

4.01

307

541

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

117

51.81

165.54

12.5

1.2

10.44

0.13

g/l

13.61

Cardiovascular diseases

1145

2365

2.61

163.90

2.2

2.0

0.59

0.53

g/l

0.21

1039

2098

Heart failure and bmi 25plus

1325

3858

2.40

163.09

2.4

2.7

0.64

1.04

g/l

3.17

1128

3187

Enlarged lymph nodes

610

1868

3.45

162.48

2.3

0.60

0.91

g/l

1.56

551

1601

Follow-up examination after treatment for conditions other than malignant neoplasms

1309

3768

2.38

162.26

2.3

2.4

0.62

0.73

g/l

0.55

1176

3197

Symptoms and signs involving cognition, perception, emotional state and behaviour

2879

11048

1.78

162.16

2.3

2.5

0.71

0.81

g/l

0.76

2509

9520

Dorsalgia

2747

8112

1.83

161.92

2.5

2.3

0.76

g/l

0.02

2384

6966

Asthma (only as main-diagnosis)

1920

5345

2.05

160.03

2.3

2.0

0.69

0.68

g/l

0.04

1688

4614

Hypertensive heart and/or renal disease

1034

3002

2.64

159.06

2.1

2.7

0.58

1.04

g/l

4.40

916

2478

Fall on same level

3129

9729

1.74

158.27

2.4

2.5

0.61

0.84

g/l

3.39

2659

8536

Certain infectious and parasitic diseases, including avohilmo

1901

4716

2.06

156.03

2.4

2.0

0.85

0.68

g/l

0.96

1679

3991

Non-ischemic cardiomyopathy

1295

4626

2.33

154.89

2.5

0.81

1.03

g/l

1.15

1096

3881

Disorders resulting from impaired renal tubular function

272

475

6.84

154.59

2.5

2.7

0.38

1.43

g/l

3.86

260

419

Other CVD (FINNGEN)

494

991

4.06

153.33

3.0

2.3

0.66

1.19

g/l

1.34

420

838

Glomerulonephritis

484

1349

3.92

151.32

3.1

2.5

0.52

1.03

g/l

1.67

441

1161

Lower back pain or/and sciatica

3138

11657

1.70

150.76

2.6

2.4

0.77

0.79

g/l

0.10

2724

10036

Atrial fibrillation and flutter

861

2019

2.84

150.51

2.8

2.3

0.64

0.88

g/l

1.04

759

1752

Diabetic nephropathy, excluding more controls

685

1889

3.18

148.38

2.0

2.4

0.37

0.83

g/l

4.34

624

1588

Abnormalities of gait and mobility

626

2081

3.27

147.93

2.0

2.5

0.38

1.02

g/l

7.30

565

1780

Type 2 diabetes, wide definition

2482

8834

1.81

147.23

2.1

2.7

0.56

0.92

g/l

6.08

2152

7586

Symptoms and signs concerning food and fluid intake

477

1331

3.83

147.12

2.0

2.3

0.33

0.96

g/l

5.32

413

1127

Purpura and other haemorrhagic conditions

608

1990

3.28

146.41

2.6

2.4

0.75

0.93

g/l

0.52

523

1701

Other pulmonary diagnosis

2059

5395

1.95

145.34

2.6

2.0

0.81

0.68

g/l

0.71

1793

4656

Osteoporosis with pathological fracture (FG)

395

988

4.43

144.43

2.0

2.6

1.04

1.20

g/l

0.18

292

816

Excluding asthma or asthma-COPD overlap

2052

5395

1.94

143.43

2.6

2.0

0.82

0.68

g/l

0.79

1794

4656

Small fibre neuropathy

246

422

7.13

143.23

2.8

2.5

0.60

1.57

g/l

2.58

220

367

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1009

2561

2.54

142.87

2.4

2.3

0.78

0.73

g/l

0.17

894

2247

Seropositive rheumatoid arthritis

861

3392

2.63

142.75

2.0

2.7

0.69

0.99

g/l

1.80

763

2878

Malignant neoplasm, including Hilmo

2361

7671

1.83

142.27

3.7

1.5

1.26

0.30

g/l

20.31

2047

6670

Secondary hypertension

329

704

4.94

141.70

2.3

0.43

1.17

g/l

2.41

293

602

Diseases of the skin and subcutaneous tissue

2650

7611

1.78

141.00

2.4

0.82

g/l

0.00

2309

6534

Neurological diseases, wide definition

539

708

3.90

140.96

2.4

2.3

0.57

1.07

g/l

1.62

487

616

Malignant neoplasm

2335

7648

1.82

139.84

3.9

1.5

1.30

0.30

g/l

21.56

2025

6644

Malignant neoplasm

2334

7665

1.82

138.60

3.9

1.5

1.29

0.30

g/l

21.19

2026

6656

Malignant neoplasm, wide definition

2355

7718

1.81

137.67

3.7

1.5

1.25

0.30

g/l

19.99

2046

6707

Endocrine, nutritional and metabolic diseases

1812

4667

1.99

137.07

2.3

2.5

0.58

0.90

g/l

2.96

1584

4054

COPD differential diagnosis

2026

5391

1.92

136.75

2.6

2.0

0.82

0.68

g/l

0.79

1773

4655

Benign neoplasm of colon, rectum, anus and anal canal

2199

10547

1.81

136.60

2.6

0.85

0.90

g/l

0.29

1892

8988

ILD differential diagnosis

2025

5389

1.92

136.60

2.6

2.0

0.82

0.68

g/l

0.79

1772

4653

Dermatitis and eczema

3184

11612

1.65

134.75

2.3

2.5

0.68

0.82

g/l

1.34

2769

9989

Bleeding

2581

10666

1.73

134.53

2.4

2.5

0.83

g/l

0.01

2221

9131

Extracorporeal dialysis

350

849

4.65

134.20

2.8

2.6

0.74

1.11

g/l

0.65

312

741

Other and unspecified dermatitis

1661

8790

1.94

132.38

2.3

2.5

0.65

0.79

g/l

1.05

1439

7537

Other necrotizing vasculopathies (FG)

322

737

4.86

132.31

1.8

2.8

0.22

1.31

g/l

6.34

284

618

Constipation

2694

10917

1.71

131.81

2.9

2.4

0.82

0.80

g/l

0.11

2284

9436

Asthma (diagnoses ohter than nonallergic)

2529

12121

1.72

131.37

2.2

2.5

0.73

0.81

g/l

0.38

2219

10407

Cardiac arrhythmias

1428

4452

2.10

131.16

2.5

0.58

0.76

g/l

1.28

1250

3913

Complications of medical and surgical care

2267

11807

1.76

131.15

2.5

0.75

0.82

g/l

0.38

1971

10123

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

737

1267

2.97

130.30

2.4

1.9

0.76

0.62

g/l

0.38

657

1091

Other dorsopathies, not elsewhere classified

2657

8118

1.73

129.68

2.4

2.3

0.80

0.76

g/l

0.20

2326

6972

COPD/asthma related infections

2712

8032

1.72

128.90

3.1

2.0

0.85

0.70

g/l

1.11

2342

6949

COPD/asthma/ILD related infections

2712

8032

1.72

128.90

3.1

2.0

0.85

0.70

g/l

1.11

2342

6949

Asthma, hospital admission 2, infections

1794

9554

1.87

128.46

2.5

0.77

0.82

g/l

0.21

1570

8158

Asthma-related infections

1794

9554

1.87

128.46

2.5

0.77

0.82

g/l

0.21

1570

8158

Nephrotic syndrome

211

345

7.19

127.62

2.9

2.7

0.63

1.15

g/l

0.61

199

312

Depression medications

456

569

4.10

127.23

1.8

1.3

0.33

0.11

g/l

2.30

417

512

Dermatitis

1913

10468

1.83

126.79

2.4

2.6

0.66

0.82

g/l

1.36

1648

8990

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2688

10209

1.69

126.79

2.8

2.4

0.80

0.77

g/l

0.17

2319

8908

Neoplasms

1655

4449

1.98

124.95

2.8

1.2

1.13

0.09

g/l

17.40

1441

3926

Atrial fibrillation and flutter with reimbursement

742

1742

2.78

123.48

2.8

2.4

0.67

0.95

g/l

1.03

649

1503

Other disorders of urethra and urinary system

2053

8082

1.80

123.02

2.4

2.5

0.67

0.90

g/l

2.30

1788

6926

Any reimbursement code in KELA

1128

2496

2.30

122.17

2.5

1.6

0.68

0.65

g/l

0.08

1017

2174

Pain (limb, back, neck, head abdominally)

1897

5132

1.88

121.92

2.3

2.4

0.77

0.89

g/l

0.71

1656

4375

Haemorrhage from respiratory passages

1194

5105

2.14

121.24

2.4

2.5

0.96

0.92

g/l

0.10

1027

4342

Hyperlipidaemia, other/unspecified

1335

6051

2.05

121.11

2.6

2.5

0.69

1.02

g/l

2.21

1135

5094

ILD medications: azathioprine

449

1362

3.45

121.08

1.9

1.6

0.34

0.64

g/l

1.97

397

1185

Amyloidosis, other/unspecified

178

262

8.67

120.94

7.9

2.4

2.19

2.05

g/l

0.07

159

225

Non-follicular lymphoma

485

1568

3.38

120.60

2.7

2.5

1.33

1.02

g/l

0.78

417

1336

Hypothyroidism (congenital or acquired)

406

558

4.15

120.32

2.7

1.3

0.38

0.11

g/l

2.49

372

501

Amyloidosis

193

310

7.64

119.98

7.6

2.4

2.04

1.94

g/l

0.06

172

267

Complications of procedures, not elsewhere classified

2361

11368

1.71

119.55

2.3

2.5

0.79

0.81

g/l

0.07

2048

9766

Other diseases of urinary system

2727

9321

1.67

119.50

2.4

2.5

0.65

0.84

g/l

2.32

2374

8048

Other and unspecified diseases of blood and blood-forming organs

203

344

7.10

119.26

5.3

2.8

1.96

1.12

g/l

1.31

185

309

Soft tissue disorders

2614

8015

1.70

119.19

2.4

2.5

0.64

0.88

g/l

3.29

2311

6841

Hypothyroidism, levothyroxine purchases

402

555

4.13

118.69

2.5

1.3

0.37

0.11

g/l

2.40

368

499

Hypothyroidism and >3 levothyroxin purchases

402

555

4.13

118.69

2.5

1.3

0.37

0.11

g/l

2.40

368

499

Valvular heart disease excluding rheumatic fever

1480

5472

1.99

118.53

2.7

2.6

0.84

0.93

g/l

0.41

1261

4677

Adjustment and management of implanted device

785

3273

2.53

118.16

2.7

2.2

0.66

0.92

g/l

1.45

674

2741

Fracture of lumbar spine and pelvis

914

4059

2.36

117.83

2.5

2.3

0.92

0.94

g/l

0.06

739

3403

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

223

420

6.31

117.15

2.6

1.4

0.74

0.45

g/l

1.00

200

356

Chronic lymphocytic leukaemia, helper endpoint

223

420

6.31

117.15

2.6

1.4

0.74

0.45

g/l

1.00

200

356

Chronic lymphocytic leukaemia

223

420

6.31

117.15

2.6

1.4

0.74

0.45

g/l

1.00

200

356

Symptoms and signs involving the circulatory and respiratory systems

2457

7283

1.72

116.38

2.3

0.73

0.76

g/l

0.13

2153

6331

Other antidepressants

2828

8889

1.65

116.05

2.3

2.6

0.70

0.86

g/l

1.40

2408

7693

Non-rheumatic valve diseases

1470

5460

1.98

115.92

2.7

2.6

0.84

0.93

g/l

0.41

1252

4666

Parasetamol

1677

4475

1.92

115.25

2.5

2.1

0.78

0.79

g/l

0.04

1442

3929

Spinal stenosis

1689

6821

1.88

114.72

2.4

0.80

0.88

g/l

0.36

1452

5783

Disorders of other endocrine glands

1325

6714

2.00

114.40

2.6

2.4

0.59

0.82

g/l

1.96

1127

5753

Disorders of parathyroid gland

828

3542

2.43

113.99

2.5

2.4

0.64

0.92

g/l

1.52

700

2981

Other necrotizing vasculopathies

376

1076

3.86

113.74

2.0

2.7

0.31

1.18

g/l

5.86

331

915

Myelodysplastic syndrome, including Hilmo

218

412

6.21

113.74

2.5

1.4

1.19

0.41

g/l

2.15

194

352

Chronic gastritis

1014

4781

2.21

113.13

2.3

2.6

0.49

1.02

g/l

7.64

885

4050

Cardiomyopathy

665

2611

2.68

113.04

2.7

2.4

0.49

1.02

g/l

4.75

594

2221

Diseases of liver

1166

5787

2.09

112.91

1.9

2.6

0.50

0.85

g/l

4.43

997

5000

Diseases of the musculoskeletal system and connective tissue

1147

2651

2.20

112.62

2.3

0.78

0.84

g/l

0.19

1016

2288

Spondylosis

1697

7343

1.85

112.35

2.4

0.72

0.81

g/l

0.50

1468

6266

Kidney transplant status

263

584

5.00

112.23

2.1

2.6

0.28

1.02

g/l

3.23

249

518

Genitourinary diseases

1336

3290

2.07

112.23

2.2

2.5

0.76

0.91

g/l

0.61

1181

2847

Other/unspecified dorsalgia

1131

5482

2.09

111.81

2.9

2.3

0.70

0.77

g/l

0.29

964

4671

Diarrhoea and gastroenteritis of presumed infectious origin

1979

10296

1.75

111.81

3.0

2.3

0.75

0.78

g/l

0.13

1716

8852

Rheumatoid arthritis, including avohilmo

1264

6478

2.02

111.75

2.0

2.5

0.63

0.86

g/l

1.83

1124

5480

Chronic apical periodontitis

3046

10890

1.59

110.70

2.5

2.4

0.75

0.80

g/l

0.34

2603

9427

Diaphragmatic hernia

1273

6582

2.00

109.96

2.5

2.4

0.84

g/l

0.00

1097

5555

Intestinal infectious diseases, including avohilmo, including avohilmo

3177

11404

1.57

109.93

2.9

2.3

0.75

0.81

g/l

0.36

2778

9787

Diabetic nephropathy

691

2790

2.61

109.03

2.0

2.2

0.37

0.77

g/l

4.33

629

2375

Dizziness and giddiness

2202

10290

1.70

108.78

2.3

2.6

0.69

0.85

g/l

1.32

1904

8834

Acquired haemolytic anaemia

187

323

6.98

107.86

3.6

2.3

1.03

0.98

g/l

0.05

168

281

Asthma-related pneumonia

1241

6377

2.00

107.50

2.6

2.4

0.82

0.94

g/l

0.48

1094

5353

Use of hypnotics and sedatives

2918

10614

1.60

107.39

2.8

2.4

0.75

0.78

g/l

0.21

2502

9182

Asthma, hospital admissions 3, pneumonia

1241

6387

2.00

106.99

2.6

2.4

0.82

0.94

g/l

0.47

1094

5361

Asthma-related pneumonia or sepsis

1241

6387

2.00

106.99

2.6

2.4

0.82

0.94

g/l

0.47

1094

5361

Intestinal infectious diseases

2601

12146

1.62

106.43

3.0

2.3

0.79

g/l

0.02

2263

10450

Other disorders of white blood cells

291

730

4.44

106.39

2.2

2.6

0.65

1.24

g/l

1.64

255

634

Injuries to the abdomen, lower back, lumbar spine and pelvis

1323

6889

1.95

106.11

2.6

2.3

0.80

0.85

g/l

0.20

1095

5864

Symptoms and signs involving the nervous and musculoskeletal systems

1779

10283

1.77

106.03

2.3

2.5

0.57

0.86

g/l

4.12

1560

8789

Hypercalcemia

279

685

4.66

106.02

4.4

2.6

1.34

1.29

g/l

0.04

230

582

Any event in cancer register

2333

8257

1.68

104.99

3.5

1.7

1.09

0.41

g/l

11.62

2038

7174

460

1544

3.12

104.90

2.4

0.50

0.86

g/l

1.43

410

1328

Certain disorders involving the immune mechanism

676

2774

2.56

104.84

2.9

2.3

0.63

0.82

g/l

0.76

599

2399

Haemolytic anaemias

214

427

5.74

104.50

3.3

2.4

0.92

1.18

g/l

0.31

193

368

Arthropathies

2147

6374

1.73

104.49

2.2

2.5

0.63

0.87

g/l

2.23

1871

5525

Gastro-oesophageal reflux disease

1970

9837

1.72

104.41

2.2

2.6

0.68

0.85

g/l

1.40

1656

8483

Hypertensive Renal Disease

230

489

5.30

103.96

2.1

2.9

0.47

1.52

g/l

3.72

211

405

Thrombocytopenia, unspecified

357

1049

3.72

103.38

2.2

2.5

0.86

1.12

g/l

0.46

302

904

Hypothyroidism, drug reimbursement

282

439

4.61

102.89

2.4

1.3

0.45

0.12

g/l

2.18

256

390

Chronic periodontitis, including avohilmo

2806

11472

1.59

102.79

2.5

0.76

0.79

g/l

0.15

2400

9911

Abnormal findings on diagnostic imaging of lung

1660

8994

1.80

102.55

2.6

1.00

0.88

g/l

0.48

1435

7625

Benign neoplasm: Colon

1838

10152

1.75

102.31

2.5

2.6

0.81

0.93

g/l

0.71

1585

8643

Myalgia

722

3082

2.42

101.57

2.3

0.60

0.88

g/l

1.79

632

2616

STROKE

1565

5825

1.85

100.91

2.7

0.62

0.97

g/l

3.82

1356

4987

Periodontitis

2798

11470

1.58

100.78

2.5

0.76

0.79

g/l

0.15

2395

9907

Heart failure and coronary heart disease

1568

6126

1.85

100.41

2.2

2.7

0.80

1.00

g/l

1.08

1349

5142

Antihypertensive medication - note that there are other indications

1082

2684

2.14

99.87

2.1

2.4

0.57

0.75

g/l

0.87

972

2379

Disorders of lens

1971

7243

1.72

98.59

2.5

0.79

0.81

g/l

0.08

1693

6336

Sicca syndrome [Sjögren]

375

1170

3.46

98.39

1.9

2.6

0.42

0.96

g/l

3.26

330

1001

Diabetes, varying definitions

2632

9702

1.60

97.48

2.1

2.6

0.58

0.84

g/l

3.84

2275

8379

Chronic lower respiratory diseases

3133

10860

1.54

97.42

2.2

2.5

0.67

0.81

g/l

1.24

2755

9331

3084

10240

1.55

97.35

3.3

2.2

0.90

0.78

g/l

0.79

2645

8808

Dorsopathies

2555

8123

1.61

96.63

2.5

2.3

0.73

0.76

g/l

0.17

2241

6976

Azathioprine

449

1557

3.01

96.57

1.9

2.4

0.34

0.78

g/l

3.68

397

1351

Diabetes mellitus

2637

9707

1.59

96.51

2.1

2.6

0.58

0.84

g/l

3.80

2279

8385

Disorders of eyelid, lacrimal system and orbit

2481

11559

1.60

96.49

2.5

0.69

0.84

g/l

1.30

2138

9940

Other diseases of blood and blood-forming organs

332

975

3.72

96.24

4.4

2.5

1.72

1.07

g/l

1.57

289

847

Injuries to the head

2972

11579

1.54

95.84

2.5

0.66

0.82

g/l

1.79

2545

10024

Lymphoid leukaemia

303

847

3.98

95.32

3.1

2.7

0.97

1.28

g/l

0.60

273

722

Hypertensive Heart Disease

833

2885

2.27

95.03

2.1

2.7

0.58

1.05

g/l

3.92

726

2385

Need for other prophylactic measures

281

744

4.14

94.98

2.6

2.5

0.63

1.12

g/l

1.50

272

638

Injuries to the hip and thigh

1598

8260

1.78

94.84

2.3

2.5

0.72

0.94

g/l

1.92

1293

7066

1238

6582

1.91

94.64

2.5

2.4

0.68

0.77

g/l

0.33

1085

5653

Venous thromboembolism

1739

9921

1.73

94.63

2.9

2.5

1.06

0.88

g/l

0.83

1495

8444

Other disorders involving the immune mechanism, not elsewhere classified

185

354

5.95

94.53

2.5

2.6

0.36

1.13

g/l

2.29

169

320

Other disorders of kidney and ureter

547

2144

2.71

94.33

2.7

2.4

0.70

0.92

g/l

0.84

505

1835

COPD (mode)

982

3746

2.11

94.22

2.0

2.1

0.75

0.80

g/l

0.15

853

3177

Other special examinations and investigations of persons without complaint or reported diagnosis

1554

4335

1.84

94.22

2.3

2.4

0.83

0.80

g/l

0.14

1365

3679

Other joint disorders

2040

6373

1.69

93.23

2.2

2.5

0.64

0.87

g/l

2.08

1781

5524

Intracranial trauma

1338

4866

1.89

93.17

2.5

0.70

0.93

g/l

1.19

1140

4222

Type 2 diabetes

2588

9592

1.58

93.11

2.1

2.6

0.58

0.85

g/l

4.21

2233

8274

Neurological diseases

1986

5921

1.71

92.96

2.3

2.5

0.66

0.93

g/l

2.38

1733

5131

Other medical care

1537

7374

1.79

92.84

3.6

2.3

1.39

0.85

g/l

3.70

1309

6242

Gastrointestinal diseases

1258

3254

1.97

92.18

2.4

2.1

0.87

0.63

g/l

1.16

1108

2822

Other external causes of accidental injury

1978

5929

1.70

90.13

2.3

2.5

0.68

0.92

g/l

2.35

1692

5216

Abnormal weight loss

424

1496

3.05

90.00

2.0

2.4

0.35

0.94

g/l

4.59

364

1277

Persons encountering health services for examination and investigation

1548

4335

1.82

89.60

2.3

2.4

0.83

0.80

g/l

0.11

1356

3679

Weight loss

443

1604

2.95

89.42

2.2

2.4

0.36

0.92

g/l

4.45

382

1368

Other arthrosis

1489

5639

1.81

89.25

2.3

2.6

0.64

0.89

g/l

1.88

1309

4855

Bacterial pneumoniae

1258

6031

1.88

89.22

3.7

2.1

1.17

0.84

g/l

1.83

1133

5132

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1813

10812

1.68

89.11

2.4

2.5

0.71

0.85

g/l

0.79

1586

9244

Isolated proteinuria

172

328

6.02

88.44

3.0

2.8

0.65

1.43

g/l

1.39

160

290

Mood disorders, excluding more controls

2482

9374

1.58

88.19

2.3

2.6

0.66

0.80

g/l

1.17

2148

8135

Sulfasalazine

790

3713

2.19

88.04

2.0

2.5

0.53

0.81

g/l

1.88

692

3175

Hernia of abdominal wall, postoperative

529

2077

2.61

87.75

2.4

2.2

0.91

0.87

g/l

0.05

468

1822

Viral hepatitis, IBD co-morbidity

137

205

6.98

87.72

2.0

2.2

0.55

1.12

g/l

0.72

121

181

Vocal cord dysfunction

348

947

3.34

87.70

2.6

0.90

1.01

g/l

0.14

298

834

Other functional intestinal disorders

1318

6673

1.83

87.63

2.8

2.5

1.03

0.93

g/l

0.34

1120

5660

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2657

11018

1.55

87.47

2.5

0.86

0.79

g/l

0.41

2294

9492

Other and unspecified disorders of white blood cells

224

539

4.67

86.91

2.1

2.8

0.66

1.18

g/l

1.10

199

471

Depression or dysthymia

1827

5961

1.70

85.87

2.4

2.6

0.70

0.86

g/l

1.11

1553

5209

Cystitis

2234

8394

1.61

85.70

2.4

2.5

0.73

0.89

g/l

1.23

1916

7206

Other intervertebral disc disorders

2133

7946

1.62

85.64

2.4

2.3

0.78

g/l

0.01

1867

6808

Dialysis

194

420

5.12

85.48

2.8

2.1

0.55

1.10

g/l

1.26

180

373

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1809

8652

1.68

85.47

2.3

2.7

0.68

0.98

g/l

2.36

1560

7356

Bacterial pneumonia, not elsewhere classified

1196

5724

1.88

85.40

3.7

2.1

1.15

0.85

g/l

1.52

1090

4865

Cough

1152

5807

1.89

85.16

2.7

2.4

0.65

0.78

g/l

0.68

1005

4990

Other autoimmune haemolytic anaemias

118

163

9.39

85.09

2.8

2.5

1.37

0.66

g/l

0.73

107

141

Disorders of choroid and retina

2388

10835

1.57

85.05

2.5

0.89

0.84

g/l

0.27

2012

9318

SLE (Finngen)

175

349

5.57

84.85

1.8

2.5

0.32

1.34

g/l

2.78

159

307

Cerebrovascular diseases

2252

10004

1.59

84.61

2.5

2.6

0.67

0.91

g/l

2.66

1928

8558

Coxarthrosis [arthrosis of hip](FG)

1543

6172

1.76

84.42

2.3

2.8

0.65

1.02

g/l

4.65

1316

5286

Seronegative rheumatoid arthritis

396

1389

3.00

83.95

2.3

2.8

0.63

1.09

g/l

1.62

349

1186

DVT of lower extremities and pulmonary embolism

1374

7871

1.79

83.93

3.0

2.4

1.13

0.91

g/l

0.89

1171

6658

Benzodiazepine use

2690

12082

1.52

83.75

2.3

2.5

0.66

0.82

g/l

1.49

2268

10474

Hernia

2493

10859

1.55

83.15

2.6

2.4

0.93

0.75

g/l

1.33

2163

9326

Hyperparathyroidism

690

3128

2.28

82.95

2.6

2.3

0.72

0.95

g/l

0.91

595

2621

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2407

12270

1.55

82.88

2.9

2.4

0.99

0.72

g/l

2.45

2073

10606

Nerve, nerve root and plexus disorders

2870

11600

1.51

82.85

2.3

2.5

0.66

0.82

g/l

1.66

2498

9965

Accidents

1943

5929

1.66

82.81

2.2

2.5

0.67

0.92

g/l

2.48

1658

5216

Unspecified haematuria

1367

6357

1.80

82.75

2.4

2.6

0.92

0.98

g/l

0.18

1190

5413

Falls/tendency to fall

2573

8401

1.55

82.71

2.3

2.5

0.65

0.87

g/l

2.39

2199

7395

Infections of the skin and subcutaneous tissue

1581

9306

1.70

82.62

2.7

2.4

0.77

0.76

g/l

0.04

1396

8057

Non-Hodgkin lymphoma, all

241

635

4.21

82.44

3.7

1.5

2.27

0.49

g/l

4.71

210

533

Senile cataract

1836

6811

1.67

82.13

2.6

2.5

0.84

g/l

0.02

1565

5941

Other disorders of veins

1249

6917

1.82

81.93

2.3

2.5

0.60

0.79

g/l

1.18

1083

5907

Other cataract

1383

5889

1.79

81.33

2.7

2.5

0.96

0.89

g/l

0.24

1186

5129

Bronchitis

2889

11734

1.50

80.79

3.4

2.2

0.80

0.79

g/l

0.09

2501

10103

Persons encountering health services for specific procedures, not carried out

315

993

3.35

80.50

2.2

0.53

0.84

g/l

0.96

293

859

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

165

329

5.67

80.48

2.2

2.7

0.16

1.19

g/l

3.55

153

297

Peripheral artery disease

1489

6947

1.74

79.88

2.2

2.6

0.62

1.06

g/l

5.19

1295

5843

Chronic rhinitis, nasopharyngitis and pharyngitis

922

4768

1.98

79.02

2.2

2.4

0.63

0.77

g/l

0.63

812

4103

All influenza

783

3829

2.11

78.79

5.3

2.1

1.39

0.83

g/l

2.46

669

3277

Vasculitis limited to skin, not elsewhere classified

164

333

5.66

78.75

2.6

2.7

0.52

1.36

g/l

1.97

149

293

Explicit bacterial Sepsis, including avohilmo

416

1555

2.82

78.42

4.7

2.3

1.94

0.79

g/l

2.82

354

1324

Paroxysmal tachycardia

521

1758

2.53

78.29

2.1

2.3

0.49

0.92

g/l

2.16

449

1515

Other arrhythmias

1591

7133

1.69

78.18

2.4

2.5

0.59

0.80

g/l

2.07

1363

6177

Fracture of rib(s), sternum and thoracic spine

1039

5624

1.91

78.13

2.8

2.4

0.83

0.85

g/l

0.09

875

4814

Benign neoplasms

2392

8505

1.55

77.58

2.4

0.84

0.77

g/l

0.35

2070

7388

Gonarthrosis [arthrosis of knee](FG)

1900

6797

1.63

77.41

2.2

2.7

0.71

0.94

g/l

2.13

1643

5847

Streptococcal septicaemia, including avohilmo

368

1301

3.00

77.41

4.6

2.2

2.02

0.90

g/l

2.28

311

1095

Sciatica+with lumbago

1385

7176

1.74

77.35

2.2

2.3

0.59

0.75

g/l

1.16

1212

6151

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2658

11488

1.50

77.11

2.8

2.3

0.69

0.80

g/l

0.82

2322

9862

Polyuria

790

3927

2.09

76.77

2.1

2.6

0.66

0.91

g/l

1.22

689

3353

Diseases of the respiratory system

1570

4621

1.73

76.73

2.6

2.1

0.83

0.72

g/l

0.45

1361

3985

Hyperkalaemia

275

830

3.58

76.25

2.7

2.4

0.70

1.27

g/l

1.33

239

691

Other diseases of pleura

1498

7833

1.71

76.07

2.5

0.81

0.98

g/l

0.90

1284

6635

Injuries to the thorax

1417

8435

1.72

76.05

2.6

2.4

0.76

0.88

g/l

0.71

1195

7227

Care involving use of rehabilitation procedures

1672

9291

1.65

75.86

2.6

2.3

0.79

0.75

g/l

0.20

1528

7942

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2416

9481

1.53

75.58

2.1

2.6

0.63

0.86

g/l

2.62

2080

8176

Urinary track infection

1287

3597

1.82

74.84

2.2

2.3

0.50

0.62

g/l

0.72

1128

3087

Seropositive rheumatoid arthritis, wide

861

4460

2.00

74.23

2.0

2.4

0.69

0.87

g/l

0.91

763

3780

Unspecified privation

397

1493

2.81

74.13

2.0

2.4

0.38

1.03

g/l

4.17

367

1283

IgA nephropathy (IgA glomerulonephritis)

141

264

6.12

74.00

2.0

2.8

0.14

1.14

g/l

2.90

131

236

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

840

4326

2.01

73.69

2.0

2.4

0.69

0.87

g/l

0.84

744

3669

Explicit bacterial Sepsis

400

1520

2.77

73.02

4.8

2.3

2.00

0.81

g/l

2.87

340

1295

Other/unspecified seropositive rheumatoid arthritis

851

4419

1.99

72.85

2.0

2.4

0.70

0.87

g/l

0.83

753

3743

Diseases of the eye and adnexa

1668

5061

1.67

72.59

2.3

2.2

0.81

0.67

g/l

0.69

1471

4447

Streptococcal septicaemia

354

1270

2.96

72.48

4.7

2.3

2.09

0.92

g/l

2.31

299

1064

Idiopathic gout

403

1552

2.77

72.41

2.2

2.5

0.32

1.09

g/l

7.40

353

1324

Secondary and unspecified malignant neoplasm of lymph nodes

339

1192

3.03

72.20

1.8

1.5

0.51

0.37

g/l

0.50

295

1023

Arthrosis

1768

6004

1.64

72.16

2.2

2.6

0.69

0.92

g/l

1.77

1538

5174

Pulmonary heart disease, diseases of pulmonary circulation

1070

5990

1.84

72.14

2.7

2.4

0.90

0.91

g/l

0.02

922

5070

Other nutritional deficiencies

1709

9827

1.61

71.96

2.0

2.5

0.47

0.74

g/l

3.28

1501

8541

Viral pneumonia

450

1822

2.58

71.91

4.2

2.0

1.28

0.89

g/l

1.00

384

1555

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1661

10413

1.62

71.87

2.3

2.5

0.73

0.85

g/l

0.60

1451

8904

Hypo-osmolality and hyponatraemia

608

2781

2.26

71.86

2.7

2.2

0.91

1.01

g/l

0.18

495

2309

Pruritus

405

1569

2.71

71.01

2.2

2.3

0.58

0.90

g/l

1.13

359

1345

Type 2 diabetes, definitions combined

2427

9471

1.51

70.88

2.2

2.6

0.61

0.87

g/l

3.42

2080

8161

Other symptoms and signs involving cognitive functions and awareness

1470

7949

1.68

70.75

2.3

2.6

0.86

0.98

g/l

0.60

1244

6737

Other diseases of intestine

544

2415

2.35

70.71

2.5

2.4

0.64

0.84

g/l

0.80

498

2063

Sleep disorders (combined)

2833

10195

1.47

70.67

2.2

2.5

0.75

0.84

g/l

0.67

2431

8789

Systemic lupus erythematosus

175

407

4.76

70.64

1.8

2.5

0.32

1.23

g/l

2.69

159

350

Other and unspecified vasculitis limited to skin

146

295

5.68

70.53

2.7

2.6

0.57

1.18

g/l

1.11

132

256

Type 2 diabetes, strict (exclude DM1)

2439

9542

1.51

70.38

2.2

2.6

0.60

0.86

g/l

3.47

2091

8221

Fracture of femur

963

4719

1.90

70.26

2.4

0.85

1.05

g/l

0.90

738

3975

Gingivitis and periodontal diseases

2574

8996

1.50

70.19

2.4

0.81

0.83

g/l

0.11

2198

7722

Bacterial pneumonia (organism specified)

1351

7322

1.71

70.12

3.9

2.3

1.25

0.88

g/l

2.17

1207

6161

Other disorders of lacrimal gland

1082

6120

1.81

70.11

2.9

2.5

0.65

0.83

g/l

1.04

927

5231

Obesity related asthma

996

5497

1.86

70.02

2.2

2.5

0.63

0.80

g/l

0.61

858

4745

Diffuse large B-cell lymphoma

237

690

3.77

69.97

1.7

1.5

0.72

0.42

g/l

0.75

200

589

Diffuse large B-cell lymphoma, including Hilmo

237

690

3.77

69.97

1.7

1.5

0.72

0.42

g/l

0.75

200

589

Diffuse large B-cell lymphoma, helper endpoint

237

690

3.77

69.97

1.7

1.5

0.72

0.42

g/l

0.75

200

589

Diseases of the digestive system

1398

8422

1.68

69.79

2.4

2.5

0.85

0.94

g/l

0.40

1207

7147

Fibromyalgia

283

919

3.22

68.59

2.3

2.1

0.47

0.89

g/l

1.42

253

793

Other diseases of hard tissues of teeth

1568

4937

1.67

68.47

2.3

0.74

0.85

g/l

0.53

1337

4230

Other acute lower respiratory infections

1471

8630

1.65

68.39

3.4

2.3

0.82

0.87

g/l

0.22

1286

7374

Insulin medication

1677

8810

1.61

68.20

2.2

2.6

0.53

0.92

g/l

5.37

1450

7521

Acute myeloid leukaemia and myelodysplastic syndromes

146

304

5.48

68.03

1.9

1.4

0.92

0.41

g/l

0.77

130

263

Diseases of oral cavity, salivary glands and jaws

1585

4984

1.67

67.99

2.4

2.3

0.93

0.86

g/l

0.23

1349

4268

Other abnormal findings of blood chemistry

213

587

3.94

67.92

3.8

2.5

1.45

1.12

g/l

0.56

200

516

Myelodysplastic syndrome

105

162

7.92

67.88

2.1

1.3

1.26

0.24

g/l

1.39

138

Concussion

1104

4837

1.80

67.75

2.4

2.5

0.65

0.93

g/l

1.47

932

4195

Giant cell arteritis

227

661

3.82

67.47

1.9

2.8

0.29

1.46

g/l

5.50

195

554

Marginal zone B-cell lymphoma, including Hilmo

116

200

6.93

67.05

2.8

1.3

1.75

0.45

g/l

2.40

100

168

Asthma, including avohilmo

2984

11568

1.44

66.97

2.2

2.5

0.74

0.80

g/l

0.40

2607

9942

Hard cardiovascular diseases

2176

8543

1.53

66.93

2.4

2.6

0.67

0.85

g/l

1.75

1899

7359

Polyarthrosis

656

2863

2.13

66.74

2.5

2.7

0.75

1.01

g/l

1.16

550

2432

Undetermined asthma, excluding more controls

375

1438

2.70

66.49

2.3

1.8

0.79

0.83

g/l

0.06

329

1230

Mood [affective] disorders

2573

11366

1.47

66.48

2.2

2.5

0.63

0.77

g/l

1.28

2234

9802

Mood disorders

2578

11376

1.47

66.35

2.2

2.5

0.63

0.77

g/l

1.31

2239

9811

Any mental disorder

2757

9566

1.46

66.23

2.2

2.6

0.75

0.81

g/l

0.32

2359

8298

Statin medication

1437

4870

1.68

65.91

2.2

2.7

0.59

0.98

g/l

3.24

1273

4153

Immunodeficiency with predominantly antibody defects

142

296

5.40

65.85

5.0

2.3

0.79

0.74

g/l

0.05

127

272

Hypotension

679

3390

2.09

65.59

2.7

2.4

0.80

1.00

g/l

0.55

555

2836

Other CVD

751

3889

2.01

65.19

2.7

2.4

0.86

1.01

g/l

0.39

619

3259

Atherosclerosis, excluding cerebral and coronary sclerosis

1375

6597

1.68

65.04

2.2

2.6

0.59

1.06

g/l

5.87

1200

5545

Asthma, hospital admissions , main diagnosis only

2080

12147

1.51

64.84

2.3

2.5

0.71

0.80

g/l

0.49

1815

10448

Abnormal findings on examination of urine, without diagnosis

207

579

3.91

64.83

3.4

2.6

0.66

1.19

g/l

1.20

190

507

Other gastritis (incl. Duodenitis)

720

3675

2.03

64.81

2.4

2.5

0.74

0.93

g/l

0.66

621

3137

Pulmonary embolism

963

5425

1.83

63.65

2.8

2.4

0.90

0.88

g/l

0.04

827

4605

Other bacterial intestinal infections, including avohilmo

726

3738

2.00

63.54

3.5

2.2

0.98

0.85

g/l

0.42

629

3181

Factors influencing health status and contact with health services

665

1561

2.17

63.53

2.5

2.1

1.26

0.83

g/l

1.22

585

1338

Other diseases of liver

575

2725

2.19

63.45

2.1

2.4

0.39

0.83

g/l

4.21

499

2362

Pulmonary heart disease

963

5436

1.82

63.22

2.8

2.4

0.90

0.89

g/l

0.04

827

4614

Solid cancers, including Hilmo

1997

7674

1.54

63.20

2.4

1.5

0.69

0.30

g/l

7.12

1735

6664

Implicit fungal Sepsis, including avohilmo

294

1030

3.05

63.18

2.9

2.3

0.76

0.82

g/l

0.13

245

880

Retention of urine

1108

5212

1.76

63.07

2.3

2.6

0.80

1.03

g/l

1.38

940

4424

Postmenopausal osteoporosis with pathological fracture

309

1120

2.99

63.01

2.1

2.3

1.16

0.86

g/l

0.31

224

949

Type 2 diabetes, definitions combined, including avohilmo

2382

9424

1.48

62.94

2.1

2.6

0.60

0.87

g/l

3.50

2044

8122

Other retinal disorders

1904

9573

1.54

62.86

2.5

0.93

0.89

g/l

0.17

1593

8192

Mycoses, including avohilmo

2349

12324

1.47

62.85

2.3

2.5

0.63

0.79

g/l

1.49

2041

10643

Other specified/unspecified systemic involvement of connective tissue

231

706

3.52

62.75

1.9

2.8

0.59

0.97

g/l

0.75

215

604

Diabetes, insulin treatment (Kela reimbursement)

2602

10805

1.45

62.45

2.1

2.6

0.61

0.84

g/l

2.79

2248

9291

Cardiomyopathy in other diseases

13.66

62.33

7.9

2.1

0.66

0.98

g/l

0.26

Persons with potential health hazards related to communicable diseases

768

4000

1.94

62.27

2.5

2.1

0.61

0.64

g/l

0.09

684

3542

Acute bronchitis

1166

6823

1.71

61.98

3.4

2.3

0.78

0.91

g/l

0.60

1017

5784

Chronic periodontitis, complicated

1626

10254

1.58

61.95

2.6

0.70

0.81

g/l

0.53

1418

8837

Obesity, other/unspecified

841

4574

1.88

61.76

1.7

2.4

0.39

0.71

g/l

3.84

763

3983

Disorders of gallbladder, biliary tract and pancreas

2607

11368

1.44

61.75

2.4

2.5

0.78

0.82

g/l

0.19

2220

9802

Shoulder lesions

1919

7572

1.54

61.68

2.4

2.5

0.67

0.91

g/l

2.07

1674

6444

Coxarthrosis

1377

5443

1.66

61.40

2.3

2.7

0.64

1.00

g/l

3.99

1175

4666

Irritable bowel syndrome

712

3680

1.98

61.22

2.5

2.3

0.51

0.75

g/l

1.70

617

3145

SLE, strict definition

163

402

4.48

61.05

1.8

2.2

0.34

0.94

g/l

1.56

149

353

SLE, ICD10

163

402

4.48

61.05

1.8

2.2

0.34

0.94

g/l

1.56

149

353

Malignant neoplasm of skin, including Hilmo

1465

6129

1.63

60.96

2.7

1.5

0.92

0.34

g/l

7.89

1249

5262

Disorders of lacrimal system

1244

7467

1.67

60.74

2.8

2.5

0.68

0.84

g/l

1.02

1063

6373

Asthma/COPD (KELA code 203)

2352

10858

1.46

60.71

2.2

2.5

0.71

0.81

g/l

0.54

2033

9330

Anxiety disorders, excluding more controls

1992

8497

1.52

60.61

2.4

2.5

0.57

0.73

g/l

1.47

1735

7400

Obesity

1567

9490

1.58

60.51

2.0

2.5

0.47

0.73

g/l

2.67

1384

8240

Immunodeficiencies

197

557

3.83

60.47

4.6

2.5

0.81

1.05

g/l

0.37

173

491

Symptoms and signs involving the digestive system and abdomen

2465

8527

1.46

60.38

2.3

2.5

0.71

0.84

g/l

1.05

2141

7315

Exposure to other specified factors

2006

11648

1.50

60.22

2.2

2.5

0.60

0.75

g/l

1.30

1736

10105

Obesity and other hyperalimentation

1574

9542

1.57

60.11

2.0

2.5

0.47

0.73

g/l

2.75

1388

8284

Zoster [herpes zoster], including avohilmo

1527

9476

1.59

59.78

2.9

2.4

1.11

0.82

g/l

1.74

1287

8079

Viral infections characterized by skin and mucous membrane lesions

1130

6761

1.70

59.44

3.6

2.3

1.21

0.78

g/l

2.44

976

5824

Selective serotonin reuptake inhibitors

2464

8890

1.46

59.18

2.3

2.6

0.68

0.86

g/l

1.81

2130

7694

Depression

2330

10801

1.46

59.06

2.3

2.5

0.62

0.74

g/l

0.97

2021

9338

External causes of morbidity and mortality

1491

4642

1.63

59.02

2.3

2.4

0.74

0.89

g/l

0.72

1279

4077

Urticaria and erythema

905

5103

1.81

59.00

2.4

2.3

0.64

0.75

g/l

0.44

791

4410

Sleep apnoea

2473

10917

1.45

58.98

2.3

2.5

0.68

0.81

g/l

0.87

2131

9457

Soft tissue disorders related to use, overuse and pressure

797

4333

1.89

58.96

2.5

0.62

0.97

g/l

2.61

713

3680

ILD, hospital admission 2, with pulmonary infections

375

1538

2.57

58.79

2.7

2.0

0.60

0.92

g/l

1.13

331

1309

Episodal and paroxysmal disorders

2605

9266

1.44

58.78

2.2

2.5

0.65

0.85

g/l

2.22

2251

8008

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1373

5755

1.64

58.66

2.8

1.5

0.97

0.35

g/l

8.10

1166

4915

Temporal arteritis

196

571

3.82

58.31

1.9

2.9

0.24

1.58

g/l

5.65

169

474

Other bacterial intestinal infections

588

2904

2.10

58.17

3.6

2.2

1.04

0.87

g/l

0.48

505

2463

Conduction disorders

887

3966

1.84

58.04

2.4

2.5

0.72

1.03

g/l

1.88

754

3350

Fibrosis and cirrhosis of liver

313

1187

2.81

58.02

1.7

2.6

0.66

1.15

g/l

1.46

277

1023

Dental caries, including avohilmo

1956

6671

1.52

57.74

2.3

2.5

0.82

0.90

g/l

0.36

1668

5726

Diseases of pulp and periapical tissues and dental caries

1778

5957

1.55

57.46

2.3

2.5

0.83

0.89

g/l

0.23

1514

5107

Cardiomyopathy, other and unspecified

288

1049

2.91

57.44

2.5

2.3

0.45

1.11

g/l

3.06

259

891

Abnormalities of heart beat

942

5244

1.78

57.43

2.3

2.4

0.81

0.83

g/l

0.05

800

4470

Unspecified fall

1423

8922

1.59

57.32

2.4

0.66

0.89

g/l

1.78

1160

7661

Malignant neoplasm of skin

1402

5962

1.62

57.14

2.8

1.5

0.92

0.35

g/l

7.71

1196

5104

Later onset COPD, excluding more controls

706

2806

1.98

57.05

1.8

2.1

0.85

0.89

g/l

0.09

600

2328

Biological medication for rheuma

446

1988

2.31

56.98

1.7

2.3

0.24

0.82

g/l

6.52

404

1760

Undetermined asthma

375

1558

2.49

56.30

2.3

1.8

0.79

0.75

g/l

0.04

329

1336

Agranulocytosis

384

1625

2.48

56.13

4.7

2.4

1.72

0.94

g/l

1.66

340

1399

Dysphagia

796

4400

1.86

56.04

2.6

0.69

0.95

g/l

1.36

680

3748

Diabetes medication

2553

10570

1.43

55.96

2.0

2.6

0.60

0.83

g/l

3.06

2205

9093

Gonarthrosis

1591

5807

1.57

55.18

2.1

2.6

0.67

0.95

g/l

2.52

1385

4993

Diseases of pulp and periapical tissues, including avohilmo

2596

9529

1.42

55.17

2.3

2.4

0.73

0.83

g/l

0.71

2196

8232

Non-allergic asthma (mode), excluding more controls

464

2107

2.24

55.14

2.1

1.9

0.75

0.81

g/l

0.11

404

1798

Other and unspecified coagulation defects

191

561

3.64

55.13

2.6

2.7

0.43

1.27

g/l

3.09

180

492

Visual disturbances and blindness

1444

9340

1.57

55.06

2.4

2.5

0.75

0.84

g/l

0.39

1253

7959

Symptoms and signs involving speech and voice

972

5719

1.74

55.02

2.6

2.4

0.52

0.86

g/l

3.65

844

4881

Abdominal and pelvic pain

2424

8527

1.44

54.98

2.4

2.5

0.69

0.84

g/l

1.35

2106

7315

Systemic lupus erythematosus, unspecified

142

342

4.59

54.95

1.9

2.2

0.24

0.81

g/l

1.71

131

301

Solid cancers

1923

7602

1.50

54.91

2.3

1.5

0.66

0.30

g/l

5.95

1662

6594

Basal cell carcinoma, including Hilmo

1327

5634

1.63

54.68

2.8

1.5

0.97

0.36

g/l

8.14

1125

4812

Nausea and vomiting

774

4161

1.86

54.42

3.1

2.5

0.77

0.90

g/l

0.42

673

3518

Lumbar disc prolapse

1568

7601

1.55

53.99

2.4

2.3

0.76

0.75

g/l

0.02

1396

6541

Chronic nephritic syndrome

172

482

3.89

53.77

2.8

2.6

0.32

1.23

g/l

3.11

157

425

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

506

2441

2.16

53.76

1.5

2.5

0.47

0.93

g/l

3.02

435

2105

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1259

7590

1.61

53.55

2.2

2.3

0.68

0.66

g/l

0.04

1093

6565

Conjunctivitis

1788

9736

1.50

53.19

2.4

0.75

0.71

g/l

0.16

1552

8431

Other dialysis

151

391

4.29

53.17

2.8

0.62

1.22

g/l

1.14

141

350

Presence of cardiac and vascular implants and grafts

1386

6537

1.59

52.94

1.9

2.5

0.70

0.97

g/l

2.13

1172

5615

Early onset COPD, excluding more controls

539

2663

2.08

52.81

2.2

2.0

0.51

0.79

g/l

1.17

480

2294

Other inflammation of eyelid, including avohilmo

1046

6329

1.68

52.69

2.7

2.4

0.73

0.72

g/l

0.03

919

5503

COPD

1373

7173

1.59

52.58

2.0

2.6

0.79

0.97

g/l

0.75

1183

6068

Cutaneous abscess, furuncle and carbuncle

697

3769

1.89

52.44

2.3

0.61

0.79

g/l

0.83

625

3267

Other coagulation defects

256

919

2.94

52.37

2.6

0.51

1.13

g/l

2.89

236

792

Other diseases of pericardium

189

572

3.56

52.28

1.9

2.6

0.49

1.31

g/l

1.70

162

478

Osteonecrosis

249

886

3.00

52.19

7.4

2.2

1.40

1.06

g/l

0.52

222

778

Giant cell arteritis with polymyalgia rheumatica

196

614

3.55

52.11

1.9

2.7

0.24

1.47

g/l

5.45

169

518

Anxiety (asthma-related co-morbidities)

1288

6181

1.60

52.03

2.1

2.4

0.42

0.70

g/l

3.40

1145

5438

Noninfective enteritis and colitis

1161

7228

1.63

52.02

2.4

0.76

0.79

g/l

0.10

1004

6234

Visual disturbances

1330

8571

1.58

51.90

2.4

0.77

0.82

g/l

0.21

1169

7338

Allergic conjunctivitis

1301

8002

1.59

51.81

2.1

2.4

0.67

g/l

0.00

1129

6924

Insulin, intermediate and long-acting

1515

9683

1.54

51.73

2.1

2.5

0.49

0.91

g/l

6.09

1318

8284

Ischemic heart diseases

2138

8880

1.45

51.69

2.5

2.6

0.74

0.85

g/l

0.73

1868

7620

Caries of dentine, including avohilmo

2046

7192

1.47

51.65

2.2

2.6

0.85

0.89

g/l

0.19

1744

6186

Insulin, combination of fast acting with intermediate-acting or long-acting

1678

10278

1.50

51.60

2.2

2.5

0.53

0.91

g/l

5.34

1451

8789

Other headache syndromes

1016

6123

1.68

51.34

2.1

2.6

0.55

0.79

g/l

1.78

885

5294

Other anxiety disorders

963

4847

1.71

51.32

2.0

2.3

0.39

0.66

g/l

2.47

860

4254

Open wound of head

1483

9188

1.54

51.32

2.4

2.5

0.64

0.92

g/l

3.00

1250

7897

Other (seronegative) rheumatoid arthritis, wide

594

3081

2.00

51.30

2.2

2.4

0.67

0.88

g/l

0.79

520

2616

Other respiratory diseases principally affecting the interstitium

630

3338

1.96

51.26

2.6

2.3

0.64

0.99

g/l

1.90

554

2821

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1301

5598

1.61

51.25

2.8

1.5

0.94

0.36

g/l

7.76

1105

4780

Overexertion and strenuous or repetitive movements

316

1277

2.59

50.96

2.6

2.5

0.51

1.05

g/l

2.43

275

1117

Volume depletion

333

1384

2.51

50.54

2.3

0.93

1.17

g/l

0.32

276

1153

Other reaction to severe stress, and adjustment disorders

757

4234

1.82

50.44

2.6

2.2

0.56

0.66

g/l

0.36

673

3728

General examination and investigation of persons without complaint and reported diagnosis

1325

4328

1.61

50.29

2.3

2.4

0.79

0.80

g/l

0.01

1133

3674

Methotrexate

392

1749

2.32

50.26

2.0

2.5

0.72

0.87

g/l

0.39

349

1493

Primary hyperparathyroidism

407

1860

2.30

49.97

2.8

2.4

0.67

0.95

g/l

0.83

349

1583

Special screening examination for infectious and parasitic diseases

443

1473

2.23

49.72

2.4

2.3

0.49

0.61

g/l

0.32

397

1307

GI-bleeding

995

6057

1.68

49.57

2.3

2.5

0.93

0.96

g/l

0.10

857

5116

Disorders of conjunctiva

2003

10863

1.44

49.56

2.4

0.75

0.73

g/l

0.07

1737

9395

Other and unspecified immunodeficiencies with predominantly antibody defects

122

7.48

49.38

5.2

2.7

0.27

0.73

g/l

0.84

112

Psychiatric diseases

2383

8503

1.42

49.36

2.4

2.6

0.80

0.82

g/l

0.08

2037

7402

Bacterial intestinal infections, IBD co-morbidities

584

3050

1.98

49.35

3.7

2.2

1.03

0.83

g/l

0.61

502

2599

Prurigo nodularis

130

319

4.55

49.32

1.8

3.2

0.45

1.28

g/l

1.78

115

281

Other diseases of the digestive system

993

6052

1.68

49.28

2.3

2.5

0.89

0.96

g/l

0.24

853

5121

Sleep apnoea, including avohilmo

2513

11004

1.40

49.14

2.2

2.5

0.70

0.81

g/l

0.76

2158

9547

Other noninfective gastroenteritis and colitis

679

3719

1.87

49.02

2.7

2.3

0.73

0.83

g/l

0.31

588

3184

Other diseases of anus and rectum

849

4958

1.74

48.58

2.4

0.72

0.95

g/l

1.19

702

4177

Hypokalaemia

386

1739

2.31

48.58

2.6

2.2

0.57

1.01

g/l

2.28

332

1470

Cardiomyopathies, Primary/intrinsic

387

1748

2.30

48.46

2.0

2.4

0.40

0.99

g/l

3.98

345

1488

Substance abuse, excluding more controls

1352

7367

1.55

48.39

1.8

2.6

0.47

0.83

g/l

3.90

1148

6449

Endocarditis

152

422

3.89

48.03

2.2

2.6

0.80

1.67

g/l

1.25

138

359

All anxiety disorders

1300

6522

1.56

47.59

2.1

2.4

0.42

0.68

g/l

3.13

1157

5716

Other and unspecified types of non-Hodgkin lymphoma, hilmo

192

625

3.35

47.57

3.2

2.7

1.49

1.45

g/l

0.03

159

532

Zoster [herpes zoster]

605

3241

1.93

47.43

3.8

2.3

1.47

0.85

g/l

2.15

505

2751

Missing teeth due to accident, extraction or parodontitis

1751

10835

1.47

47.32

2.4

2.6

0.78

0.84

g/l

0.25

1440

9363

Subjective visual disturbances

718

4050

1.82

47.27

2.4

0.62

0.78

g/l

0.64

644

3467

Cardiomyopathy (excluding other)

396

1824

2.26

47.25

2.0

2.4

0.43

0.97

g/l

3.46

354

1552

Arthropathies in other diseases classified elsewhere

145

394

3.97

47.23

2.5

2.6

0.75

1.43

g/l

0.93

131

333

Neurotic, stress-related and somatoform disorders

2053

9996

1.43

47.21

2.4

2.5

0.54

0.72

g/l

2.11

1794

8666

Percutaneous Coronary Intervention

2037

8724

1.44

47.09

2.3

2.6

0.76

0.86

g/l

0.67

1791

7480

Candidiasis, including avohilmo

789

4574

1.76

47.02

2.5

2.4

0.57

0.78

g/l

1.33

678

3910

Basal cell carcinoma

1256

5498

1.59

46.98

2.8

1.5

0.94

0.36

g/l

7.43

1071

4688

Amputation

378

1723

2.30

46.60

2.3

2.4

0.76

1.14

g/l

0.94

334

1443

Other neurological diseases

1988

10915

1.43

46.56

2.4

2.5

0.69

0.91

g/l

2.32

1684

9341

Cirrhosis of liver, NAS

233

855

2.93

46.39

1.7

2.7

0.69

1.30

g/l

1.62

211

741

Other/unspecified cytomegaloviral diseases

102

217

5.28

46.29

5.7

2.6

1.09

1.07

g/l

0.02

199

Anxiety disorders

2073

10104

1.42

46.28

2.4

2.5

0.55

0.73

g/l

1.91

1809

8755

ILD, hospital admissions

539

2810

2.00

46.26

2.6

2.4

0.63

1.02

g/l

2.00

475

2397

Urticaria

696

3909

1.82

46.14

2.4

2.3

0.58

0.75

g/l

0.68

606

3392

Rotator cuff syndrome

1572

7314

1.50

46.14

2.4

2.6

0.62

0.91

g/l

2.74

1363

6224

Voice disturbances

752

4339

1.78

45.83

2.8

2.4

0.54

0.85

g/l

2.44

659

3713

Secondary uncertain malignant neoplasm

422

2017

2.17

45.81

1.9

1.5

0.66

0.37

g/l

1.35

364

1731

ILD, hospital admissions 3, with pneumonia sepsis

322

1383

2.45

45.80

2.6

2.1

0.57

1.08

g/l

1.98

283

1178

Convulsions, not elsewhere classified

511

2571

2.00

45.70

1.8

2.3

0.59

0.88

g/l

1.51

454

2218

Other interstitial pulmonary diseases

543

2851

1.98

45.61

2.6

2.4

0.63

1.01

g/l

2.02

478

2428

Other diseases of arteries and capillaries

311

1317

2.47

45.48

2.5

0.69

1.01

g/l

0.92

275

1123

Interstitial lung disease endpoints

543

2857

1.98

45.32

2.6

2.4

0.63

1.01

g/l

2.02

478

2434

Interstitial lung disease

543

2857

1.98

45.32

2.6

2.4

0.63

1.01

g/l

2.02

478

2434

Obesity due to excess calories

1101

7019

1.59

44.93

2.0

2.5

0.49

0.75

g/l

1.87

968

6114

Atopic dermatitis

1227

6330

1.56

44.74

1.9

2.4

0.50

0.67

g/l

1.22

1078

5538

Emergency coronary revascularization (for ACS)

2240

9778

1.40

44.46

2.2

2.6

0.79

0.86

g/l

0.36

1959

8350

Isolated proteinuria with specified morphological lesion

130

6.89

44.24

4.7

2.8

0.32

1.06

g/l

1.19

116

Injuries to the shoulder and upper arm

2183

12214

1.39

44.17

2.7

2.4

0.70

0.82

g/l

0.93

1837

10550

Idiopathic thrombocytopenic purpura

133

358

4.05

44.15

2.6

0.98

1.24

g/l

0.33

116

316

Abnormal involuntary movements

419

2029

2.14

43.97

2.2

2.4

0.52

0.94

g/l

2.31

366

1745

Other chronic obstructive pulmonary disease

1291

6982

1.54

43.92

2.0

2.6

0.77

0.98

g/l

0.91

1115

5909

Nonalcoholic fatty liver disease

310

1330

2.43

43.88

2.1

2.5

0.35

1.02

g/l

4.30

275

1165

Coronary revascularization (ANGIO or CABG)

2018

8728

1.42

43.88

2.2

2.6

0.76

0.86

g/l

0.68

1772

7483

Other diseases of upper respiratory tract

2718

10527

1.36

43.81

2.4

2.5

0.82

g/l

0.00

2362

9024

Other abnormalities of plasma proteins

201

5.41

43.67

6.0

3.0

2.40

1.48

g/l

0.75

176

Peripheral artery operations in Hilmo

437

2157

2.10

43.61

2.4

0.80

1.17

g/l

1.08

386

1822

Non-allergic asthma (mode)

464

2307

2.04

43.55

2.1

2.0

0.75

0.81

g/l

0.12

404

1967

Seropositive rheumatoid arthritis, strict definition

460

2315

2.06

43.49

1.9

2.4

0.62

0.90

g/l

1.16

410

1986

Enterocolitis due to Clostridium difficile

370

1719

2.24

43.41

4.1

2.3

1.16

0.93

g/l

0.46

322

1456

Amputation of toe

282

1173

2.55

43.31

2.2

2.6

0.72

1.17

g/l

1.04

248

997

Trochanteric bursitis

429

2105

2.10

43.30

2.3

2.4

0.53

1.07

g/l

3.09

382

1774

Secondary right heart disease

189

644

3.18

43.25

2.0

2.5

0.81

1.44

g/l

1.20

171

558

Cytomegalovirus infection, IBD co-morbidity

109

258

4.68

43.24

5.4

2.5

1.01

0.98

g/l

0.03

235

Acute upper respiratory infections

2598

11569

1.36

43.16

3.4

2.2

0.89

0.79

g/l

0.60

2230

9955

Rash and other nonspecific skin eruption

306

1317

2.42

43.06

2.4

0.45

1.02

g/l

2.93

279

1128

Chronic sinusitis

1041

6611

1.60

43.02

2.6

2.5

0.77

0.76

g/l

0.03

918

5704

Superficial injury of head

681

3890

1.79

42.73

2.1

2.3

0.43

0.88

g/l

4.86

579

3322

Injury, poisoning and certain other consequences of external causes

1171

3725

1.59

42.70

2.2

2.5

0.76

1.00

g/l

1.20

1013

3246

Asthma and allergy, excluding more controls

234

876

2.69

42.24

2.0

1.6

0.49

0.65

g/l

0.42

208

774

Acute upper respiratory infections of multiple and unspecified sites

1814

9353

1.43

42.23

3.7

2.2

0.80

0.71

g/l

0.55

1568

8095

Cytomegaloviral disease

110

269

4.51

41.79

5.4

2.4

1.00

0.91

g/l

0.08

247

Osteomyelitis

232

894

2.74

41.65

2.6

2.2

0.64

1.11

g/l

0.87

199

781

Cytomegaloviral disease, including avohilmo

110

270

4.48

41.57

5.4

2.4

1.00

0.96

g/l

0.04

248

Drug-induced osteoporosis with pathological fracture

104

248

4.84

41.49

1.7

3.0

0.55

0.74

g/l

0.19

217

Pericarditis

142

416

3.66

41.37

2.1

2.3

0.88

1.49

g/l

0.72

126

353

Open wound of lower leg

447

2264

2.04

41.33

2.2

2.3

0.65

0.89

g/l

0.85

384

1932

AV-block

562

2603

1.90

41.19

2.4

0.72

1.20

g/l

2.57

476

2173

Disease of hard tissues of teeth, NOS

1374

4793

1.52

40.98

2.3

0.74

0.82

g/l

0.37

1173

4117

Benign neoplasm: Colon, unspecified

795

4811

1.70

40.96

2.5

0.79

0.89

g/l

0.38

673

4095

Major coronary heart disease event

2152

9376

1.39

40.85

2.3

2.6

0.73

0.85

g/l

0.99

1882

8036

Fracture of shoulder and upper arm

985

6258

1.60

40.85

2.8

2.4

0.78

0.87

g/l

0.37

818

5347

Stroke, including SAH

1783

9103

1.43

40.40

2.5

2.6

0.62

0.98

g/l

5.05

1528

7765

Other (not insulin) diabetes medications

2385

10369

1.36

40.36

2.1

2.6

0.62

0.85

g/l

2.74

2050

8902

Speech therapy

741

4415

1.72

40.32

2.4

0.66

0.86

g/l

0.97

700

3758

Stroke, excluding SAH

1722

8802

1.43

40.12

2.5

2.6

0.63

0.99

g/l

4.86

1473

7505

Type 1 diabetes

577

3199

1.84

39.86

1.9

2.4

0.53

0.88

g/l

1.83

518

2778

Tumor necrosis factor alpha inhibitors

365

1737

2.16

39.75

1.6

2.4

0.29

0.81

g/l

4.48

329

1537

Pleural effusion

521

2822

1.91

39.71

2.9

2.4

0.53

1.04

g/l

5.04

461

2393

Ischaemic Stroke, excluding all haemorrhages

1641

8512

1.44

39.48

2.5

2.6

0.65

1.00

g/l

4.26

1404

7232

Iron deficiency anaemia secondary to blood loss (chronic)

491

2611

1.94

39.43

2.2

2.4

1.13

1.00

g/l

0.27

406

2209

Injuries to the knee and lower leg

2837

11682

1.32

39.01

2.2

2.5

0.56

0.84

g/l

5.28

2449

10089

ILD, hospital admissions 1, main diag only

476

2524

1.96

38.96

2.7

2.4

0.65

0.99

g/l

1.41

421

2145

Adverse effects, not elsewhere classified

472

2481

1.95

38.93

2.3

0.62

0.81

g/l

0.70

434

2153

Disorder of lipoprotein metabolism, unspecified

405

2028

2.07

38.88

2.1

2.4

0.59

1.05

g/l

1.93

361

1709

Personality disorders, excluding more controls

479

2518

1.93

38.87

1.9

2.3

0.39

0.63

g/l

1.22

428

2255

Alcohol use disorder, Swedish definition

1354

8435

1.48

38.76

1.7

2.6

0.47

0.87

g/l

4.37

1159

7349

Insulin, fast-acting

923

5854

1.60

38.72

2.2

2.5

0.39

0.84

g/l

6.16

809

5041

In situ neoplasms

1116

7393

1.54

38.70

2.7

2.5

0.89

0.90

g/l

0.04

940

6270

Osteopathy in diseases classified elsewhere

100

7.68

38.67

15.0

2.8

1.24

0.48

g/l

1.13

Spondylopathies in diseases classified elsewhere

171

5.58

38.55

19.6

1.7

4.26

1.52

g/l

1.83

147

Acute sinusitis

1146

6909

1.53

38.46

3.5

2.1

0.76

0.66

g/l

0.46

985

6032

Other degenerative diseases of the nervous system

758

3303

1.71

38.41

1.9

2.6

0.93

1.17

g/l

0.83

633

2816

Disorders of continuity of bone

275

1187

2.40

38.31

3.5

2.1

0.78

0.88

g/l

0.16

240

1045

Recurrent or chronic depression

840

3568

1.65

38.10

2.2

2.5

0.54

0.72

g/l

0.88

738

3174

Lichen simplex chronicus and prurigo

220

864

2.68

38.01

2.1

2.6

0.50

1.09

g/l

2.32

192

742

1413

8755

1.46

37.81

1.7

2.6

0.48

0.86

g/l

3.95

1205

7632

Marginal zone B-cell lymphoma

115

6.77

37.76

2.1

1.2

1.80

0.22

g/l

1.87

102

Asthma and allergy

234

926

2.54

37.74

2.0

1.7

0.49

0.68

g/l

0.52

208

812

Caries of enamel

2242

10911

1.36

37.64

2.6

2.5

0.68

0.73

g/l

0.24

1990

9438

Eosinophilic disease (BM)

124

6.14

37.60

2.6

1.6

0.57

1.44

g/l

0.89

113

Artrosis, including avohilmo

1936

7668

1.40

37.52

2.2

2.6

0.74

0.83

g/l

0.46

1666

6638

Nonorganic sleeping disorders, excluding more controls

444

2312

1.96

37.51

1.9

2.4

0.50

0.72

g/l

0.85

392

2046

Renal tubulo-interstitial disorders in diseases classified elsewhere

102

7.12

37.48

6.9

2.5

0.67

0.93

g/l

0.25

L01XX Other antineoplastic agents

237

976

2.59

37.45

3.9

2.5

1.44

1.12

g/l

0.44

211

840

Other pulmonary heart/vessel disease

195

732

2.86

37.26

2.0

2.5

0.79

1.39

g/l

1.20

175

629

Other inflammation of eyelid

426

2204

2.00

37.19

3.1

2.4

0.64

0.94

g/l

1.34

362

1897

Cellulitis

598

3433

1.78

37.17

3.0

2.4

0.94

0.82

g/l

0.31

533

2952

1467

8937

1.45

37.16

1.7

2.6

0.49

0.86

g/l

4.02

1256

7791

Reactive arthropathies, FINNGEN

192

710

2.81

37.06

2.5

2.7

0.38

1.26

g/l

3.81

165

603

Pyoderma gangrenosum

7.54

36.98

2.1

2.9

0.29

0.74

g/l

0.61

DVT of lower extremities

556

3136

1.82

36.92

3.3

2.4

1.59

0.83

g/l

2.34

469

2676

Diseases of the myoneural junction and muscle

390

1965

2.06

36.92

1.9

2.3

0.60

0.97

g/l

1.41

328

1664

Budesonide

342

1637

2.14

36.78

2.2

2.4

0.55

0.76

g/l

0.60

296

1411

Deforming dorsopathies

666

3944

1.72

36.73

2.5

2.3

0.75

0.76

g/l

0.04

568

3352

Rheumatism, unspecified

363

1781

2.10

36.73

2.3

2.4

0.72

1.03

g/l

0.92

320

1498

Acetic acid derivatives and related substances

675

2000

1.77

36.69

2.3

2.5

0.89

0.96

g/l

0.16

590

1706

Complications of internal orthopaedic prosthetic devices, implants and grafts

692

4157

1.71

36.69

2.1

2.4

0.59

0.91

g/l

2.30

591

3498

Functional dyspepsia

669

3973

1.72

36.65

2.5

0.70

0.88

g/l

0.66

578

3426

Progressive vascular leukoencephalopathy

187

695

2.91

36.63

2.2

2.5

0.52

1.30

g/l

2.67

159

582

Coxibs

669

2011

1.77

36.54

2.3

2.5

0.76

0.95

g/l

0.60

576

1717

Abnormal findings on diagnostic imaging of other body structures

439

2310

1.96

36.52

2.8

2.4

1.00

0.83

g/l

0.34

381

1966

Ischaemic heart disease, wide definition

2008

9087

1.38

36.30

2.6

0.71

0.88

g/l

1.52

1763

7756

Dental operations

1612

5838

1.44

36.22

2.4

0.93

0.85

g/l

0.29

1370

5032

Rare circulating lymphoid malignancy, including Hilmo

117

331

3.81

36.07

5.1

1.4

2.16

0.37

g/l

1.91

101

285

Other chronic obstructive pulmonary disease, including avohilmo

1541

8992

1.43

36.06

2.0

2.7

0.76

0.94

g/l

0.88

1327

7660

Sequelae of external causes of morbidity and mortality

721

4405

1.67

35.65

2.6

2.4

0.75

0.85

g/l

0.31

638

3781

Hypoparathyroidism

157

538

3.16

35.65

2.1

2.4

0.33

1.08

g/l

2.24

120

465

Failure and rejection of transplanted organs and tissues

143

5.68

35.46

6.7

2.6

0.34

1.11

g/l

1.23

129

Allergic asthma (mode), excluding more controls

408

2051

1.97

35.27

2.0

1.8

0.55

0.67

g/l

0.39

369

1785

Biguanides

2331

10618

1.34

35.17

2.0

2.6

0.63

0.84

g/l

2.35

2007

9121

Charcot foot

208

4.69

35.08

2.4

2.9

0.69

1.69

g/l

1.06

182

Calcific aortic valvular stenosis, including rheumatic fever

945

5937

1.57

35.05

2.5

0.98

1.03

g/l

0.15

805

4960

Spondylopathies (FG)

291

1333

2.24

34.96

2.0

2.6

0.71

1.00

g/l

0.75

261

1158

Meniscus derangement

1262

5724

1.48

34.86

2.5

2.6

0.74

0.89

g/l

0.77

1068

4938

Calcific aortic valvular stenosis

941

5924

1.56

34.77

2.5

0.98

1.04

g/l

0.15

802

4948

Calcific aortic valvular stenosis, operated

941

5924

1.56

34.77

2.5

0.98

1.04

g/l

0.15

802

4948

Calcific aortic valvular stenosis, diagnosis (helper)

940

5920

1.56

34.67

2.5

0.98

1.04

g/l

0.15

801

4944

Operations 2 for CAVS

940

5920

1.56

34.67

2.5

0.98

1.04

g/l

0.15

801

4944

Fungal Sepsis

163

583

2.98

34.02

3.2

2.4

0.83

1.05

g/l

0.36

140

501

Insulin, fast-acting or short human

927

6067

1.55

33.89

2.1

2.5

0.39

0.85

g/l

6.32

813

5222

Cardiodefibrillation

1065

7176

1.51

33.85

2.5

0.67

0.98

g/l

2.74

918

6100

Somatoform disorder

399

2083

1.96

33.74

2.6

2.4

0.47

0.87

g/l

2.11

350

1814

Spondyloarthritis

441

2379

1.90

33.66

2.3

0.85

0.87

g/l

0.04

396

2024

Migraine without aura

357

1789

2.03

33.63

2.2

0.35

0.61

g/l

1.33

323

1586

Other disorders of bone

450

2445

1.88

33.57

3.9

2.1

0.71

0.77

g/l

0.15

391

2158

Injuries to the elbow and forearm

1677

10487

1.38

33.37

2.3

2.5

0.60

0.78

g/l

1.53

1413

9070

Elevated blood glucose level

249

1098

2.36

33.22

2.0

2.3

0.28

0.97

g/l

4.56

209

950

Viral pneumonia (unknown virus, not influenza)

208

847

2.56

33.22

3.7

2.5

0.96

1.11

g/l

0.24

175

733

Chronic ulcer of skin, not elsewhere classified

238

1035

2.41

33.01

2.4

0.54

1.00

g/l

1.37

206

876

Persons encountering health services in other circumstances

915

5937

1.55

32.97

2.5

2.4

0.78

0.82

g/l

0.13

771

5027

Abnormal serum enzyme levels

856

5357

1.57

32.79

2.3

2.5

0.84

0.88

g/l

0.14

770

4609

Other and unspecified effects of external causes

596

3534

1.72

32.79

2.2

2.3

0.68

0.75

g/l

0.21

541

3073

Pain in thoracic spine

369

1894

1.99

32.77

2.9

2.3

0.73

0.82

g/l

0.19

327

1607

Bipolar affective disorders

374

1929

1.98

32.59

1.9

2.4

0.40

0.83

g/l

2.56

338

1698

Type 1 diabetes, wide definition, subgroup 1

446

2438

1.86

32.44

1.9

2.4

0.37

0.90

g/l

3.22

396

2143

Other extrapyramidal and movement disorders in other diseases

690

4273

1.65

32.41

2.2

2.4

0.58

0.88

g/l

1.58

594

3656

Diabetic retinopathy, excluding more controls

688

2320

1.70

32.35

2.0

2.3

0.44

0.77

g/l

2.18

588

1966

Other disorders of skin and subcutaneous tissue, not elsewhere classified

415

2234

1.91

32.20

2.5

2.3

0.81

0.84

g/l

0.04

355

1894

Decubitus ulcer and pressure area

226

973

2.44

32.15

1.6

2.5

0.45

1.05

g/l

2.24

189

813

Phlebitis and thrombophlebitis (not including DVT)

600

3596

1.71

32.00

2.9

2.4

0.86

0.80

g/l

0.16

522

3076

Reactive arthropathies

222

946

2.43

31.90

2.3

2.6

0.28

1.09

g/l

5.04

190

817

Extrapyramidal and movement disorders

1071

7329

1.49

31.79

2.1

2.5

0.56

0.93

g/l

3.56

911

6228

L04AC Interleukin inhibitors

175

672

2.71

31.47

1.9

2.5

0.08

0.92

g/l

6.25

159

600

Other viral diseases, including avohilmo

733

4576

1.61

31.42

3.1

2.2

0.77

0.64

g/l

0.43

667

4011

Superficial injury of lower leg

619

3755

1.68

31.32

2.0

2.3

0.46

0.84

g/l

2.74

525

3226

Other symptoms and signs involving the urinary system

317

1574

2.09

31.31

2.7

2.6

0.76

0.98

g/l

0.55

293

1341

Metatarsalgia

255

1163

2.26

31.24

2.5

2.2

0.61

1.11

g/l

1.75

223

997

Myeloproliferative diseases

279

1327

2.20

31.16

2.9

2.4

1.39

1.00

g/l

0.87

240

1131

Non-selective monoamine reuptake inhibitors

918

5855

1.53

31.11

2.4

2.6

0.63

0.88

g/l

2.02

796

5015

Implicit fungal Sepsis

150

540

2.96

30.99

3.4

2.4

0.91

1.12

g/l

0.30

127

462

Mental and behavioural disorders due to psychoactive substance use

1390

9139

1.41

30.93

1.8

2.6

0.50

0.84

g/l

3.47

1178

7947

Phobic anxiety disorders

231

1008

2.33

30.91

2.4

2.2

0.33

0.72

g/l

2.06

212

904

Oxicams

581

1920

1.75

30.87

2.5

0.72

1.00

g/l

0.99

494

1630

Hypothyroidism, strict autoimmune

1562

7437

1.39

30.85

2.2

2.6

0.73

0.92

g/l

1.26

1345

6334

Haemorrhage, not elsewhere classified

141

491

3.04

30.85

2.9

2.5

0.59

1.34

g/l

1.64

125

413

Benign neoplasm of other and ill-defined parts of digestive system

527

3088

1.76

30.83

2.3

2.4

0.65

0.86

g/l

0.85

460

2639

Substance abuse

1352

8988

1.41

30.71

1.8

2.6

0.47

0.84

g/l

4.30

1148

7822

Conjunctivitis (acute, non atopic), including avohilmo

2355

10950

1.31

30.71

2.4

2.5

0.69

0.77

g/l

0.56

2063

9434

Cervicalgia

511

2963

1.76

30.69

2.3

0.62

0.79

g/l

0.58

451

2514

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

258

1193

2.24

30.68

3.4

2.3

1.11

1.01

g/l

0.15

222

1024

Hypocalcemia

105

310

3.70

30.62

4.9

2.8

0.53

0.94

g/l

0.54

276

Other general symptoms and signs

131

432

3.11

30.58

1.5

2.5

1.03

1.36

g/l

0.33

115

371

Hypertrophic cardiomyopathy

160

601

2.84

30.57

2.8

0.59

1.42

g/l

2.15

144

521

Pacemaker

1095

7041

1.47

30.51

2.2

2.5

0.84

1.03

g/l

0.87

893

5932

Cholelithiasis, broad definition with cholecystitis

2138

10855

1.32

30.48

2.5

0.90

0.84

g/l

0.30

1817

9334

Other enthesopathies

677

4229

1.63

30.37

2.2

2.5

0.59

0.87

g/l

1.77

581

3618

Psoriatic and enteropathic arthropathies

264

1235

2.19

30.25

2.0

2.6

0.63

1.09

g/l

1.23

237

1076

Gastroduodenal ulcer

730

4647

1.60

30.10

2.1

2.5

0.63

1.04

g/l

2.77

624

3940

Motor neuron disease ALS

225

4.15

29.82

1.5

2.0

0.63

1.60

g/l

0.99

187

Localized swelling, mass and lump of skin and subcutaneous tissue

785

5103

1.56

29.79

2.5

0.90

0.88

g/l

0.06

693

4365

Etanercept

176

697

2.63

29.77

1.8

2.5

0.35

0.97

g/l

2.76

159

618

Coronary atherosclerosis

1677

7813

1.37

29.74

2.5

2.6

0.69

0.92

g/l

1.88

1475

6655

Need for immunization against other single viral diseases

208

4.31

29.73

2.8

2.7

0.41

1.02

g/l

1.04

187

COPD, early/later onset

1303

7821

1.42

29.69

2.0

2.6

0.77

0.98

g/l

0.98

1124

6634

Allergic asthma (mode)

408

2175

1.86

29.58

2.0

1.8

0.55

0.65

g/l

0.34

369

1898

Myeloproliferative diseases (CML excluded)

257

1210

2.23

29.54

3.0

2.5

1.46

1.06

g/l

0.81

221

1033

Other disorders of eye and adnexa

363

1927

1.93

29.34

2.1

2.3

0.52

0.84

g/l

1.00

334

1663

All influenza (not pneumonia)

351

1841

1.95

29.31

5.2

2.0

1.26

0.84

g/l

0.83

304

1589

Atopic dermatitis, strict definition with reimbursement

511

2870

1.73

29.30

2.0

2.2

0.42

0.63

g/l

0.95

446

2524

Other diseases of lip and oral mucosa

1028

7087

1.47

29.26

2.7

2.5

0.68

0.78

g/l

0.45

881

6109

Motor neuron disease (with DMD)

228

4.08

29.25

1.5

2.0

0.63

1.57

g/l

0.96

190

Other viral diseases

580

3507

1.67

29.20

3.4

2.2

0.83

0.69

g/l

0.36

530

3070

Pyogenic arthritis

195

819

2.48

29.13

2.6

0.93

1.21

g/l

0.43

171

695

COPD related to multimorbidity

1167

6952

1.44

29.00

1.9

2.6

0.63

1.01

g/l

3.66

998

5895

Superficial injury of hip and thigh

434

2446

1.82

28.95

2.1

2.3

0.40

0.96

g/l

5.33

363

2084

Disorders of sclera, cornea, iris and ciliary body

1301

9369

1.41

28.91

2.4

0.78

0.76

g/l

0.06

1135

8061

Essential (haemorrhagic) thrombocythaemia

137

489

2.98

28.79

2.7

1.4

1.42

0.39

g/l

2.29

118

419

Intracranial injury

1398

9481

1.39

28.73

2.4

0.64

0.90

g/l

2.38

1183

8133

Presence of other functional implants

1588

8028

1.37

28.65

2.6

2.5

0.93

0.91

g/l

0.07

1252

6917

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

800

5269

1.54

28.60

2.5

2.4

0.49

0.84

g/l

2.97

704

4526

Cholelithiasis

2050

10716

1.32

28.57

2.5

0.90

0.84

g/l

0.26

1739

9208

Disorders of muscles

265

1273

2.14

28.48

1.8

2.2

0.67

1.01

g/l

0.67

238

1085

Diabetic neuropathy

369

1990

1.92

28.42

2.3

0.65

0.73

g/l

0.17

329

1703

Stomatitis and related lesions

490

2874

1.74

28.34

2.6

2.3

0.84

0.78

g/l

0.13

431

2474

Other peripheral vascular diseases

239

1108

2.24

28.33

2.1

2.4

0.47

0.98

g/l

2.26

212

962

Noninfectious colitis NAS

358

1915

1.92

28.31

2.7

2.3

0.72

0.88

g/l

0.37

319

1640

COPD, hospital admissions

1280

7761

1.41

28.13

2.0

2.6

0.76

0.99

g/l

1.09

1103

6589

Migraine

960

5074

1.49

28.12

2.1

2.5

0.48

0.69

g/l

1.66

853

4442

Other enthesopathy of foot (+metatarsalgia)

262

1260

2.14

28.06

2.5

2.2

0.59

1.06

g/l

1.66

229

1080

Diseases of spleen

213

4.17

28.02

2.2

2.4

0.41

0.94

g/l

0.80

187

Disorders of adult personality and behaviour

518

3087

1.70

27.97

2.0

2.2

0.35

0.69

g/l

2.34

462

2738

Generalized anxiety disorder

285

1408

2.05

27.96

1.9

2.3

0.32

0.70

g/l

1.87

257

1252

Major coronary heart disease event excluding revascularizations

1606

7866

1.36

27.90

2.4

2.7

0.74

0.92

g/l

1.11

1386

6690

Fracture of lower leg, including ankle

1306

9288

1.40

27.87

2.2

2.5

0.53

0.82

g/l

3.36

1122

8004

Other and unspecified aplastic anaemias

118

5.51

27.83

2.3

3.1

0.61

0.56

g/l

0.06

105

Migraine with aura

460

2659

1.75

27.71

1.7

2.4

0.30

0.67

g/l

3.87

408

2328

Disorders of synovium and tendon

1160

6968

1.43

27.64

2.1

2.5

0.67

0.87

g/l

1.28

993

5950

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

132

5.41

27.62

3.7

2.3

1.39

0.99

g/l

0.25

117

Myocardial infarction

1321

6665

1.40

27.62

2.3

2.6

0.76

0.95

g/l

0.91

1131

5647

Heart failure and hypertrophic cardiomyopathy

268

3.81

27.62

3.3

2.9

0.73

1.43

g/l

0.89

232

Mycoses

699

4510

1.58

27.54

2.9

2.5

0.69

0.83

g/l

0.57

615

3876

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

416

2353

1.82

27.52

2.1

1.5

0.62

0.36

g/l

1.30

359

2037

Polyarthritis, unspecified

119

403

3.12

27.36

2.9

2.4

0.57

1.43

g/l

1.61

106

344

Any death

1722

9081

1.34

27.27

3.2

2.5

1.19

0.75

g/l

3.29

1460

7814

Collagenous colitis

272

1345

2.10

27.27

2.8

2.4

0.88

g/l

0.01

234

1159

Oter anti-inflammatory and antirheumatic agents, non-steroids

566

1859

1.70

27.22

2.5

2.6

0.81

1.03

g/l

0.65

475

1571

Valvular operations

383

2122

1.85

27.12

1.9

2.4

1.05

1.08

g/l

0.04

336

1796

Paralytic ileus and intestinal obstruction

669

4290

1.59

26.98

2.9

2.5

0.96

g/l

0.00

574

3624

Substance use, excluding alcohol

427

2443

1.78

26.91

1.7

2.4

0.42

0.74

g/l

2.16

355

2158

Adalimumab

221

1011

2.25

26.87

1.4

2.4

0.25

0.79

g/l

3.22

204

901

Myositis

300

3.50

26.85

1.7

2.3

0.29

1.66

g/l

3.41

255

Injuries to unspecified part of trunk, limb or body region

288

1462

2.03

26.76

2.1

2.4

0.79

1.01

g/l

0.49

253

1256

Diseases of external ear

891

6085

1.49

26.74

2.3

2.5

0.68

0.84

g/l

0.69

730

5243

Gastric ulcer

503

3025

1.70

26.66

2.1

2.5

0.62

1.03

g/l

1.95

426

2565

Crystal arthropathies, rheuma endpoint

244

3.84

26.66

1.9

3.0

0.41

2.12

g/l

3.28

210

Type 1 diabetes, wide definition

457

2670

1.74

26.57

1.9

2.3

0.37

0.90

g/l

3.39

406

2330

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1295

8594

1.38

26.32

2.1

2.4

0.52

0.71

g/l

1.74

1150

7497

Herpesviral [herpes simplex] infections, including avohilmo

541

3317

1.66

26.31

3.1

2.3

1.03

0.69

g/l

1.09

481

2883

Disorders of the thyroid gland

2185

11053

1.29

26.29

2.3

2.5

0.70

0.83

g/l

0.97

1881

9529

Other and unspecified acquired haemolytic anaemias

125

5.34

26.27

3.1

1.9

0.48

0.60

g/l

0.13

112

Papulosquamous disorders

960

6677

1.46

26.17

2.3

2.5

0.68

0.83

g/l

0.61

845

5767

Other hammer toe(s) (acquired)

446

2363

1.76

26.16

1.9

2.7

0.51

1.09

g/l

3.50

364

1996

Cerebral palsy and other paralytic syndromes

294

1515

2.00

26.11

2.3

0.50

0.98

g/l

1.92

265

1310

Other and unspecified urticaria

430

2490

1.76

26.02

2.5

2.2

0.70

0.83

g/l

0.30

372

2160

Sequelae of cerebrovascular disease

1051

6339

1.44

25.94

2.2

2.5

0.71

1.03

g/l

2.01

885

5356

Enthesopathies of lower limb, excluding foot

507

3072

1.68

25.88

2.5

2.3

0.56

0.73

g/l

0.83

448

2628

Use of pramipexole

609

3871

1.61

25.86

1.9

2.4

0.47

0.87

g/l

3.43

503

3296

Diseases of salivary glands

768

5127

1.52

25.81

2.4

0.67

0.82

g/l

0.49

666

4405

Other pleural conditions

332

1794

1.92

25.78

2.9

2.5

0.75

1.06

g/l

1.14

287

1508

Raynaud syndrome

233

1110

2.17

25.74

1.7

2.5

0.45

0.96

g/l

2.21

207

967

Other metabolic disorders

298

1550

1.97

25.60

3.7

2.2

0.74

0.95

g/l

0.42

277

1337

Dermatophytosis, including avohilmo

1513

11140

1.34

25.48

2.2

2.5

0.66

0.76

g/l

0.51

1306

9622

Systemic sclerosis (FG)

248

3.67

25.10

2.0

2.9

1.00

1.73

g/l

0.57

214

Fissure and fistula of anal and rectal regions

550

3433

1.63

24.97

2.4

0.74

0.80

g/l

0.16

468

2950

Postprocedural endocrine and metabolic disorders, not elsewhere classified

277

1418

2.00

24.96

3.7

2.2

0.64

0.95

g/l

0.76

257

1222

Neuromuscular dysfunction of bladder

259

1300

2.06

24.93

2.1

2.7

0.54

1.19

g/l

2.82

228

1116

Degeneration of macula and posterior pole

1393

7984

1.37

24.91

2.5

1.09

0.96

g/l

0.44

1145

6766

Kela reimbursement Agammaglobulinemia (D80-84)

6.21

24.91

2.6

2.7

0.56

0.90

g/l

0.29

Other specified and unspecified disorders of eye and adnexa

130

488

2.82

24.84

2.4

2.5

0.74

1.16

g/l

0.41

120

427

5-aminosalicylic acid

405

2336

1.76

24.77

2.0

2.4

0.63

0.75

g/l

0.33

356

2025

Injuries to the ankle and foot

1508

9690

1.34

24.65

2.2

2.4

0.52

0.70

g/l

1.52

1334

8441

Nonischemic cardiomyopathy

300

1590

1.95

24.61

2.7

2.4

0.55

0.96

g/l

1.69

260

1349

Pneumonia derived septicemia

120

435

2.92

24.52

5.5

2.6

3.75

1.25

g/l

2.32

380

Paracetamol or NSAID medication

296

745

2.03

24.40

2.7

2.0

0.93

0.84

g/l

0.11

262

655

Other complications of surgical and medical care, not elsewhere classified

259

1309

2.04

24.38

2.9

2.3

1.05

0.92

g/l

0.19

222

1126

Sequelae of other external causes

173

748

2.41

24.38

2.8

2.7

0.56

1.26

g/l

2.38

161

648

Peripheral arterial reconstruction

524

3265

1.65

24.35

2.2

2.4

0.61

1.05

g/l

2.21

452

2748

Memory loss

300

1602

1.95

24.31

2.1

2.4

0.77

1.05

g/l

0.70

258

1366

Cramp and spasm

141

556

2.65

24.29

2.8

2.5

0.96

1.06

g/l

0.12

125

492

Vasomotor and allergic rhinitis

731

4771

1.51

24.24

2.4

2.3

0.48

0.70

g/l

1.77

635

4138

Infection of intervertebral disc (pyogenic)

185

4.21

24.24

2.2

2.4

0.43

1.39

g/l

1.81

164

Carcinoma in situ of skin of other and unspecified parts of face

311

1686

1.92

24.13

2.4

0.74

1.13

g/l

1.22

265

1410

Mixed and other personality disorders

170

730

2.40

24.08

2.1

2.2

0.06

0.68

g/l

6.93

158

657

Faecal incontinence

279

1459

1.98

23.91

1.9

2.5

0.59

0.96

g/l

1.24

235

1235

Psoriasis

679

4494

1.54

23.88

2.1

2.5

0.64

0.81

g/l

0.58

600

3893

Other embolism and thrombosis

347

1944

1.83

23.82

3.0

2.3

0.81

0.87

g/l

0.12

307

1645

Congenital malformations, deformations and chromosomal abnormalities

1130

7772

1.39

23.74

2.2

2.4

0.53

0.69

g/l

1.13

1007

6778

Thoracic aortic aneurysm

421

2499

1.73

23.68

2.7

2.6

0.76

1.04

g/l

0.90

351

2170

KRA_PSY_EATING, excluding more controls

109

375

2.93

23.47

1.4

1.9

0.09

0.50

g/l

1.74

102

338

Anaemia in chronic diseases classified elsewhere

316

3.27

23.47

1.8

2.8

0.30

1.24

g/l

2.22

280

Panic disorder

258

1314

2.00

23.46

1.6

2.4

0.28

0.74

g/l

3.22

230

1170

Nonorganic sleeping disorders

444

2672

1.69

23.31

1.9

2.3

0.50

0.73

g/l

0.91

392

2332

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

468

2814

1.66

23.26

2.2

2.3

0.33

0.65

g/l

3.29

404

2506

Pneumococcal septicemia

115

421

2.89

23.10

5.5

2.7

3.81

1.02

g/l

2.61

368

Other crystal arthropathies

269

3.47

22.99

1.9

2.3

0.41

1.87

g/l

2.91

227

Fracture of forearm

1275

8512

1.36

22.98

2.2

2.5

0.60

0.81

g/l

1.55

1071

7307

Benign neoplasm: Transverse colon

339

1913

1.83

22.96

2.8

2.5

0.59

0.99

g/l

1.57

296

1635

Persistent mood disorders

434

2613

1.69

22.84

2.2

2.3

0.62

0.81

g/l

0.61

389

2249

Migraine without aura and triptan purchases

272

1425

1.94

22.76

1.7

2.1

0.33

0.60

g/l

1.07

245

1258

Fall on and from stairs and steps

647

4288

1.53

22.66

2.3

2.4

0.62

0.82

g/l

1.03

540

3697

Personality disorders

479

2966

1.64

22.41

1.9

2.2

0.39

0.68

g/l

1.64

428

2627

Amputation of foot

108

391

2.97

22.39

2.7

2.8

0.57

1.39

g/l

0.97

340

Other/unspecified reactive arthropathies

176

796

2.29

22.30

2.6

0.34

1.05

g/l

3.42

154

701

Recurrent aphthous stomatitis , including avohilmo

361

2086

1.77

22.24

2.7

2.4

0.97

0.89

g/l

0.13

318

1789

Malignant neoplasm of bone and articular cartilage

105

5.22

22.20

7.3

1.2

1.08

0.47

g/l

0.51

Oesophageal varices

138

566

2.57

22.07

1.5

2.6

0.49

1.02

g/l

1.39

120

487

Gonarthrosis,primary

2260

10900

1.26

22.03

2.2

2.6

0.76

0.87

g/l

0.76

1920

9360

Retinal detachments and breaks

949

6806

1.42

21.99

2.7

2.6

0.83

0.88

g/l

0.18

813

5812

Other and unspecified drugs and medicaments

233

1179

2.04

21.99

3.3

2.4

1.06

1.03

g/l

0.03

199

1014

Other disorders of eyelid

1183

8287

1.36

21.83

2.3

2.5

0.74

0.94

g/l

1.27

1016

7027

Restless leg syndrome

376

2214

1.74

21.72

2.1

2.4

0.40

0.86

g/l

3.10

323

1907

Aortic aneurysm

650

4272

1.52

21.64

2.6

2.5

0.79

1.13

g/l

1.55

535

3643

Alcoholic liver disease

283

1538

1.90

21.60

1.4

2.5

0.22

1.02

g/l

7.95

230

1335

Atopic dermatitis, strict definition

477

2907

1.62

21.60

2.0

2.1

0.39

0.66

g/l

1.36

421

2584

Malignant neoplasm of bone and articular cartilage, including Hilmo

199

3.78

21.59

6.6

1.3

2.03

0.32

g/l

1.17

179

Mucosal proctocolitis

274

1469

1.91

21.57

2.3

2.4

0.48

0.88

g/l

1.63

252

1296

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

282

1532

1.90

21.54

2.1

1.4

1.25

0.35

g/l

2.80

249

1314

Biomechanical lesions, not elsewhere classified

163

728

2.34

21.47

2.4

2.6

0.51

1.21

g/l

2.06

146

629

Malignant neoplasm of urinary organs, including Hilmo

317

1786

1.83

21.46

2.1

1.5

1.25

0.37

g/l

3.06

277

1526

Invasive ventilation

216

1076

2.08

21.40

2.4

2.5

1.16

g/l

0.00

186

928

Carcinoma in situ of skin of scalp and neck

123

489

2.71

21.35

2.3

2.8

0.87

1.45

g/l

0.79

107

413

Viral pneumonia (known virus, not influenza)

105

383

2.92

21.35

7.1

2.8

1.65

1.39

g/l

0.19

333

Eosinophilia

197

3.82

21.28

2.6

0.57

0.90

g/l

0.37

177

Myocardial infarction, without ST-elevation

1141

7631

1.37

21.28

2.3

2.5

0.66

1.02

g/l

3.44

969

6435

Chronic pancreatitis

343

1983

1.78

21.25

1.8

2.5

0.30

0.83

g/l

5.55

298

1713

Hyperplasia of prostate

921

3662

1.44

21.24

2.4

2.8

1.07

0.99

g/l

0.20

797

3187

Fracture of skull and facial bones

495

3139

1.60

21.15

2.8

2.3

0.85

0.82

g/l

0.06

422

2738

Nonhereditary hypogammaglobulinemia

122

4.73

21.08

3.5

2.2

0.59

0.65

g/l

0.05

113

Amiodarone users

310

1752

1.83

20.97

2.2

2.5

0.21

1.05

g/l

11.09

284

1492

Sequelae with surgical and medical care as external cause

541

3515

1.57

20.96

2.4

0.84

0.87

g/l

0.07

472

3009

Other diseases of the respiratory system

566

3714

1.56

20.96

2.1

2.3

1.01

0.93

g/l

0.12

474

3140

Other respiratory disorders and diseases

566

3714

1.56

20.96

2.1

2.3

1.01

0.93

g/l

0.12

474

3140

Viral hepatitis, including avohilmo

165

745

2.28

20.87

2.3

2.2

0.52

0.84

g/l

0.62

144

666

Internal derangement of knee

760

5225

1.46

20.84

2.2

2.6

0.50

0.86

g/l

3.31

624

4513

Intestinal malabsorption

140

593

2.47

20.78

1.8

2.7

0.67

1.26

g/l

1.00

129

517

Fracture of foot, except ankle

520

3348

1.58

20.75

2.4

2.3

0.58

0.78

g/l

0.68

456

2924

Myocardial infarction, strict

1207

6379

1.36

20.64

2.2

2.6

0.66

0.95

g/l

2.37

1039

5398

Idiopathic urticaria

210

3.58

20.52

1.3

2.2

0.00

0.51

g/l

2.77

191

Spirochaetal infections, other/unspecified, including avohilmo

791

5562

1.44

20.49

2.6

2.5

0.73

0.80

g/l

0.25

689

4799

Other spirochaetal diseases, including avohilmo

800

5637

1.44

20.48

2.6

2.5

0.72

0.80

g/l

0.27

696

4868

Osteonecrosis due to drugs

218

3.65

20.47

15.8

2.6

1.90

1.12

g/l

0.63

191

Mixed connective tissue disease

197

3.72

20.44

2.0

2.7

0.21

0.95

g/l

1.53

172

Other encephalitis

314

3.07

20.41

1.8

2.9

1.39

0.79

g/l

0.43

279

Fenamates

340

1323

1.78

20.27

2.4

2.5

0.45

0.82

g/l

1.96

297

1123

Other spirochaetal diseases

790

5565

1.44

20.27

2.6

2.5

0.73

0.80

g/l

0.24

689

4803

Other and unspecified myopathies

262

1421

1.91

20.21

2.1

2.4

0.64

1.08

g/l

1.26

212

1205

Radiculopathy

404

2470

1.67

20.20

2.6

2.3

0.88

g/l

0.00

347

2089

Allergic rhinitis

525

3360

1.56

20.17

2.5

2.2

0.50

0.66

g/l

0.76

460

2949

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

102

376

2.84

20.15

1.7

2.2

0.43

0.88

g/l

0.98

339

Spondylolisthesis/Spondylolysis

423

2616

1.65

20.15

2.8

2.4

0.80

0.84

g/l

0.10

367

2224

Hallux valgus (acquired)

702

3427

1.48

20.12

2.3

2.7

0.81

0.92

g/l

0.26

592

2928

Psoriatic arthropathies

222

1137

2.00

20.12

2.0

2.6

0.73

1.03

g/l

0.57

196

988

Personal history of malignant neoplasm

225

1161

2.00

20.09

2.6

2.1

0.26

0.58

g/l

1.40

203

1014

Other viral hepatitis, including avohilmo

138

588

2.41

20.00

2.4

2.3

0.54

0.74

g/l

0.29

123

534

Spirochaetal infections, other/unspecified

250

1340

1.93

20.00

2.5

2.4

0.58

0.98

g/l

1.55

211

1162

Lyme disease

783

5521

1.44

19.99

2.6

2.5

0.74

0.81

g/l

0.23

682

4767

Lyme disease, including avohilmo

783

5521

1.44

19.99

2.6

2.5

0.74

0.81

g/l

0.23

682

4767

Dilated cardiomyopathy

337

1977

1.76

19.93

1.9

2.5

0.32

1.02

g/l

6.30

298

1695

Disorders of skin appendages

1005

7342

1.37

19.90

2.4

0.83

0.70

g/l

0.47

903

6385

Mental and behavioural disorders due to alcohol

1140

8126

1.35

19.87

1.7

2.6

0.49

0.85

g/l

2.98

969

7091

COPD, hospital admission 2, with asthma infections

895

5554

1.41

19.80

2.1

2.5

0.87

1.02

g/l

0.43

768

4720

Benign neoplasm: Stomach

288

1620

1.84

19.78

2.4

0.64

0.99

g/l

1.12

248

1387

Conjunctivitis (acute, non atopic)

577

3823

1.52

19.76

3.0

2.2

0.91

0.72

g/l

0.54

502

3321

Inflammatory bowel disease

657

4490

1.48

19.75

2.2

2.4

0.74

0.76

g/l

0.04

571

3910

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

336

1904

1.74

19.73

1.8

2.4

0.37

0.87

g/l

3.45

300

1659

Benign neoplasm: Sigmoid colon

532

3496

1.56

19.68

2.7

2.4

0.98

0.86

g/l

0.26

468

2983

1180

8003

1.35

19.68

3.1

2.5

1.11

0.98

g/l

0.48

976

6744

Juvenile arthritis (FINNGEN)

270

3.12

19.65

2.1

2.2

0.78

1.38

g/l

0.68

243

Transient ischemic attack

1388

8503

1.32

19.62

2.4

2.6

0.64

1.01

g/l

4.62

1172

7215

Unspecified acute lower respiratory infection

361

2161

1.70

19.56

3.0

2.3

0.95

0.92

g/l

0.06

322

1865

Delirium, not induced by alcohol and other psychoactive substances

385

2346

1.68

19.51

2.2

2.5

1.02

1.06

g/l

0.07

319

1968

Traumatic subdural haemorrhage

369

2077

1.70

19.46

2.5

1.10

1.22

g/l

0.22

304

1758

Herpesviral [herpes simplex] infections

277

1543

1.84

19.42

3.8

2.4

1.31

0.76

g/l

1.10

249

1334

Thyrotoxicosis

578

3869

1.52

19.38

2.0

2.4

0.37

0.84

g/l

4.57

501

3314

Other disorders of glucose regulation and pancreatic internal secretion

212

1085

2.01

19.37

2.1

2.4

0.22

1.09

g/l

7.14

184

939

Chronic tubulo-interstitial nephritis

111

437

2.66

19.28

2.5

2.2

0.24

1.11

g/l

3.03

373

Allergic urticaria

185

903

2.10

19.23

2.4

2.5

0.38

0.99

g/l

2.20

161

793

Viral hepatitis

156

713

2.25

19.21

2.2

2.3

0.55

0.83

g/l

0.49

136

637

COPD, hospital admissions 3, with asthma pneumonia sepsis

779

4726

1.44

19.19

2.1

2.5

0.78

1.06

g/l

1.15

670

3990

Cyst of kidney

224

1178

1.98

19.13

2.9

2.6

1.16

1.13

g/l

0.03

201

1008

Congenital malformations of the urinary system, including avohilmo

150

677

2.29

19.13

2.1

2.7

0.26

1.17

g/l

4.54

138

597

Thyrotoxicosis, other and/or unspecified

452

2877

1.60

19.09

2.1

2.4

0.38

0.84

g/l

3.07

399

2478

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

360

2103

1.69

19.02

1.8

2.4

0.35

0.85

g/l

3.82

321

1824

Scoliosis

187

920

2.08

19.00

2.0

2.2

0.72

1.01

g/l

0.64

161

777

Vascular disorders of the intestines

212

1095

2.00

18.99

2.4

2.2

0.77

1.02

g/l

0.62

189

907

Hydronephrosis

280

1576

1.82

18.99

2.3

2.2

0.70

0.88

g/l

0.47

243

1344

Pollen allergy

282

1561

1.80

18.96

2.8

2.2

0.55

0.61

g/l

0.16

240

1408

Injury of unspecified body region

209

1074

2.01

18.95

1.7

2.5

0.77

1.13

g/l

0.74

180

927

Ankylosing spondylitis

198

996

2.04

18.95

1.7

2.3

0.79

1.03

g/l

0.40

180

853

Systemic sclerosis

296

3.06

18.87

2.0

2.3

1.00

1.08

g/l

0.05

254

Coxarthrosis, primary

1592

10407

1.28

18.84

2.3

2.6

0.66

0.95

g/l

3.65

1342

8847

Skin changes due to chronic exposure to nonionizing radiation

1130

7719

1.34

18.82

3.1

2.5

1.13

0.99

g/l

0.48

936

6497

Mental and behavioural disorders due to alcohol, excluding acute intoxication

998

7328

1.36

18.81

1.7

2.5

0.47

0.83

g/l

2.69

847

6386

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

374

2284

1.67

18.79

2.8

2.4

0.75

0.86

g/l

0.23

341

1976

Actinic keratosis

1108

7590

1.35

18.73

3.1

2.5

1.14

1.00

g/l

0.48

916

6389

Cervical disc disorders

808

5797

1.41

18.65

2.5

2.4

0.58

0.78

g/l

1.14

698

4966

Open wound of ankle and foot

249

1360

1.88

18.65

2.7

2.4

0.60

1.06

g/l

1.66

220

1180

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1138

8290

1.34

18.63

2.5

0.84

0.78

g/l

0.15

988

7162

Agoraphobia

183

3.55

18.53

2.0

1.8

0.49

0.47

g/l

0.03

167

Congenital malformations of the urinary system

141

629

2.32

18.52

2.1

2.7

0.26

1.10

g/l

3.94

130

554

Other infectious diseases, including avohilmo

245

1337

1.89

18.51

2.9

2.4

0.44

1.03

g/l

2.59

215

1145

Encephalitis

337

2.87

18.51

1.8

2.8

1.37

0.82

g/l

0.40

298

Protozoal diseases

106

419

2.69

18.49

5.7

2.7

1.37

1.32

g/l

0.03

367

Other viral hepatitis

130

561

2.38

18.36

2.4

2.2

0.57

0.72

g/l

0.20

116

507

Organ-limited amyloidosis

6.35

18.35

4.6

1.4

0.63

0.34

g/l

0.43

Thyroiditis, ILD-related definition

243

1324

1.87

18.29

2.4

0.36

0.87

g/l

2.87

209

1144

Macular pucker

470

3061

1.57

18.27

2.0

2.6

0.79

0.90

g/l

0.26

397

2619

Polycystic kidney disease

307

2.97

18.22

2.2

2.6

0.31

1.09

g/l

1.92

276

Migraine with aura and triptan purchases

260

1446

1.82

18.16

1.6

2.1

0.33

0.62

g/l

1.46

236

1266

Other or unspecified ileus, impaction or obstruction

462

2993

1.57

18.10

2.8

2.4

1.17

0.95

g/l

0.34

397

2517

Erosion of teeth , including avohilmo

513

3395

1.53

18.10

2.3

2.2

0.43

0.73

g/l

1.97

460

2977

Other disorders of bladder

323

1923

1.72

18.07

2.6

2.5

0.77

1.09

g/l

0.84

259

1643

Autoimmune hepatitis, wide definition

120

505

2.46

18.05

1.9

2.5

0.40

1.28

g/l

2.42

104

437

Primary biliary cholangitis, wide definition

260

3.14

18.02

1.5

2.6

0.34

1.44

g/l

2.00

229

Exclusions for E4_PCOS_BROAD

364

2230

1.66

17.97

3.1

2.3

0.44

0.86

g/l

2.63

316

1939

Primary biliary cholangitis (PBC)

250

3.19

17.97

1.8

2.3

0.70

1.41

g/l

0.76

222

Disorders of vitreous body and globe

1315

9644

1.30

17.89

2.4

2.6

0.82

0.85

g/l

0.10

1136

8241

Abnormality of white blood cells, not elsewhere classified

4.83

17.89

2.4

2.3

0.68

0.95

g/l

0.24

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

5.71

17.87

9.0

1.2

1.31

0.40

g/l

0.59

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

138

4.12

17.87

7.0

1.3

2.21

0.39

g/l

0.81

123

Bronchiectasis

242

1334

1.88

17.86

2.9

2.4

0.82

1.02

g/l

0.49

216

1117

Poisoning by drugs, medicaments and biological substances

432

2761

1.59

17.85

2.3

0.47

0.76

g/l

1.55

374

2425

Systemic atrophies primarily affecting the central nervous system

138

623

2.32

17.85

1.6

2.7

0.64

1.35

g/l

1.30

124

535

Protozoal diseases, including avohilmo

107

433

2.62

17.77

5.6

2.8

1.36

1.31

g/l

0.04

380

Fibroblastic disorders

554

3751

1.50

17.62

2.6

2.5

0.68

1.09

g/l

2.10

481

3156

Allergic purpura

312

2.89

17.59

2.0

2.9

0.40

0.82

g/l

0.79

278

Poisoning by medicine

392

2460

1.62

17.54

2.3

0.49

0.78

g/l

1.41

341

2168

Pneumonia due to other infectious organisms, not elsewhere classified

102

406

2.63

17.42

5.2

2.1

1.56

1.11

g/l

0.32

347

Demyelinating diseases of the central nervous system

173

856

2.07

17.36

1.6

2.3

0.37

0.88

g/l

1.54

159

759

Bullous disorders

180

909

2.06

17.36

2.0

2.5

0.55

1.22

g/l

2.75

161

777

Disorders of vestibular function (Vertigo)

1162

8675

1.32

17.35

2.3

2.5

0.86

0.85

g/l

0.04

977

7385

Other viral diseases, not elsewhere classified, including avohilmo

486

3187

1.53

17.35

3.1

2.3

0.78

0.70

g/l

0.15

440

2775

Vitamin B12 deficiency anaemia

281

1631

1.77

17.26

2.0

2.4

0.43

1.02

g/l

2.91

244

1377

Ptosis of eyelid

322

1942

1.70

17.25

2.6

2.5

0.86

0.96

g/l

0.23

285

1657

Other and unspecified mood [affective] disorders

126

551

2.33

17.20

1.8

2.3

0.23

0.76

g/l

2.29

117

494

Benign neoplasm: Ascending colon

409

2618

1.60

17.19

2.5

2.4

0.95

0.89

g/l

0.14

356

2229

Other symptoms and signs involving the circulatory and respiratory systems

166

816

2.09

17.03

2.4

1.14

0.88

g/l

0.23

143

690

Ascites

219

1188

1.90

16.97

1.5

2.5

0.57

1.00

g/l

1.35

189

1013

Behavioural syndromes associated with physiological disturbances and physical factors

2035

11228

1.23

16.95

2.2

2.5

0.65

0.76

g/l

0.83

1760

9709

Diseases of male genital organs

1079

4071

1.35

16.93

2.2

2.6

0.91

0.90

g/l

0.01

950

3572

Sub-endpoint used in defining T1D endpoints

609

4158

1.46

16.93

1.9

2.3

0.50

0.88

g/l

2.41

544

3569

Alcohol induced polyneuropathy

126

4.22

16.85

1.4

2.1

0.12

1.29

g/l

1.80

111

Candidiasis

334

2041

1.67

16.83

3.1

2.3

0.77

0.88

g/l

0.25

290

1750

Vitreous haemorrhage

271

1570

1.77

16.81

2.0

2.5

0.71

0.96

g/l

0.54

241

1346

Ulcerative colitis

506

3395

1.51

16.81

2.4

2.3

0.78

0.76

g/l

0.05

439

2954

Infections with a predominantly sexual mode of transmission

485

3214

1.52

16.78

2.0

2.1

0.47

0.67

g/l

0.93

431

2851

Pneumocystosis, including avohilmo

290

2.99

16.72

6.2

2.6

1.37

1.52

g/l

0.10

257

Pneumocystosis

290

2.99

16.72

6.2

2.6

1.37

1.52

g/l

0.10

257

Lesion of lateral popliteal nerve

135

619

2.26

16.71

2.4

0.32

1.37

g/l

3.86

114

544

Disorders of vitreous body

1274

9451

1.30

16.67

2.4

2.6

0.81

0.85

g/l

0.14

1099

8081

Suppurative and necrotic conditions of lower respiratory tract

166

826

2.09

16.66

2.9

2.6

0.55

1.15

g/l

1.79

141

713

Other infectious diseases

209

1124

1.92

16.63

3.1

2.4

0.47

1.13

g/l

2.48

185

963

Acute pancreatitis

482

3214

1.53

16.62

2.3

2.4

0.48

0.84

g/l

2.42

415

2757

Sarcoidosis

320

1943

1.68

16.61

2.2

2.3

0.65

0.88

g/l

0.58

278

1685

Problems related to lifestyle

207

1108

1.90

16.49

1.6

2.6

0.73

1.04

g/l

0.40

178

957

Dermatitis due to substances taken internally

136

628

2.24

16.48

3.5

2.8

0.92

1.24

g/l

0.32

110

549

Alcohol use disorder, ICD-based

912

6808

1.35

16.48

1.7

2.6

0.45

0.84

g/l

2.98

780

5932

Diseases of inner ear

1326

9955

1.29

16.47

2.3

2.6

0.82

0.85

g/l

0.12

1120

8501

Exclusions for E4_PCOS_CONSORTIUM

1372

6693

1.29

16.38

2.3

0.56

0.70

g/l

1.00

1161

5779

Chronic viral hepatitis

105

434

2.49

16.38

2.0

0.49

0.69

g/l

0.22

400

Olecranon bursitis

167

837

2.06

16.36

2.5

2.4

0.88

1.15

g/l

0.38

148

715

Respiratory insufficiency

209

1126

1.90

16.30

1.8

1.9

0.57

0.93

g/l

0.76

170

939

Iridocyclitis

513

3477

1.50

16.29

2.6

2.3

1.15

0.82

g/l

0.92

437

2998

Covid-19 suspected case

398

2553

1.58

16.26

2.8

2.2

0.76

0.68

g/l

0.20

366

2224

Other inflammatory liver diseases

172

874

2.03

16.21

1.9

2.7

0.53

1.10

g/l

1.70

145

755

Other abnormal immunological findings in serum

186

3.40

16.16

1.8

2.7

0.70

0.86

g/l

0.15

165

Early onset COPD

539

3703

1.48

16.06

2.2

2.5

0.51

0.88

g/l

1.89

480

3178

Cutaneous lupus erythematosus

312

2.82

16.04

2.3

2.5

0.11

1.31

g/l

3.59

269

Malignant melanoma

384

2459

1.59

16.01

3.2

1.5

1.06

0.36

g/l

3.30

315

2126

Transport accidents

862

5306

1.36

16.00

2.1

2.5

0.71

0.87

g/l

0.66

756

4676

Chronic laryngitis and laryngotracheitis

343

2139

1.64

15.99

1.8

2.3

0.52

0.88

g/l

1.11

281

1826

Other disorders of the musculoskeletal system and connective tissue

380

2430

1.60

15.98

2.5

2.4

0.61

0.90

g/l

1.23

336

2089

Cystic kidney disease

376

2.62

15.94

2.1

2.6

0.28

1.18

g/l

2.64

332

Systemic sclerosis, icd10

319

2.80

15.93

2.1

2.2

1.02

0.92

g/l

0.06

280

Acute posthaemorrhagic anaemia

104

436

2.49

15.92

3.0

2.8

0.92

1.52

g/l

0.82

373

Other and unspecified visual disturbances

265

1549

1.75

15.90

2.6

2.4

0.83

0.90

g/l

0.12

239

1337

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

409

2659

1.57

15.87

2.9

2.4

0.76

0.84

g/l

0.16

375

2291

Other diseases of stomach and duodenum

184

967

1.97

15.76

2.5

2.6

0.76

1.23

g/l

0.79

163

819

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

347

2156

1.63

15.75

2.7

1.5

0.89

0.38

g/l

2.68

292

1813

Diagnoses used for exclusion with ILD

624

4420

1.43

15.72

2.4

0.86

0.93

g/l

0.17

525

3773

Artificial joint operation, meniscal resection

2181

11545

1.22

15.67

2.3

2.6

0.70

0.85

g/l

1.21

1843

9948

Alcohol-induced chronic pancreatitis

166

845

2.03

15.61

1.9

2.7

0.34

1.18

g/l

3.91

138

742

Other/unspecified rheumatoid arthritis

328

2041

1.65

15.54

1.9

2.3

0.78

0.90

g/l

0.28

279

1725

Special screening examination for neoplasms

161

810

2.04

15.54

2.9

2.4

0.83

0.89

g/l

0.06

142

681

Psoriasis vulgaris

425

2805

1.54

15.42

2.0

2.4

0.69

0.80

g/l

0.22

374

2447

Other viral diseases, not elsewhere classified

355

2240

1.60

15.41

3.4

2.3

0.83

0.81

g/l

0.03

324

1943

Carpal tunnel syndrome

1381

9499

1.27

15.36

2.4

2.5

0.56

0.77

g/l

1.62

1217

8151

Lesion of ulnar nerve

326

2028

1.64

15.36

2.2

2.3

0.76

0.88

g/l

0.24

299

1763

Hallux rigidus

319

1974

1.65

15.35

2.3

2.6

0.88

0.99

g/l

0.14

262

1689

Other local infections of skin and subcutaneous tissue

250

1452

1.76

15.34

3.2

2.4

0.59

0.96

g/l

1.15

212

1242

Other shoulder lesions

203

1107

1.87

15.34

1.7

2.2

0.38

1.07

g/l

2.98

180

948

Cystic kidney disease, including avohilmo

402

2.52

15.25

2.0

2.6

0.28

1.14

g/l

2.70

356

Striking against or struck by other objects

655

4689

1.41

15.23

1.9

2.4

0.74

g/l

0.02

559

4117

Benign neoplasm of other and unspecified endocrine glands

329

2060

1.63

15.16

2.5

2.3

0.46

0.91

g/l

2.73

279

1784

Fentanyl

249

1446

1.75

15.14

5.7

1.9

2.25

0.88

g/l

2.64

203

1210

Haemorrhoids and perianal venous thrombosis

768

5619

1.37

15.13

2.4

2.5

0.93

0.92

g/l

0.01

649

4752

Tubulo-interstitial nephritis, not specified as acute or chronic

163

832

2.01

15.12

2.9

2.1

0.67

1.00

g/l

0.72

139

715

therapeutic use

108

475

2.40

15.01

2.1

2.7

0.50

1.57

g/l

2.50

405

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

116

520

2.28

15.00

1.6

2.0

0.32

0.63

g/l

0.91

477

Primary gonarthrosis, bilateral

1336

8877

1.27

14.97

2.1

2.6

0.68

0.93

g/l

1.73

1131

7566

Other specified/unspecified hearing loss

256

1513

1.74

14.87

2.3

0.71

0.90

g/l

0.48

237

1293

Myeloid leukaemia

378

2.57

14.87

1.6

2.9

0.27

1.31

g/l

3.15

335

Superficial injury of abdomen, lower back and pelvis

337

2128

1.61

14.86

2.4

2.2

0.58

0.85

g/l

1.07

288

1839

Hypoglycaemia, other or unspecified

163

838

2.00

14.84

1.8

2.4

0.26

1.21

g/l

5.57

143

731

Malignant melanoma, including Hilmo

417

2767

1.53

14.81

3.1

1.5

1.14

0.36

g/l

3.71

342

2386

Hypothyroidism, other/unspecified

1920

10377

1.22

14.81

2.3

2.5

0.68

0.84

g/l

1.18

1661

8935

Other/unspecified enthesopathies of lower limb, excluding foot

159

811

2.01

14.76

2.1

2.3

0.49

0.94

g/l

1.44

143

698

Mixed hyperlipidaemia

114

515

2.30

14.72

1.6

2.4

0.31

1.34

g/l

3.95

101

441

Sequelae of injuries, of poisoning and of other consequences of external causes

504

3475

1.47

14.70

2.8

2.4

0.67

0.83

g/l

0.49

432

3032

Other diseases of pancreas

235

1362

1.78

14.68

2.4

2.6

0.53

0.93

g/l

1.51

202

1164

Specific personality disorders

387

2529

1.55

14.58

1.9

2.3

0.45

0.73

g/l

1.19

343

2233

Infections with a predominantly sexual mode of transmission, including avohilmo

592

3833

1.42

14.57

2.0

2.1

0.52

0.62

g/l

0.31

528

3399

Ankylosing spondylitis, ICD10

193

1055

1.87

14.56

1.7

2.5

0.75

1.02

g/l

0.50

175

926

Mantle cell lymphoma, including Hilmo

169

3.44

14.52

2.9

1.3

0.76

0.24

g/l

0.74

150

Other and unspecified local infections of skin and subcutaneous tissue

235

1364

1.76

14.49

3.3

2.4

0.62

1.01

g/l

1.18

204

1168

Adhesive capsulitis of shoulder

373

2428

1.56

14.45

2.1

2.5

0.39

1.00

g/l

4.61

323

2060

Other hearing loss

797

5770

1.36

14.43

2.6

2.4

0.94

g/l

0.01

654

4915

Secondary thrombocytopenia

150

3.61

14.40

3.7

1.9

0.76

1.08

g/l

0.24

137

Benign neoplasm: Rectum, anus and anal canal

530

3713

1.45

14.35

2.6

2.4

1.06

0.91

g/l

0.35

459

3166

Intestinal stricture

776

5786

1.36

14.32

2.8

2.5

0.97

0.90

g/l

0.14

661

4913

Malignant neoplasm of kidney, except renal pelvis

233

1356

1.76

14.30

2.0

1.4

1.37

0.38

g/l

2.49

206

1160

Benign neoplasm: Caecum

310

1947

1.64

14.27

2.8

2.4

0.95

0.98

g/l

0.04

276

1663

Other lack of coordination

202

3.17

14.24

2.2

2.9

0.39

1.04

g/l

1.25

178

Emotionally unstable personality disorder

180

966

1.89

14.23

1.8

2.0

0.36

0.67

g/l

0.85

161

871

Other localized connective tissue disorders

241

2.95

14.12

3.0

2.3

1.53

0.71

g/l

0.60

212

Benign thyroid growths and nodules

767

5307

1.36

14.10

2.3

2.5

0.87

0.86

g/l

0.03

657

4496

Benign neoplasm: Rectum

480

3314

1.48

14.10

2.6

2.4

0.97

0.90

g/l

0.13

418

2823

Pemphigoid

100

438

2.42

14.09

1.6

2.6

0.40

1.42

g/l

2.95

375

Acute generalized exanthematous pustulosis

121

570

2.20

14.09

3.7

2.7

1.30

1.34

g/l

0.02

497

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

640

4570

1.39

14.07

2.2

2.3

0.40

0.69

g/l

2.32

569

4044

Gingival hyperplasia

100

436

2.39

14.06

3.4

2.8

0.79

1.10

g/l

0.34

386

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

249

1483

1.72

14.05

3.2

2.5

0.73

1.06

g/l

0.73

222

1282

Keratitis

763

5686

1.36

14.04

2.3

2.4

0.53

0.81

g/l

2.65

667

4904

Sleep disorders

1924

10963

1.21

14.02

2.1

2.5

0.63

0.76

g/l

1.03

1667

9483

Social phobias

117

541

2.19

13.98

2.3

2.0

0.23

0.62

g/l

1.79

110

490

Diabetic maculopathy, excluding more controls

249

1483

1.71

13.97

1.5

2.4

0.15

1.12

g/l

11.39

216

1276

Guillain-Barre syndrome

194

3.20

13.95

2.6

2.3

0.38

1.18

g/l

1.18

173

Other juvenile arthritis

229

2.91

13.94

2.2

1.9

0.56

1.35

g/l

1.05

207

Acute nephritic syndrome

243

2.92

13.89

2.6

2.8

0.41

1.10

g/l

1.37

216

Pyothorax

127

614

2.15

13.89

3.2

2.6

0.58

1.30

g/l

1.69

107

530

Malignant neoplasm of urinary organs

251

1503

1.71

13.88

2.1

1.5

1.34

0.36

g/l

2.67

221

1284

Speech and linguistic disorders, excluding more controls

115

495

2.21

13.86

2.1

2.4

0.54

1.07

g/l

0.89

430

Trigger finger

312

1969

1.61

13.85

1.8

2.4

0.72

0.93

g/l

0.47

279

1689

Abnormal results of function studies

208

1182

1.80

13.84

2.6

1.11

0.90

g/l

0.29

178

1027

Colonic or urogenital fistula

591

4242

1.41

13.83

2.6

2.4

0.75

0.81

g/l

0.15

502

3655

Bacterial, viral and other infectious agents, including avohilmo

184

1007

1.87

13.81

3.0

2.4

0.35

0.95

g/l

3.20

166

892

Other and unspecified injuries of head

189

1045

1.86

13.81

1.8

2.4

0.57

1.12

g/l

1.83

160

887

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

112

517

2.26

13.81

2.5

2.7

0.67

1.28

g/l

1.19

101

455

Other disorders of ear

2099

11326

1.20

13.79

2.5

2.4

0.88

0.77

g/l

0.54

1748

9834

Other demyelinating diseases of the central nervous system

329

2.58

13.75

1.8

2.2

0.65

0.75

g/l

0.09

299

Hypothyreosis and Thyroxine purchase for inclusion criteria

2003

10915

1.21

13.70

2.3

2.5

0.67

0.83

g/l

1.32

1730

9387

Acute pancreatitis (for exclusion)

482

3347

1.46

13.66

2.3

2.4

0.48

0.89

g/l

2.91

415

2877

Eating disorder

109

494

2.23

13.64

1.4

1.8

0.09

0.37

g/l

1.80

102

452

Parkinson's disease, strict definition, excluding more controls

319

1894

1.60

13.58

1.9

2.6

0.45

1.17

g/l

4.31

268

1614

Vitamin deficiency

123

591

2.15

13.58

2.8

2.6

0.34

1.39

g/l

3.82

102

512

Vitamin deficiency, wide

123

591

2.15

13.58

2.8

2.6

0.34

1.39

g/l

3.82

102

512

Other skin changes

487

3395

1.46

13.52

3.2

2.5

0.95

0.96

g/l

0.02

402

2895

Mantle cell lymphoma

108

4.06

13.51

1.6

1.2

0.36

0.29

g/l

0.08

Artificial joint re-operation

208

1198

1.80

13.42

2.0

2.5

0.71

1.10

g/l

1.11

182

1016

Parkinson's disease, excluding more controls

337

2003

1.58

13.41

1.9

2.7

0.43

1.18

g/l

4.93

283

1708

Sequelae of injuries of lower limb

205

1172

1.79

13.36

2.4

0.33

1.01

g/l

3.75

187

1028

Diabetic retinopathy

882

4164

1.33

13.33

2.0

2.3

0.54

0.70

g/l

0.85

748

3577

Squamous cell neoplasms and carcinomas of the skin

277

1721

1.65

13.25

2.8

1.5

0.86

0.42

g/l

1.93

235

1442

Other specified/unspecified inflammatory spondylopathies

427

2.33

13.23

2.1

0.41

0.97

g/l

1.41

375

Other bursopathies

304

1931

1.60

13.21

2.8

2.3

0.76

0.98

g/l

0.42

260

1635

Hypermobility syndrome

396

2.38

13.17

2.4

2.1

0.25

0.56

g/l

0.85

358

Drug-induced polyneuropathy

111

3.97

13.05

15.8

1.7

1.73

0.44

g/l

0.95

100

Carcinoma in situ of skin

254

1556

1.68

13.02

2.4

2.5

1.00

1.09

g/l

0.10

215

1317

Alcohol-induced acute pancreatitis

432

2.34

13.02

2.3

2.9

0.37

1.21

g/l

2.52

390

Other congenital malformations, including avohilmo

230

1365

1.71

13.00

2.2

2.4

0.46

0.85

g/l

1.35

210

1196

Ocular pain

186

1043

1.82

12.96

1.8

2.6

0.32

1.00

g/l

4.13

172

903

Fall involving bed

111

525

2.21

12.95

2.3

2.6

0.55

1.47

g/l

2.48

446

Dementia in Alzheimer disease

251

3363

0.61

12.86

1.7

2.4

1.73

1.18

g/l

0.78

179

2810

Anosmia

118

3.59

12.84

3.2

1.4

0.27

0.13

g/l

0.26

Inguinal hernia

1303

6948

1.26

12.83

2.9

2.4

0.95

0.81

g/l

0.63

1129

5979

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

277

1731

1.62

12.79

2.2

2.3

0.26

0.79

g/l

4.52

235

1544

Heartburn

256

1572

1.66

12.79

2.1

2.4

0.68

0.90

g/l

0.48

220

1344

Folate deficiency anaemia

147

3.49

12.77

3.3

2.1

0.77

0.79

g/l

0.02

130

Otitis externa

486

3421

1.44

12.75

2.4

2.3

0.79

0.78

g/l

0.03

411

2972

Syphilis, including avohilmo

289

2.64

12.73

2.2

2.6

0.39

1.09

g/l

1.79

261

Syphilis

289

2.64

12.73

2.2

2.6

0.39

1.09

g/l

1.79

261

Epilepsy

640

4701

1.37

12.71

2.0

2.5

0.77

0.92

g/l

0.51

538

4042

Injuries to the neck

451

3133

1.46

12.69

2.9

2.3

0.54

0.78

g/l

0.99

389

2726

Disorders of orbit

115

554

2.15

12.68

3.4

2.6

0.95

1.05

g/l

0.07

104

485

Carbimazole or st.post thyroidectomy, condition for graves disease

433

2988

1.47

12.67

2.6

2.3

0.39

0.79

g/l

2.92

382

2580

Temporomandibular joint disorders, including avohilmo

774

5677

1.33

12.65

2.4

2.3

0.59

0.65

g/l

0.25

678

4959

Lung cancer and mesothelioma

449

2637

1.46

12.63

2.3

2.1

1.05

0.87

g/l

0.35

387

2215

Other specified and unspecified personality disorders

162

877

1.88

12.61

1.9

2.3

0.33

0.80

g/l

1.30

145

782

Eating disorders

145

754

1.95

12.61

2.0

0.10

0.67

g/l

4.50

133

675

Monoamine oxidase A inhibitors

260

1610

1.65

12.59

2.1

2.5

0.65

0.95

g/l

0.63

225

1396

Insomnia

1856

10765

1.21

12.57

2.1

2.5

0.63

0.74

g/l

0.85

1611

9321

Other nonthrombocytopenic purpura

114

3.82

12.51

2.4

2.3

0.61

0.77

g/l

0.11

102

Speech disturbances, not elsewhere classified

237

1439

1.69

12.50

2.0

2.4

0.47

1.06

g/l

3.09

199

1228

Algoneurodystrophy

304

2.55

12.37

1.3

2.3

0.02

0.90

g/l

3.93

275

Left bundle-branch block

189

1083

1.79

12.32

1.8

2.4

0.66

1.14

g/l

1.09

153

917

Inflammatory diseases of the central nervous system

188

1075

1.79

12.31

2.9

2.6

1.32

1.00

g/l

0.35

161

937

Drug-induced osteoporosis

182

3.14

12.29

1.9

2.4

1.36

0.97

g/l

0.26

163

Diseases of the ear and mastoid process

2400

10229

1.18

12.27

2.4

0.87

0.73

g/l

0.88

2058

8917

Intestinal adhesions without obstruction

214

1271

1.72

12.26

3.7

2.2

0.95

0.94

g/l

0.00

186

1070

Malignant neoplasm of other connective and soft tissue

301

2.58

12.23

4.5

1.4

2.97

0.37

g/l

1.80

263

Suggestive for eosinophilic asthma

226

1363

1.70

12.23

2.3

2.4

1.04

0.92

g/l

0.10

206

1178

Benign paroxysmal vertigo

704

5304

1.34

12.21

2.4

2.5

0.88

0.87

g/l

0.03

585

4498

Neuralgia and neuritis, unspecified

122

609

2.06

12.18

2.6

2.3

0.45

1.26

g/l

1.94

104

519

Chronic myeloproliferative disease

200

3.03

12.14

3.3

2.9

1.49

0.95

g/l

0.36

179

Barrett oesophagus

141

744

1.96

12.10

2.4

2.9

0.58

1.44

g/l

2.27

126

642

Exposure to other and unspecified inanimate mechanical forces

161

884

1.86

12.05

2.7

2.5

0.69

0.99

g/l

0.65

153

777

Anti-inflammatory and antirheumatic products, non-steroids

562

2019

1.41

12.03

2.8

2.4

1.37

0.95

g/l

1.12

492

1725

Alcohol abuse, main dg, excluding more controls

288

1846

1.58

12.01

1.4

2.6

0.24

0.74

g/l

5.31

247

1639

Nummular dermatitis

205

1212

1.73

11.96

2.4

2.6

0.72

1.09

g/l

0.73

176

1039

Open wound of forearm

214

1278

1.71

11.96

2.4

0.81

1.08

g/l

0.53

185

1101

Hernia of abdominal wall

1045

8307

1.27

11.95

2.6

2.5

0.91

0.81

g/l

0.34

932

7121

Personal history of other diseases and conditions

172

959

1.81

11.92

3.8

2.1

1.13

0.65

g/l

0.66

151

848

Acute myeloid leukaemia, helper endpoint

158

3.25

11.92

1.2

1.3

0.20

0.42

g/l

0.49

138

Acute myeloid leukaemia

158

3.25

11.92

1.2

1.3

0.20

0.42

g/l

0.49

138

Acute myeloid leukaemia, including Hilmo

158

3.25

11.92

1.2

1.3

0.20

0.42

g/l

0.49

138

Cardiac arrest

141

626

1.95

11.91

2.1

2.3

0.97

1.52

g/l

0.84

121

530

Angina pectoris

1358

7329

1.24

11.90

2.5

2.7

0.77

0.95

g/l

1.10

1181

6238

Emphysema

203

1201

1.74

11.87

2.9

2.5

1.29

1.11

g/l

0.16

173

1009

Cardiomyopathy, Hypertrophic obstructive

213

2.87

11.79

1.8

2.8

0.37

2.11

g/l

2.86

186

Drug-induced cataract

295

2.57

11.77

3.1

2.7

0.40

1.00

g/l

1.09

261

Other symptoms and signs involving the nervous and musculoskeletal systems

863

6712

1.30

11.74

2.4

2.5

0.70

0.87

g/l

0.84

744

5768

Synovial cyst of popliteal space [Baker]

178

1018

1.79

11.70

2.8

2.2

0.95

1.14

g/l

0.23

154

851

Unspecified nephritic syndrome

272

2.63

11.69

2.0

2.7

0.23

1.18

g/l

2.46

244

Bacterial, viral and other infectious agents

166

933

1.82

11.52

2.8

2.5

0.33

0.98

g/l

3.40

148

829

Propionic acid derivatives

558

2019

1.40

11.49

2.7

2.4

1.35

0.95

g/l

1.17

485

1725

Polyarteritis nodosa and related conditions

135

3.37

11.49

2.6

0.05

1.05

g/l

1.82

117

Umbilical hernia

592

4386

1.37

11.49

2.3

2.4

0.96

0.75

g/l

0.54

530

3818

Certolizumab pegol

140

3.27

11.41

1.4

2.3

0.17

0.54

g/l

0.86

131

Benign neoplasm: Adrenal gland

206

1238

1.71

11.40

2.4

2.6

0.45

1.11

g/l

2.89

174

1071

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

468

3338

1.41

11.37

2.2

2.3

0.33

0.71

g/l

4.14

404

2947

Calculus of kidney and ureter

700

5327

1.33

11.35

2.4

2.5

0.64

0.93

g/l

1.75

603

4592

COPD-related respiratory insufficiency

322

2152

1.53

11.30

2.2

2.5

1.11

1.14

g/l

0.03

275

1804

Impingement syndrome of shoulder

497

3592

1.40

11.28

2.5

2.6

0.62

0.93

g/l

1.28

429

3073

Cervicocranial syndrome

226

1393

1.65

11.19

2.0

2.3

0.67

0.96

g/l

0.60

200

1167

Carcinoma in situ of skin of upper limb, including shoulder

465

2.21

11.12

2.7

2.8

0.66

1.48

g/l

1.93

390

Carcinoma in situ of skin of trunk

114

579

2.06

11.11

3.5

2.5

1.21

1.36

g/l

0.14

100

486

Retinal vascular occlusion

324

2176

1.52

11.10

2.7

2.4

0.75

0.95

g/l

0.53

274

1840

Acute peritonitis

161

911

1.82

11.05

2.4

2.6

0.55

1.25

g/l

1.88

151

782

Follicular lymphoma, hilmo

129

684

1.96

11.03

1.7

2.9

0.53

1.39

g/l

2.57

108

592

Misadventures to patients during surgical and medical care

330

2226

1.51

10.98

2.2

2.3

0.76

0.88

g/l

0.27

277

1896

Pain associated with micturition

270

1745

1.57

10.98

2.8

2.4

1.04

0.89

g/l

0.21

235

1495

Benign neoplasm: Rectosigmoid junction

123

643

1.99

10.97

2.1

2.8

0.78

1.32

g/l

0.84

101

552

Adrenocortical insufficiency

432

2.20

10.91

2.5

2.8

0.55

1.00

g/l

0.65

381

Insulin, fast-acting (human)

252

1603

1.59

10.90

1.8

2.2

0.39

0.87

g/l

2.24

228

1404

Impacted cerumen

299

1983

1.54

10.88

2.0

2.4

0.34

0.97

g/l

5.97

222

1696

Generalized skin eruption due to drugs and medicaments

102

499

2.11

10.88

3.8

2.7

1.13

1.35

g/l

0.15

440

Myocarditis

398

2.23

10.86

2.7

2.2

1.17

0.92

g/l

0.23

339

Acute and subacute iridocyclitis

405

2846

1.44

10.85

2.8

2.3

1.15

0.84

g/l

0.67

340

2457

Acute pharyngitis

234

1450

1.61

10.77

2.9

2.1

0.48

0.71

g/l

0.78

218

1303

Bullous pemphigoid

340

2.39

10.77

1.5

2.9

0.47

1.25

g/l

1.64

292

Carcinoma in situ of skin of lower limb, including hip

366

2.35

10.76

3.0

2.8

0.54

1.08

g/l

1.21

306

Other disorders of adrenal gland

105

521

2.07

10.74

2.4

2.7

0.50

1.03

g/l

0.97

463

Symptoms and signs involving emotional state

282

2.49

10.73

1.6

2.3

0.35

1.02

g/l

1.40

248

Crohn disease

242

1533

1.60

10.69

1.7

2.3

0.36

0.86

g/l

2.39

213

1333

Hyperhidrosis

258

2.55

10.68

2.4

2.6

0.48

1.06

g/l

0.68

217

Retinal vascular disorders

326

2210

1.50

10.68

2.7

2.4

0.75

0.95

g/l

0.55

276

1869

Disorders of psychological development

146

744

1.84

10.68

1.9

2.0

0.48

0.74

g/l

0.50

129

666

Other specified/unspecified bacterial intestinal infections

164

943

1.78

10.66

2.9

2.4

0.67

1.06

g/l

0.90

138

816

Other abnormal uterine and vaginal bleeding

463

2379

1.41

10.65

2.2

2.3

1.04

0.73

g/l

0.82

364

2024

Other orthopaedic follow-up care

136

739

1.89

10.64

1.8

2.1

0.61

0.84

g/l

0.22

122

634

Diplopia

304

2036

1.52

10.52

2.2

2.4

0.64

0.87

g/l

0.69

270

1754

Congenital malformations of the circulatory system

264

1662

1.56

10.50

1.8

2.4

0.47

0.90

g/l

1.97

229

1454

Suicide or other Intentional self-harm

421

2997

1.42

10.43

2.2

2.3

0.30

0.77

g/l

5.75

363

2637

Superficial injury of wrist and hand

378

2640

1.45

10.42

2.0

2.3

0.54

0.75

g/l

0.84

332

2303

Fall on same level involving ice and snow

1264

10403

1.22

10.42

2.2

2.5

0.45

0.81

g/l

6.43

1068

8957

Mental and behavioural disorders due to sedatives or hypnotics

129

693

1.90

10.41

1.5

2.3

0.30

0.70

g/l

1.57

111

617

Gonarthrosis, primary, with knee surgery

1454

9424

1.21

10.39

2.2

2.6

0.70

0.91

g/l

1.71

1222

8050

Other/unspecified synovitis and tenosynovitis

230

1452

1.61

10.35

1.9

2.3

0.89

1.06

g/l

0.22

200

1233

Other/unspecified disorders of vestibular function

118

620

1.97

10.35

2.1

2.8

0.45

1.33

g/l

2.71

104

536

Artificial opening status

149

842

1.82

10.35

3.4

2.3

0.81

0.90

g/l

0.09

133

725

Ulcerative colitis, NAS

267

1744

1.55

10.33

2.0

2.4

0.51

0.87

g/l

1.69

239

1516

Anterior Iridocyclitis

428

3066

1.41

10.31

2.7

2.3

1.09

0.82

g/l

0.58

361

2647

Polycythaemia vera

443

2.16

10.29

2.6

1.4

0.99

0.48

g/l

0.80

379

Other disorders of patella

267

1744

1.55

10.27

2.2

2.6

0.37

0.88

g/l

3.69

241

1538

Infection due to other mycobacteria, including avohilmo

206

2.76

10.26

1.9

2.6

1.12

0.78

g/l

0.21

178

Biological medicines for asthma

211

2.71

10.26

2.1

2.0

0.80

0.73

g/l

0.04

195

Benign neoplasm of mouth and pharynx

254

1651

1.57

10.16

3.2

2.4

1.03

0.97

g/l

0.08

218

1423

D07AA Corticosteroids, weak (group I)

262

1708

1.55

10.12

1.9

2.3

0.51

0.86

g/l

1.35

221

1488

Other superficial mycoses, including avohilmo

191

1158

1.67

10.11

2.0

2.4

0.17

0.95

g/l

6.94

172

1012

Superficial injury of thorax

330

2264

1.48

10.10

1.6

2.4

0.55

0.86

g/l

1.42

276

1957

Mental and behavioural disorders due to opioids

259

2.49

10.09

1.8

1.9

0.20

0.72

g/l

1.19

240

Primary Sclerosing Cholangitis, IBD and UDCA required

207

2.71

10.09

2.1

2.6

0.22

0.74

g/l

1.67

190

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

640

4891

1.32

10.09

1.8

2.7

0.36

0.85

g/l

6.10

562

4259

Glucagon-like peptide-1 (GLP-1) analogues

640

4891

1.32

10.09

1.8

2.7

0.36

0.85

g/l

6.10

562

4259

Traumatic subarachnoid haemorrhage

446

2.13

10.05

2.7

2.5

0.81

1.38

g/l

0.52

386

Urolithiasis

750

5859

1.29

10.04

2.4

2.5

0.64

0.94

g/l

1.99

644

5036

Familial hypercholesterolemia

347

2408

1.46

10.04

2.8

2.3

0.84

1.04

g/l

0.61

298

2019

Speech and linguistic disorders

116

581

1.94

10.02

2.1

2.2

0.54

0.82

g/l

0.41

100

515

Viral agents as the cause of diseases classified to other chapters, including avohilmo

280

2.45

10.00

3.6

2.4

0.56

0.95

g/l

0.63

250

Other and unspecified erythematous conditions

428

2.16

10.00

2.4

2.6

0.95

1.24

g/l

0.24

372

Mature T/NK-cell lymphomas, hilmo

193

2.83

9.95

1.5

2.7

0.41

1.13

g/l

0.82

171

Monoplegia

181

2.86

9.93

2.3

2.8

1.23

1.08

g/l

0.07

160

Microscopic polyangiitis

3.95

9.92

1.5

2.4

0.08

0.50

g/l

1.20

Cluster headache, strict

337

2.29

9.88

1.8

3.0

0.35

0.70

g/l

0.71

295

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

218

1379

1.62

9.86

2.3

2.5

0.46

0.98

g/l

2.61

182

1179

Arthropathic psoriasis

240

1550

1.58

9.86

2.0

2.5

0.68

0.96

g/l

0.60

213

1351

Exposure to other and unspecified animate mechanical forces

281

2.42

9.85

2.7

2.2

0.27

0.69

g/l

1.09

259

Deviated nasal septum

687

5313

1.30

9.82

2.9

2.5

0.92

0.84

g/l

0.16

601

4617

Other renal tubulo-interstitial diseases

234

2.57

9.77

1.9

2.1

0.38

0.66

g/l

0.52

207

Coeliac disease

244

1587

1.56

9.69

2.8

2.2

0.87

0.83

g/l

0.04

209

1364

IBD patients in KELA-register

405

2903

1.41

9.69

2.4

2.3

0.68

0.74

g/l

0.13

358

2550

Carcinoma in situ of other and unspecified digestive organs

125

685

1.89

9.68

2.1

2.8

0.68

1.36

g/l

1.30

112

594

Unspecified urinary incontinence

219

1393

1.61

9.68

1.6

2.4

1.12

0.92

g/l

0.15

164

1184

Other infective otitis externa

140

793

1.81

9.61

2.4

0.12

1.09

g/l

8.02

125

692

Other specified/unspecified soft tissue disorders

114

606

1.93

9.60

2.6

2.1

0.72

1.30

g/l

1.08

105

504

Ulcerative ileocolitis

387

2.18

9.59

2.8

2.4

0.60

0.89

g/l

0.44

347

Other Crohn's disease

125

683

1.87

9.59

1.5

2.4

0.14

0.84

g/l

4.55

109

603

Other prurigo

119

3.30

9.58

1.3

3.5

0.07

0.84

g/l

1.86

102

Cluster headache, wide

374

2.19

9.57

1.9

2.9

0.44

0.77

g/l

0.63

325

Viral and other specified intestinal infections, including avohilmo

417

2891

1.40

9.56

2.2

2.1

0.56

0.72

g/l

0.40

381

2517

Diseases of peritoneum

237

1539

1.57

9.55

2.2

2.5

0.61

1.06

g/l

1.39

213

1307

Pneumonia due to Streptococcus pneumoniae

475

2.05

9.55

5.7

2.0

2.45

1.19

g/l

1.02

407

Inflammatory diseases of female pelvic organs

1132

6335

1.23

9.51

1.9

2.5

0.67

0.65

g/l

0.05

962

5454

Background retinopathy and retinal vascular changes

275

2.44

9.50

2.1

3.1

0.64

1.07

g/l

0.49

241

Sacroiliitis, not elsewhere classified

368

2.19

9.49

2.1

2.0

0.24

0.72

g/l

1.62

324

Paraplegia, diplegia of upper limbs

269

2.45

9.47

2.2

2.7

0.45

0.98

g/l

0.88

240

Malignant melanoma of skin

271

1814

1.52

9.46

2.7

1.5

0.90

0.36

g/l

1.63

226

1578

Other and unspecified injuries of lower leg

151

877

1.75

9.44

2.4

0.68

1.03

g/l

0.73

136

757

Cervicobrachial syndrome

410

2960

1.40

9.42

2.3

0.90

0.77

g/l

0.24

370

2515

Hypothyroidism, strict autoimmune, 3 medication purchases required

1761

10084

1.18

9.39

2.2

2.5

0.71

0.82

g/l

0.62

1504

8656

Attention to artificial openings

110

584

1.94

9.37

2.4

2.2

0.78

1.02

g/l

0.37

497

Hyperkinetic disorders, excluding more controls

101

480

1.98

9.33

1.4

1.8

0.52

0.36

g/l

0.25

450

Adenomyosis (Endometriosis of uterus)

278

1872

1.50

9.31

2.3

2.4

1.10

0.71

g/l

0.52

251

1590

Fracture of neck

160

955

1.72

9.19

3.7

2.4

0.73

1.18

g/l

0.91

139

815

Arterial embolism and thrombosis

146

849

1.76

9.17

1.6

2.5

0.48

1.27

g/l

3.11

120

716

Entropion and trichiasis of eyelid

237

1556

1.56

9.17

2.6

1.24

1.21

g/l

0.03

203

1312

Abscess of anal and rectal regions

160

952

1.71

9.17

1.5

2.3

1.05

0.93

g/l

0.09

146

826

Other congenital malformations

140

802

1.77

9.15

2.4

0.40

0.87

g/l

1.34

132

706

Alzheimer disease, excluding more controls

435

2043

1.39

9.15

2.0

2.7

1.16

1.18

g/l

0.03

350

1740

Abnormal findings on diagnostic imaging of central nervous system

113

609

1.90

9.14

2.4

2.6

1.07

0.96

g/l

0.09

102

537

Complications of cardiac and vascular prosthetic devices, implants and grafts

300

2.34

9.09

2.4

3.1

0.94

1.44

g/l

0.55

260

Pain and other conditions associated with female genital organs and menstrual cycle

309

1775

1.47

9.08

2.0

2.1

0.36

0.54

g/l

0.73

270

1552

Childhood asthma (age<16), excluding more controls

105

423

1.95

9.07

1.5

0.39

0.31

g/l

0.12

396

Respiratory disorders in diseases classified elsewhere

179

2.79

9.05

2.4

0.08

0.79

g/l

1.82

159

malignant neoplasm of male genital organs, including Hilmo

632

2915

1.31

8.99

2.4

1.5

1.02

0.37

g/l

3.85

540

2547

Infection due to other mycobacteria

197

2.67

8.96

1.9

2.5

1.18

0.82

g/l

0.20

169

Supplementary factors related to causes of morbidity and mortality classified elsewhere

639

4964

1.30

8.96

2.1

2.3

0.79

0.81

g/l

0.05

517

4295

Exfoliative dermatitis

119

3.22

8.93

1.8

2.7

0.64

0.79

g/l

0.08

101

Other immunodeficiencies

119

3.21

8.93

6.2

2.5

1.90

0.53

g/l

0.81

107

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

313

2.26

8.92

1.7

2.1

0.21

0.74

g/l

1.33

291

Disorders of oesophagus in diseases classified elsewhere

290

2.35

8.89

4.1

3.3

0.78

1.29

g/l

0.71

251

Other diseases of oesophagus

223

1453

1.56

8.88

2.7

2.6

1.22

1.09

g/l

0.16

191

1240

Clear cell adenocarcinoma of kidney

118

653

1.86

8.85

1.7

1.5

0.67

0.37

g/l

0.60

564

Other/unspecified enthesopathies, not elsewhere classified

182

1133

1.64

8.80

1.9

2.2

0.56

1.07

g/l

1.49

157

951

Follow-up examination after treatment for malignant neoplasms

219

1423

1.56

8.80

2.8

2.4

1.14

0.90

g/l

0.34

194

1183

Disorders of myoneural junction and muscle in diseases classified elsewhere

100

3.47

8.78

1.7

2.8

0.11

0.75

g/l

1.42

Superficial injury of shoulder and upper arm

251

1680

1.52

8.77

2.4

2.3

0.50

0.94

g/l

1.65

217

1458

Vitamin D deficiency

187

2.67

8.74

1.8

2.3

0.29

0.90

g/l

1.19

171

Childhood asthma (age<16)

105

429

1.92

8.73

1.5

0.39

0.31

g/l

0.13

401

Disorders of optic nerve and visual pathways

186

1166

1.62

8.73

2.3

2.5

0.22

1.00

g/l

5.95

168

1021

Malignant neoplasm of other connective and soft tissue, including Hilmo

102

541

1.94

8.73

5.0

1.4

2.33

0.40

g/l

1.80

470

Asthma and opportunity respiratory infection

132

760

1.79

8.72

2.8

2.7

1.00

1.30

g/l

0.46

122

643

Cholecystectomy

1583

11465

1.18

8.72

2.5

0.78

0.84

g/l

0.25

1360

9813

Nasal polyp

418

3074

1.38

8.68

2.8

2.5

1.00

0.91

g/l

0.12

372

2642

Other specified/unspecified spondylopathies

338

2.22

8.68

3.1

2.2

1.94

1.41

g/l

0.27

284

MS-disease / Multiple Sclerosis

123

692

1.81

8.62

1.7

2.3

0.29

0.89

g/l

2.39

117

616

Other and unspecified glaucoma

196

1253

1.60

8.59

2.3

2.5

0.84

1.02

g/l

0.29

160

1054

Otalgia

174

1078

1.64

8.58

2.1

2.3

0.92

0.85

g/l

0.07

146

939

Right bundle-branch block

495

1.98

8.57

3.2

2.5

0.45

1.44

g/l

2.54

415

Superficial injury of ankle and foot

205

1319

1.57

8.55

1.9

2.4

0.65

0.90

g/l

0.37

184

1166

Alzheimer’s disease (Late onset), excluding more controls

383

1791

1.41

8.54

2.0

2.7

1.11

1.24

g/l

0.23

317

1518

Other and unspecified disorders of vitreous body

995

7996

1.23

8.53

2.4

2.6

0.77

0.84

g/l

0.23

855

6852

Thyrotoxicosis with toxic multinodular goitre

159

968

1.69

8.52

1.7

2.4

0.31

1.05

g/l

4.38

136

822

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

167

1018

1.65

8.50

1.8

2.3

0.72

0.70

g/l

0.02

155

906

Hemiplegia

116

646

1.84

8.49

2.0

2.4

0.46

1.17

g/l

2.47

100

562

Golimumab

320

2.21

8.48

1.8

2.1

0.22

0.70

g/l

1.19

294

Autoimmune hyperthyroidism

116

646

1.83

8.44

2.1

2.5

0.32

1.08

g/l

1.66

107

567

Psoriatic arthropathies, ICD10

218

1431

1.55

8.41

2.0

2.5

0.74

0.97

g/l

0.39

192

1250

Alcohol dependence

560

4316

1.31

8.41

1.7

2.6

0.47

0.86

g/l

1.62

472

3786

Other follicular disorders

138

809

1.74

8.40

2.1

2.5

0.60

0.89

g/l

0.65

124

716

Plantar fascial fibromatosis

191

1216

1.60

8.40

2.7

2.1

0.56

1.07

g/l

1.49

173

1044

Procreative management

520

3252

1.33

8.38

2.1

2.3

0.51

0.64

g/l

0.51

476

2878

Anogenital herpesviral [herpes simplex] infection, including avohilmo

154

930

1.67

8.33

2.3

2.2

0.61

0.75

g/l

0.15

139

833

Fracture at wrist and hand level

656

5144

1.28

8.32

2.3

2.4

0.59

0.74

g/l

0.61

559

4471

Crohn's disease NAS

122

693

1.79

8.32

1.9

2.5

0.39

1.02

g/l

2.22

105

608

Lactose intolerance

310

2.22

8.31

1.7

1.8

0.33

0.86

g/l

1.21

268

Mental and behavioural disorders due to tobacco

185

1174

1.61

8.30

2.1

2.6

0.62

1.01

g/l

0.98

150

1030

Sleep disorders, other/unspecified

323

2.19

8.28

1.6

2.3

0.32

0.86

g/l

0.98

291

Viral agents as the cause of diseases classified to other chapters

248

2.39

8.24

2.8

2.2

0.49

0.96

g/l

0.81

223

Obsessive-compulsive disorder

416

2.02

8.22

2.1

2.2

0.77

0.62

g/l

0.13

381

Event of undetermined intent

120

681

1.80

8.21

2.7

2.5

0.86

0.98

g/l

0.14

106

609

Drug-induced Cushing's syndrome

13.55

8.21

2.0

1.0

0.07

0.79

g/l

0.47

Orchitis and epididymitis

203

1319

1.57

8.20

2.2

2.6

1.57

0.88

g/l

0.70

167

1143

Erythema multiforme

274

2.31

8.20

2.2

2.6

0.75

1.24

g/l

0.47

242

Carcinoma in situ of colon

449

2.02

8.19

2.2

2.7

0.51

1.39

g/l

1.45

386

Hepatic failure, not elsewhere classified

504

1.94

8.17

1.9

2.8

0.74

1.48

g/l

1.36

435

Type of accident

596

4648

1.29

8.17

2.1

2.3

0.80

0.82

g/l

0.06

479

4022

Extreme obesity with alveolar hypoventilation

101

547

1.90

8.15

2.6

2.8

0.87

1.27

g/l

0.49

473

Inflammatory bowel disease, strict (require KELA)

405

2993

1.37

8.13

2.4

2.3

0.68

0.74

g/l

0.14

358

2632

Other erythematous conditions

484

1.96

8.12

2.4

2.6

0.95

1.33

g/l

0.34

425

Dislocation, sprain and strain of joint and ligaments of hip

101

548

1.90

8.12

2.0

2.5

0.84

1.40

g/l

0.93

476

Other and unspecified tonsillitis

457

2845

1.34

8.10

1.8

2.1

0.68

0.58

g/l

0.18

412

2559

Other disorders of nervous system

164

1021

1.64

8.04

2.7

2.5

0.55

1.14

g/l

1.73

137

875

Vascular diseases of the intestine

107

593

1.86

8.03

2.5

0.56

1.41

g/l

2.50

503

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

204

3066

0.66

8.03

2.0

1.5

0.68

0.36

g/l

1.19

171

2639

Coronary artery bypass grafting

651

3801

1.28

8.00

1.8

2.7

0.81

1.12

g/l

1.02

568

3178

Smoking dependency

185

1185

1.59

7.99

2.1

2.5

0.62

1.00

g/l

0.98

150

1040

Crushed, pushed or stepped on by crowd or human stampede

117

664

1.79

7.97

2.8

2.2

0.32

0.77

g/l

1.78

108

597

Blepharochalasis

682

5429

1.27

7.97

2.2

2.6

0.53

0.95

g/l

4.43

587

4606

Melanocytic naevi of lower limb, including hip

536

1.89

7.97

3.4

2.5

0.55

1.00

g/l

0.74

471

Ventral hernia

529

4079

1.31

7.96

2.8

2.4

0.82

0.79

g/l

0.07

472

3475

Palmar fascial fibromatosis [Dupuytren]

352

2558

1.40

7.95

2.5

0.74

1.09

g/l

1.02

299

2141

Hepatocellular carcinoma, including Hilmo

391

2.06

7.93

2.4

1.4

0.69

0.39

g/l

0.40

335

Cerebral cysts

113

638

1.81

7.90

1.5

2.4

0.61

0.98

g/l

0.71

559

Bronchitis, not specified as acute or chronic

179

1142

1.59

7.86

2.3

2.4

0.58

0.99

g/l

1.20

159

960

Colectomy operation

400

2974

1.36

7.85

2.8

2.4

0.73

0.94

g/l

0.57

355

2522

Other psoriatic arthropathies

210

1390

1.54

7.83

2.1

2.5

0.77

0.97

g/l

0.32

185

1212

Oesophagitis

129

760

1.74

7.83

2.4

2.7

0.64

1.21

g/l

1.43

118

657

Later onset COPD

771

4995

1.25

7.82

1.8

2.5

0.97

1.09

g/l

0.27

649

4191

COPD, hospital admissions 1, only main diagnosis

859

6027

1.24

7.81

2.1

2.5

0.84

1.01

g/l

0.61

738

5107

Malignant neoplasm of digestive organs, including Hilmo

917

5524

1.23

7.81

2.2

1.5

0.74

0.35

g/l

3.47

784

4727

Melanoma in situ

127

748

1.75

7.80

3.3

2.7

1.15

1.35

g/l

0.23

639

Portal vein thrombosis

193

2.55

7.77

1.7

2.8

0.76

1.00

g/l

0.16

176

Other and unspecified haemorrhagic conditions

175

2.63

7.76

4.8

2.3

1.13

0.57

g/l

0.50

158

Postzoster neuralgia

218

2.46

7.75

3.9

2.4

1.76

1.14

g/l

0.42

187

Other and unspecified psoriasis

157

976

1.64

7.74

2.1

2.6

0.49

1.11

g/l

1.63

139

849

Iridocyclitis in diseases classified elsewhere

224

2.42

7.73

2.1

2.5

2.38

1.07

g/l

0.76

204

Iron deficiency

204

2.45

7.73

2.1

2.3

0.39

0.74

g/l

0.59

186

Panniculitis affecting regions of neck and back

415

2.00

7.70

2.0

2.4

0.44

1.46

g/l

2.77

359

Deficiency of other B group vitamins

269

2.28

7.68

3.7

2.2

0.14

1.13

g/l

2.63

237

Malignant neoplasm of breast, HER-positive

610

3564

1.28

7.67

2.2

1.5

0.62

0.31

g/l

1.50

507

3028

Polycystic ovarian syndrome, consortium definition

1272

6150

1.19

7.66

2.1

2.4

0.71

0.65

g/l

0.26

1067

5309

Dermatographic urticaria

124

726

1.74

7.64

2.0

2.6

0.20

0.98

g/l

4.36

109

649

Diseases of tongue

132

787

1.71

7.62

2.8

2.2

0.79

0.90

g/l

0.15

111

658

Malignant neoplasm of breast, ER-positive, including Hilmo

611

3569

1.28

7.62

2.2

1.5

0.62

0.31

g/l

1.50

508

3032

Total colectomy

488

1.91

7.57

2.5

2.7

0.04

1.18

g/l

6.17

432

Total colectomy operation

488

1.91

7.57

2.5

2.7

0.04

1.18

g/l

6.17

432

Thyrotoxicosis with diffuse goitre

256

1774

1.46

7.56

2.2

2.3

0.30

0.84

g/l

2.84

223

1541

Drug-induced adrenocortical insufficiency

233

2.38

7.55

2.6

2.3

0.48

0.78

g/l

0.29

208

Amenorrhoea

494

1.89

7.51

1.9

2.1

0.17

0.63

g/l

1.86

441

Malignant melanoma of skin, including Hilmo

311

2237

1.41

7.50

2.6

1.5

1.03

0.37

g/l

2.25

260

1940

Other keratitis

216

1451

1.51

7.49

2.1

2.3

0.32

0.95

g/l

3.78

191

1261

Ovarian cyst

584

2600

1.29

7.47

2.1

2.3

0.69

0.68

g/l

0.02

509

2238

Hodgkin lymphoma, hilmo

318

2.14

7.46

1.4

2.8

0.62

1.12

g/l

0.45

287

Menorrhagia

590

2565

1.29

7.44

2.1

2.3

0.77

0.69

g/l

0.17

482

2197

Monoarthritis, not elsewhere classified

455

1.93

7.43

1.7

2.6

0.40

1.40

g/l

2.65

390

Causalgia

149

2.72

7.43

1.2

2.4

0.02

1.17

g/l

2.25

138

Specific development disorders of speech and language

423

1.94

7.42

1.8

2.3

0.58

0.97

g/l

0.44

373

Excessive, frequent and irregular menstruation

629

2638

1.28

7.39

2.0

2.3

0.68

0.67

g/l

0.03

536

2268

Excessive attrition of teeth

1148

9588

1.19

7.39

2.4

0.73

0.68

g/l

0.18

997

8370

Congenital malformations and deformations of the musculoskeletal system

123

720

1.72

7.38

1.7

2.2

0.87

0.60

g/l

0.26

114

642

Anogenital herpesviral [herpes simplex] infection

505

1.87

7.36

2.1

2.2

0.27

0.74

g/l

1.47

451

Periapical abscess

924

7660

1.21

7.32

2.2

2.5

0.75

g/l

0.02

796

6681

Idiopathic pulmonary fibrosis

203

1358

1.53

7.31

2.2

2.5

0.64

1.16

g/l

1.59

176

1140

Malignant neoplasm of prostate, including Hilmo

615

2860

1.28

7.26

2.4

1.5

1.06

0.37

g/l

4.05

527

2495

Malignant neoplasm of bladder, including Hilmo

268

1865

1.44

7.25

2.5

1.5

0.76

0.38

g/l

1.35

226

1597

Cardiac murmurs and other cardiac sounds

160

1002

1.60

7.21

2.0

2.2

0.46

0.78

g/l

0.82

134

855

Mental disorders, not otherwise specified

131

791

1.68

7.20

1.8

2.3

0.40

0.78

g/l

1.05

123

706

Drug-induced neutropenia

166

1066

1.59

7.19

4.0

2.6

1.38

1.07

g/l

0.28

140

922

Acidosis

277

2.22

7.19

2.1

2.6

0.61

1.84

g/l

1.02

240

Other symptoms and signs involving the digestive system and abdomen

340

2499

1.38

7.16

2.2

2.5

0.79

0.91

g/l

0.16

281

2131

6-mercaptopurine

237

2.28

7.13

1.7

2.6

0.03

0.89

g/l

2.75

213

Psychotic depression

111

643

1.76

7.12

2.6

2.7

0.51

1.04

g/l

1.17

559

Spontaneous rupture of synovium and tendon

177

1155

1.56

7.10

2.5

2.2

0.92

1.08

g/l

0.23

148

970

Injuries to the wrist and hand

2111

12349

1.14

7.06

2.3

2.5

0.64

0.78

g/l

1.25

1830

10676

Malignant neoplasm of breast, including Hilmo

747

3872

1.24

7.06

2.3

1.5

0.61

0.30

g/l

1.95

620

3310

Malignant neoplasm of breast, HER2-negative, including Hilmo

747

3873

1.24

7.05

2.3

1.5

0.61

0.30

g/l

1.95

620

3311

Personal history of medical treatment

125

2.87

7.04

1.5

2.9

0.24

0.59

g/l

0.93

113

Use of donepezil

341

4361

0.74

7.02

1.8

2.4

1.20

1.12

g/l

0.13

260

3599

Acute bronchiolitis

272

2.11

7.01

5.6

2.0

0.53

0.66

g/l

0.15

243

Thyroiditis

142

885

1.63

6.95

2.2

2.5

0.34

0.90

g/l

2.19

115

776

Retinal detachment with retinal break

303

2202

1.40

6.94

2.9

2.5

1.30

0.86

g/l

0.77

262

1891

Acute gastritis

165

1067

1.57

6.92

2.0

2.5

0.39

1.04

g/l

3.69

138

906

Cluster headache, strict, including avohilmo

488

1.86

6.90

1.7

2.5

0.30

0.87

g/l

1.64

435

Necrosis of pulp, including avohilmo

1078

9000

1.19

6.88

2.3

2.4

0.64

0.68

g/l

0.15

940

7884

Dermatophytosis

301

2188

1.39

6.87

2.7

2.3

0.60

0.91

g/l

0.92

263

1870

Viral warts, including avohilmo

372

2790

1.34

6.86

2.4

2.3

0.77

0.75

g/l

0.04

328

2432

Other sleep disorders

225

1553

1.47

6.85

2.0

2.4

0.54

0.90

g/l

1.50

183

1344

Other disorders of iris and ciliary body

371

2.00

6.83

2.1

3.0

0.71

1.35

g/l

0.87

324

Crohn's disease of large intestine

541

1.81

6.82

1.5

2.5

0.19

0.79

g/l

3.07

476

Melanocytic naevi of trunk

238

1662

1.45

6.82

2.8

2.5

0.59

0.92

g/l

0.95

212

1451

Visual impairment including blindness (binocular or monocular)

163

1056

1.57

6.80

2.3

2.2

0.43

1.10

g/l

2.50

129

890

Other or ill-defined heart diseases

103

593

1.77

6.78

2.2

2.3

0.47

1.32

g/l

2.32

506

Ganglion

352

2624

1.35

6.76

2.2

2.4

0.46

0.83

g/l

2.14

299

2247

severe traumatic brain injury, does not include concussion

522

4111

1.28

6.75

2.5

2.4

0.83

1.01

g/l

0.54

437

3480

Cluster headache, wide,, including avohilmo

528

1.81

6.75

1.8

2.5

0.38

0.88

g/l

1.32

467

Other condition

275

1974

1.41

6.74

2.4

2.3

0.88

0.86

g/l

0.03

242

1714

Alcohol abuse, main dg

288

2085

1.40

6.70

1.4

2.4

0.24

0.86

g/l

6.87

247

1844

Other and/or unspecified nontoxic goitre

184

1228

1.53

6.70

2.4

0.44

0.93

g/l

1.94

164

1054

Superficial injury of forearm

181

1201

1.53

6.70

2.3

0.41

0.90

g/l

2.03

152

1057

Ankylosing spondylitis, strict definition

401

1.93

6.66

1.6

2.6

0.22

0.89

g/l

2.27

365

Coxarthrosis, primary, with hip surgery

1155

9138

1.18

6.63

2.3

2.6

0.66

0.98

g/l

3.43

970

7751

Chondropathies

272

1955

1.41

6.61

2.2

2.3

0.68

0.86

g/l

0.40

229

1708

Bursitis of shoulder

286

2.13

6.61

3.7

2.3

0.40

1.79

g/l

2.73

243

Xerosis cutis

241

2.25

6.60

1.9

2.9

0.51

1.05

g/l

0.62

214

Malignant neoplasm of breast, HER2-negative

732

3843

1.24

6.59

2.3

1.5

0.59

0.30

g/l

1.70

607

3281

Duodenal ulcer

251

1785

1.43

6.55

2.0

2.6

0.50

1.15

g/l

3.12

220

1524

Lactose intolerance, other/unspecified

280

2.13

6.55

1.7

1.8

0.36

0.92

g/l

1.12

243

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

112

666

1.70

6.54

1.5

2.4

0.32

1.09

g/l

3.15

594

Other secondary gout

4.33

6.54

5.3

1.8

0.77

0.46

g/l

0.24

Thiazolidinediones

274

1982

1.41

6.52

1.8

2.5

0.56

1.03

g/l

2.30

240

1689

Tinnitus

504

3972

1.28

6.50

2.7

2.5

0.70

0.75

g/l

0.12

447

3443

Scabies, including avohilmo

217

1502

1.46

6.48

1.9

2.3

0.39

0.87

g/l

2.50

196

1344

Redundant prepuce, phimosis and paraphimosis

371

2761

1.33

6.48

2.3

2.6

0.37

0.84

g/l

3.28

334

2430

Disorders of speech understanding and production

349

1.97

6.43

1.8

2.5

0.71

0.89

g/l

0.14

304

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

271

1956

1.40

6.43

2.6

2.4

0.76

0.82

g/l

0.10

239

1720

Malignant neoplasm of breast

731

3848

1.23

6.42

2.3

1.5

0.59

0.30

g/l

1.71

606

3286

malignant neoplasm of male genital organs

600

2885

1.26

6.42

2.4

1.5

1.06

0.36

g/l

3.95

514

2520

Complications of genitourinary prosthetic devices, implants and grafts

317

2.05

6.41

2.1

2.4

0.19

0.91

g/l

2.14

270

Ulcerative colitis (strict definition, require KELA)

279

2026

1.39

6.38

2.6

2.4

0.79

0.82

g/l

0.04

246

1782

Abscess of lung

193

2.38

6.36

1.9

3.3

0.42

1.06

g/l

0.90

174

Recurrent dislocation and subluxation of joint

545

1.77

6.33

1.6

2.3

0.36

1.04

g/l

2.10

493

Other specified and unspecified retinal disorders

497

1.82

6.31

3.0

2.8

0.74

1.30

g/l

0.88

433

Use of antiglaucoma preparations and miotics

202

1393

1.48

6.30

2.4

2.5

1.23

1.08

g/l

0.17

160

1163

Hypopituitarism

121

743

1.65

6.29

2.9

2.5

0.53

1.05

g/l

1.62

104

672

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

116

707

1.68

6.29

2.1

1.5

0.47

0.45

g/l

0.03

599

Atypical facial pain

110

661

1.70

6.28

2.7

2.6

1.48

1.08

g/l

0.31

573

Nonsuppurative otitis media, including avohilmo

476

3223

1.28

6.26

2.4

2.2

0.68

g/l

0.00

424

2823

Perineal laceration during delivery

1008

0.53

6.24

1.9

1.7

0.30

g/l

0.01

913

Drug-induced hypoglycaemia without coma

189

2.37

6.18

2.3

2.7

0.07

0.89

g/l

2.67

169

Malignant neoplasm of mesothelium and soft tissue

537

1.78

6.17

3.8

1.4

2.40

0.40

g/l

1.66

463

Nontoxic goitre/thyroid nodule

627

5100

1.24

6.15

2.4

2.5

0.93

0.88

g/l

0.09

540

4308

Scleritis and episcleritis

119

734

1.65

6.13

2.5

2.3

0.79

1.07

g/l

0.36

108

652

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

153

2.53

6.11

3.4

2.3

0.48

0.57

g/l

0.08

135

Dissociative [conversion] disorders

301

2.03

6.09

1.6

2.1

0.30

0.73

g/l

0.83

267

Postprocedural disorders of digestive system, not elsewhere classified

444

1.85

6.08

1.8

2.8

0.44

1.29

g/l

2.06

394

Crohn's disease of small intestine

119

736

1.64

6.05

1.8

2.5

0.47

0.97

g/l

1.13

106

649

Varicella [chickenpox]

393

1.89

6.04

5.6

2.3

1.84

0.53

g/l

1.16

353

Chronic hepatitis, not elsewhere classified

416

1.88

6.03

1.8

2.8

0.59

1.09

g/l

0.74

372

Cachexia

3.76

6.03

1.8

2.2

0.09

1.08

g/l

0.98

Type 1 diabetes, definitions combined

115

702

1.65

6.03

2.0

2.1

0.81

0.79

g/l

0.02

103

635

Testicular dysfunction

401

1.88

6.02

2.1

2.7

0.63

0.95

g/l

0.40

361

Other secondary gonarthrosis

122

763

1.63

6.00

2.4

2.8

0.51

1.25

g/l

2.70

110

661

Other obstetric conditions, not elsewhere classified

293

1350

1.37

5.99

1.6

1.9

0.14

0.28

g/l

1.19

268

1232

Atypical mycobacterium lung infection

161

2.49

5.99

1.9

2.7

0.67

0.88

g/l

0.16

137

Herpesviral keratitis and keratoconjunctivitis

580

1.73

5.97

2.7

2.6

0.60

1.13

g/l

1.02

504

Type 1 diabetes, strict (exclude DM2)

114

697

1.65

5.94

2.1

0.82

0.71

g/l

0.11

102

629

Paralytic ileus

521

1.77

5.94

3.9

2.3

0.64

1.36

g/l

1.60

439

Disorders of breast

878

6499

1.19

5.92

2.1

2.4

0.52

0.69

g/l

0.99

752

5567

Inflammatory disease of uterus

206

1439

1.45

5.92

1.9

2.3

1.04

0.58

g/l

0.44

177

1252

Melanocytic naevi

571

4616

1.25

5.91

2.9

2.3

0.70

0.78

g/l

0.22

510

3995

Other and unspecified rosacea

183

1253

1.48

5.90

2.4

2.5

0.63

0.89

g/l

0.52

163

1087

Open wound of hip and thigh

340

1.96

5.90

1.3

2.7

0.08

1.05

g/l

4.47

305

Glucosamine medication

1141

7830

1.17

5.90

2.5

0.83

0.93

g/l

0.35

969

6606

Disorders of tooth development and eruption

254

1491

1.40

5.88

2.2

2.3

0.41

0.75

g/l

1.81

223

1284

Varicella [chickenpox], including avohilmo

447

1.82

5.87

5.4

2.2

1.68

0.54

g/l

1.08

403

Autonomic disorders

293

2.04

5.86

2.0

2.7

0.20

1.26

g/l

2.98

257

Primary coxarthrosis, bilateral

700

5791

1.22

5.86

2.2

2.6

0.69

0.98

g/l

2.00

597

4877

Gluteal tendinitis

545

1.74

5.85

2.0

2.4

0.57

1.08

g/l

1.08

469

Other papulosquamous disorders

138

2.58

5.85

3.9

2.4

0.64

0.88

g/l

0.24

123

Urethral stricture

135

870

1.58

5.85

2.3

2.7

0.48

1.42

g/l

4.35

117

744

Carrier of infectious disease

273

2.07

5.83

1.5

2.6

0.20

1.21

g/l

2.52

242

Other congenital malformations of skin, including avohilmo

140

909

1.56

5.81

2.1

2.5

0.54

0.95

g/l

0.88

127

794

Other aneurysm

129

825

1.60

5.79

2.3

2.6

0.69

1.21

g/l

1.32

115

704

Spontaneous abortion

487

4092

0.79

5.78

2.2

2.4

0.58

0.57

g/l

0.03

434

3551

Benign neoplasm: Descending colon

173

1180

1.50

5.77

2.0

2.6

0.47

1.13

g/l

2.92

144

1021

Other noninflammatory disorders of vulva and perineum

169

1145

1.49

5.73

2.0

2.3

0.60

0.66

g/l

0.09

146

983

Atrophic disorders of skin

303

2272

1.35

5.72

2.1

2.3

0.24

0.72

g/l

5.25

262

1943

Allergic bronchopulmonary aspergillosis (ABPA)

5.81

5.70

2.7

2.5

1.11

3.25

g/l

0.79

Endometriosis

555

2588

1.25

5.69

1.9

2.3

0.68

0.69

g/l

0.00

486

2223

Other and unspecified trigeminal disorders

158

2.43

5.68

2.7

2.3

1.16

1.06

g/l

0.06

142

Postmenopausal bleeding

557

2338

1.26

5.68

2.4

0.67

0.76

g/l

0.22

470

1988

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

522

3446

1.26

5.68

2.4

1.5

1.00

0.38

g/l

2.75

452

2941

Ectropion of eyelid

109

674

1.66

5.66

1.6

2.5

0.58

1.50

g/l

1.67

550

Bicipital tendinitis

101

612

1.68

5.63

2.2

2.6

0.28

1.44

g/l

3.20

528

Malignant neoplasm of prostate

590

2828

1.24

5.62

2.4

1.5

1.08

0.37

g/l

3.94

507

2466

Triptan medication for migraine, min. 3 purchases

832

5218

1.20

5.62

2.3

0.50

0.61

g/l

0.67

747

4608

Other and unspecified nonorganic psychotic disorders

283

2105

1.35

5.60

1.8

2.4

0.42

0.75

g/l

1.37

241

1858

Other and unspecified vascular occlusions

230

1661

1.41

5.59

2.6

2.5

0.71

0.96

g/l

0.60

195

1402

Other and specified injuries of hip and thigh

299

2.00

5.57

1.5

2.6

0.90

1.11

g/l

0.15

258

Otitis externa, unspecified

206

1458

1.43

5.56

2.3

2.4

0.84

0.93

g/l

0.10

181

1263

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

279

1290

1.37

5.55

1.6

1.9

0.15

0.29

g/l

1.15

255

1181

Arthropathy in hypersensitivity reactions classified elsewhere

13.36

5.54

1.7

1.3

0.11

0.69

g/l

—

Pustulosis palmaris et plantaris

555

1.71

5.52

2.3

2.6

0.60

1.02

g/l

0.48

492

Acute laryngitis and tracheitis

142

919

1.53

5.51

2.0

0.46

0.85

g/l

1.09

125

818

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

140

922

1.55

5.51

4.0

1.5

1.73

0.40

g/l

1.63

123

789

Ulcerative colitis (strict definition, all Crohn cases excluded)

238

1729

1.39

5.51

2.8

2.4

0.93

0.84

g/l

0.12

210

1522

Rosacea

245

1790

1.38

5.50

2.4

0.76

0.77

g/l

0.02

220

1546

Unstable angina pectoris

880

5856

1.19

5.49

2.6

0.90

0.99

g/l

0.25

765

4905

Psoriasis (vulgaris), strict definition

386

1.86

5.45

1.5

2.8

0.40

1.12

g/l

1.55

347

Unspecified/other endometriosis

122

762

1.58

5.45

2.0

2.1

0.25

0.57

g/l

1.34

104

664

Pneumothorax

149

997

1.52

5.44

2.3

2.4

0.81

1.09

g/l

0.30

132

861

Polyarteritis nodosa

3.36

5.44

1.4

2.5

0.00

0.33

g/l

1.17

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

297

2237

1.34

5.44

2.5

2.4

0.81

0.79

g/l

0.03

264

1958

Cholecystitis

318

2423

1.33

5.42

2.2

2.4

0.86

0.94

g/l

0.13

264

2048

Other, unspecified and serous retinal detachments

439

1.80

5.41

2.2

2.9

1.21

1.15

g/l

0.04

384

Mononeuritis multiplex

5.46

5.37

2.2

3.9

0.00

1.02

g/l

1.33

Astigmatism

108

673

1.63

5.35

2.5

0.85

1.00

g/l

0.18

583

Contact with and exposure to communicable diseases

370

2862

1.29

5.34

2.8

2.1

0.67

0.62

g/l

0.10

308

2553

Pediculosis, acariasis and other infestations, including avohilmo

264

1959

1.36

5.33

1.8

2.3

0.33

0.81

g/l

3.58

236

1726

Burns and corrosions

235

1714

1.38

5.33

2.1

2.3

0.53

0.88

g/l

0.89

203

1504

Congenital malformations of cardiac septa

104

623

1.64

5.31

1.6

2.5

0.28

0.97

g/l

3.13

557

Medical abortion

1117

5209

1.17

5.29

2.0

2.5

0.56

0.72

g/l

0.83

944

4457

Viral and other specified intestinal infections

275

2004

1.35

5.29

2.2

2.0

0.71

0.75

g/l

0.06

249

1746

794

5760

1.19

5.26

2.5

1.27

0.98

g/l

0.76

633

4852

Carcinoma in situ of skin of ear and external auricular canal

265

2.05

5.25

1.8

2.5

1.89

1.51

g/l

0.12

224

Erythema nodosum

355

1.88

5.25

2.9

2.4

0.46

0.89

g/l

0.66

309

Hydrocele

248

1832

1.37

5.23

2.4

2.8

0.97

0.99

g/l

0.03

217

1573

Injury of eye and orbit

244

1796

1.37

5.23

1.8

2.3

0.55

0.82

g/l

0.55

209

1578

Meralgia paraesthetica

421

1.80

5.23

1.4

2.4

0.68

1.22

g/l

0.76

365

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

182

1105

1.44

5.21

1.4

1.7

0.39

0.32

g/l

0.17

162

1021

Varicose veins

1323

8758

1.15

5.20

2.5

0.81

0.88

g/l

0.27

1106

7461

Other neurotic disorders

595

1.66

5.20

1.6

2.7

0.62

1.18

g/l

1.11

515

Diffuse brain injury

341

1.88

5.19

2.6

1.9

0.75

1.10

g/l

0.23

298

Malignant neoplasm of eye and adnexa, including Hilmo

178

2.27

5.18

3.3

1.3

1.14

0.31

g/l

0.75

153

Hyperaldosteronism

379

1.85

5.18

3.2

2.9

0.51

1.42

g/l

1.59

331

Allergic contact dermatitis

217

1570

1.40

5.18

1.8

2.3

0.88

0.75

g/l

0.17

189

1358

Other symptoms and signs involving general sensations and perceptions

550

1.69

5.17

2.3

2.8

0.72

1.30

g/l

0.84

474

Dislocation, sprain and strain of joints and ligaments of thorax

415

1.80

5.16

2.2

2.7

0.50

1.17

g/l

1.38

365

Achilles tendinitis

192

1362

1.43

5.16

2.8

2.3

0.53

0.90

g/l

1.05

171

1171

Other deformities of toe(s)

430

1.78

5.16

1.8

2.2

0.74

1.27

g/l

0.64

364

Benign neoplasm: Other and unspecified parts of mouth

476

1.75

5.15

3.2

2.7

1.17

1.47

g/l

0.22

417

Disorders of magnesium metabolism

2.78

5.14

1.4

2.8

0.09

0.83

g/l

1.55

Hordeolum and other deep inflammation of eyelid

116

745

1.58

5.13

2.3

2.7

0.25

1.18

g/l

4.82

100

656

Injury of muscle and tendon at lower leg level

294

2234

1.33

5.12

2.8

2.5

0.64

0.95

g/l

1.10

262

1955

Other disorders of optic [2nd] nerve and visual pathways

127

833

1.55

5.12

2.5

2.6

0.20

1.19

g/l

6.09

113

727

Diabetic retinopathy, strict definition

369

2563

1.29

5.12

1.8

2.2

0.41

0.67

g/l

0.93

317

2197

Uterine polyps

520

2453

1.25

5.12

2.0

2.3

0.56

0.72

g/l

0.46

433

2097

N06DA Anticholinesterases

687

6313

0.83

5.08

2.1

2.5

0.99

1.07

g/l

0.21

538

5284

Use of anticholinesterases

687

6313

0.83

5.08

2.1

2.5

0.99

1.07

g/l

0.21

538

5284

Disorders of ocular muscles, binocular movement, accommodation and refraction

845

7135

1.18

5.05

2.3

2.4

0.86

0.73

g/l

0.47

738

6197

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

561

4613

1.22

5.01

2.7

2.4

0.62

0.80

g/l

0.71

478

4019

Procedures for purposes other than remedying health state

268

1.99

5.01

1.9

1.8

0.22

0.53

g/l

0.73

237

Arthropathy in ulcerative colitis

136

2.44

5.01

1.5

2.1

0.27

0.90

g/l

0.93

125

Other and unspecified iridocyclitis

601

1.65

5.01

3.1

2.5

1.38

1.31

g/l

0.05

522

All dysplastic lesions of the cervix uteri, vagina or vulva

373

2857

1.28

4.98

2.2

2.1

0.50

g/l

0.01

326

2526

Rare circulating lymphoid malignancy

3.19

4.97

4.9

1.3

6.59

0.33

g/l

1.06

Sudden idiopathic hearing loss

225

1654

1.38

4.95

2.4

1.09

0.80

g/l

0.52

180

1431

Other and unspecified nerve root and plexus disorders, also in other diseases

390

3088

1.27

4.95

2.8

2.4

0.80

0.82

g/l

0.04

337

2682

Acne, including avohilmo

207

1205

1.40

4.92

1.7

1.9

0.41

0.47

g/l

0.11

194

1089

Degeneration of nervous system due to alcohol

299

1.94

4.91

1.4

3.0

0.92

1.25

g/l

0.15

264

Aortic valve malfunction, age under 60 years

167

1168

1.45

4.89

2.0

2.4

0.60

1.02

g/l

0.87

144

1027

Other predominantly sexually transmitted diseases, not elsewhere classified

216

1576

1.38

4.89

2.1

2.2

0.50

0.62

g/l

0.30

190

1410

Unspecified misadventure during surgical and medical care

126

835

1.54

4.89

2.2

2.6

1.09

1.21

g/l

0.12

104

724

Benign neoplasm of eye and adnexa

229

1692

1.37

4.88

2.1

2.4

1.07

0.94

g/l

0.18

190

1450

Pure hyperglyceridaemia

278

1.96

4.88

1.8

2.4

0.39

1.28

g/l

1.36

246

Maternal care for other conditions predominantly related to pregnancy

232

1668

1.36

4.87

2.1

0.64

0.40

g/l

0.60

215

1504

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

245

1824

1.35

4.87

2.0

2.2

0.46

0.55

g/l

0.25

213

1638

Degeneration of the brain due to alcohol

300

1.93

4.87

1.4

3.0

0.92

1.28

g/l

0.17

265

Crohn disease (strict definition, require KELA, min 2 HDR)

100

628

1.61

4.86

1.9

2.4

0.34

0.90

g/l

1.34

558

Benign neoplasm: Duodenum

395

1.80

4.86

2.9

1.17

1.32

g/l

0.08

345

Viral meningitis, including avohilmo

349

1.84

4.85

1.8

2.3

0.52

0.73

g/l

0.29

311

Abnormal spermatozoa

164

2314

0.70

4.85

2.5

2.7

2.25

1.00

g/l

1.26

103

2002

Benign neoplasm of urinary organs

111

717

1.58

4.85

2.2

2.8

0.79

1.40

g/l

1.06

621

Left ventricular outflow tract obstruction (LVOTO), broad definition

174

1228

1.43

4.85

1.9

2.5

0.58

1.00

g/l

0.93

151

1078

Unspecified lump in breast

296

2271

1.32

4.84

1.9

2.4

0.51

0.70

g/l

0.54

254

1933

Assault

179

1268

1.42

4.84

2.1

2.2

0.77

0.75

g/l

0.03

157

1146

Wet age-related macular degeneration

456

3556

1.25

4.84

2.7

2.3

1.36

1.06

g/l

0.49

367

2952

Follicular cysts of skin and subcutaneous tissue

355

2790

1.28

4.82

2.8

2.4

1.14

0.78

g/l

0.69

319

2418

Visual field defects

181

1291

1.42

4.79

2.2

2.3

0.81

0.99

g/l

0.30

155

1108

Use of riluzole

3.49

4.78

1.8

2.8

1.86

0.52

g/l

0.31

Somnolence, stupor and coma

539

1.66

4.77

1.6

2.9

0.56

1.40

g/l

1.51

460

Organic, including symptomatic, mental disorders

1306

8096

1.14

4.77

2.3

2.6

1.04

0.96

g/l

0.28

1060

6877

Orthopaedic devices associated with adverse incidents

296

1.93

4.76

1.3

2.5

0.76

1.08

g/l

0.26

257

Bell's palsy

228

1689

1.37

4.76

2.6

2.4

0.55

0.97

g/l

1.32

193

1448

Postprocedural disorders of nervous system

625

1.60

4.71

2.4

2.2

0.86

0.76

g/l

0.11

564

Short Achilles tendon (acquired)

286

0.27

4.70

5.3

2.4

3.44

1.45

g/l

—

247

Retinal haemorrhage

384

1.80

4.70

4.1

3.0

1.65

1.45

g/l

0.12

330

Malnutrition

268

1.96

4.69

1.7

2.4

1.05

1.19

g/l

0.08

232

Pustular psoriasis

620

1.61

4.68

2.3

2.5

0.60

0.96

g/l

0.43

544

Abnormal blood-pressure reading, without diagnosis

557

1.64

4.68

2.5

2.4

0.27

0.93

g/l

2.92

472

Viral infections of the central nervous system

127

850

1.52

4.68

2.4

1.09

0.98

g/l

0.10

107

741

Complications of other internal prosthetic devices, implants and grafts

605

1.62

4.67

3.2

2.3

0.65

1.21

g/l

1.15

511

Disorders of optic nerve, not elsewhere classified

283

1.94

4.67

2.6

3.1

0.23

1.26

g/l

2.66

249

Crohn disease (strict definition, require KELA)

101

643

1.59

4.65

1.9

2.4

0.34

0.88

g/l

1.34

572

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

122

2.44

4.63

5.8

2.1

1.79

0.39

g/l

0.42

111

Benign neoplasm: Small intestine

101

648

1.60

4.60

2.6

2.7

1.12

1.48

g/l

0.33

562

Chondrocostal junction syndrome [Tietze]

476

1.70

4.59

2.3

2.4

0.57

1.14

g/l

1.08

408

Other disorders of penis

187

1349

1.40

4.59

1.9

2.7

0.83

0.84

g/l

0.01

160

1175

Premature rupture of membranes

120

1273

0.67

4.58

2.2

2.0

0.32

0.38

g/l

0.17

105

1150

Asthma mixed form (mode), excluding more controls

467

1.69

4.58

2.2

1.7

0.84

0.95

g/l

0.08

393

380

1.79

4.58

2.2

2.8

0.99

1.63

g/l

0.77

323

Schizophrenia or delusion, excluding more controls

463

3722

1.23

4.57

2.1

2.5

0.58

0.72

g/l

0.35

390

3278

Injury of muscle and tendon at hip and thigh level

187

1353

1.40

4.54

2.0

2.5

0.83

1.01

g/l

0.32

169

1191

Other salmonella infections

447

1.71

4.54

3.3

2.3

0.85

0.96

g/l

0.08

386

Post-traumatic wound infection, not elsewhere classified

314

1.86

4.53

2.6

2.8

0.97

1.03

g/l

0.05

281

Lagophthalmos

176

2.19

4.51

2.0

2.5

1.53

1.29

g/l

0.08

154

Senility

111

2.50

4.51

1.7

2.3

0.50

0.77

g/l

0.23

Viral warts

165

1170

1.43

4.50

2.2

2.4

0.56

0.86

g/l

0.75

148

1014

Nonsuppurative otitis media

310

2089

1.29

4.50

2.3

2.1

0.87

0.76

g/l

0.14

269

1825

Tobacco use

100

642

1.58

4.49

1.5

2.6

1.24

1.01

g/l

0.14

575

Special screening examination for other diseases and disorders

190

1380

1.39

4.46

2.9

2.4

0.69

0.86

g/l

0.33

171

1172

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

106

691

1.55

4.42

1.9

2.5

0.32

0.91

g/l

1.60

614

Other obstructive and reflux uropathy

412

1.73

4.41

1.6

2.3

0.51

1.10

g/l

1.16

362

Achalasia of cardia

211

2.05

4.41

3.5

3.3

0.46

1.11

g/l

0.91

187

Viral infections of the central nervous system, including avohilmo

135

927

1.48

4.40

2.3

2.5

1.02

0.96

g/l

0.06

114

807

Other bacterial agents as the cause of diseases classified to other chapters

126

2.40

4.38

4.0

2.5

0.64

0.61

g/l

0.01

111

Congenital malformations of heart and great arteries

199

1418

1.37

4.38

2.0

2.4

0.65

0.97

g/l

0.84

173

1248

Lichen simplex chronicus

414

1.73

4.38

3.0

0.89

1.18

g/l

0.31

364

Benign neoplasm: salivary glands, exclude unknown (D119)

184

1339

1.39

4.37

2.0

2.5

0.54

1.02

g/l

1.64

159

1152

Scar conditions and fibrosis of skin

444

1.70

4.37

2.5

2.4

0.13

0.84

g/l

2.84

389

Testicular hypofunction

354

1.78

4.37

2.2

2.6

0.56

0.98

g/l

0.52

320

Sulfonylureas

833

5701

1.17

4.35

1.8

2.6

0.68

1.08

g/l

1.75

705

4765

Other arterial embolism and thrombosis

401

1.74

4.33

1.5

2.7

0.25

1.53

g/l

3.75

345

!Aliquae complicationes praecoces traumatis

546

1.62

4.32

2.8

2.7

0.63

1.08

g/l

0.75

484

Early complications of trauma

546

1.62

4.32

2.8

2.7

0.63

1.08

g/l

0.75

484

Use of memantine

544

5238

0.83

4.32

1.9

2.4

1.40

1.12

g/l

0.63

414

4364

Use of other anti-dementia drugs

544

5238

0.83

4.32

1.9

2.4

1.40

1.12

g/l

0.63

414

4364

Seborrhoeic keratosis

548

4574

1.21

4.30

2.7

2.4

1.06

0.90

g/l

0.42

470

3871

Mouth breathing

753

6443

1.17

4.30

2.5

0.88

0.77

g/l

0.39

653

5640

Single delivery by forceps and vacuum extractor

759

0.62

4.30

1.6

1.7

0.78

0.18

g/l

0.84

688

Other retinal artery occlusion

350

1.80

4.30

1.8

3.1

0.47

1.43

g/l

2.06

303

Irregular menses

700

4462

1.18

4.29

2.0

2.3

0.47

0.55

g/l

0.34

616

3918

Melanoma in situ of other and unspecified parts of face

215

2.05

4.27

3.2

2.9

1.18

0.76

g/l

0.25

187

Contact with sharp object, undetermined intent

227

1.98

4.26

2.5

2.4

1.06

1.09

g/l

0.02

205

Other salmonella infections, including avohilmo

509

1.64

4.26

3.1

2.5

0.79

0.93

g/l

0.12

443

Type 1 diabetes, strict definition

437

1.68

4.25

1.4

1.7

0.16

0.56

g/l

1.34

406

Other and unspecified mononeuropathies, also in other diseases

373

1.76

4.24

2.4

2.6

1.41

1.32

g/l

0.04

325

Viral meningitis

335

1.79

4.24

1.9

2.3

0.55

0.69

g/l

0.16

298

Other specified/unspecified disorders of bone/cartilage

299

1.85

4.24

2.1

2.2

0.84

0.96

g/l

0.10

274

Complications of labour and delivery

777

5030

0.85

4.23

2.8

2.3

0.73

0.58

g/l

0.69

689

4341

Single spontaneous delivery

570

3599

0.83

4.23

2.4

2.2

0.74

0.66

g/l

0.24

496

3056

Central retinal artery occlusion

337

1.81

4.23

3.7

2.7

0.99

1.53

g/l

0.48

286

Muscle strain

328

1.80

4.23

2.4

1.95

1.45

g/l

0.19

284

Benign neoplasm of major salivary glands

204

1518

1.36

4.22

2.0

2.5

0.49

1.06

g/l

2.37

176

1300

Salpingitis and oophoritis

302

2369

1.29

4.22

1.7

2.6

0.39

0.73

g/l

1.57

261

2044

Nail disorders

153

1085

1.43

4.22

1.9

2.4

0.77

0.93

g/l

0.25

137

940

Epiphora

308

1.84

4.20

2.4

2.5

0.79

1.65

g/l

0.58

264

Anorexia (incl.atypical)

440

1.68

4.20

2.6

2.1

0.10

0.76

g/l

3.50

395

Burns and corrosions of external body surface, specified by site

180

1313

1.38

4.19

2.1

2.4

0.59

1.02

g/l

0.85

153

1159

Benign neoplasm: Kidney

505

1.64

4.18

2.3

2.9

1.06

1.34

g/l

0.26

437

Subacute thyroiditis

435

1.69

4.17

2.8

2.4

0.51

1.01

g/l

0.77

381

Retinal breaks without detachment

338

2696

1.27

4.14

2.6

2.4

0.55

0.83

g/l

1.36

290

2331

Dislocation, sprain and strain of joints and ligaments at neck level

230

1744

1.33

4.13

2.4

0.37

0.87

g/l

2.04

204

1534

Other disorders of pigmentation

624

1.57

4.13

2.6

2.4

1.02

1.06

g/l

0.03

535

UC patients in KELA-register (code 208), prior to 1994

569

1.60

4.13

2.3

2.8

0.49

1.08

g/l

1.58

503

Aortic arch syndrome [Takayasu]

7.17

4.12

1.8

1.1

0.11

0.00

g/l

—

Amputation of thigh

462

1.66

4.07

1.6

2.6

0.19

1.43

g/l

5.24

386

Degenerative macular diseases

276

2155

1.30

4.07

2.3

2.4

0.87

0.91

g/l

0.06

236

1822

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

138

969

1.45

4.06

1.9

1.5

0.42

0.40

g/l

0.03

114

827

Graves ophthalmopathy, strict

268

1.88

4.04

1.1

2.1

0.66

0.93

g/l

0.15

242

Colitis, primary sclerosing, strict definition

2.56

4.04

2.7

2.5

0.00

1.00

g/l

2.02

Contusion of other and unspecified parts of foot

485

1.63

4.02

2.2

2.5

0.46

0.90

g/l

0.87

435

Sequelae of injuries of neck and trunk

349

1.76

4.02

3.7

2.8

0.94

1.10

g/l

0.12

310

Moderate visual impairment, binocular

433

1.68

4.01

1.8

2.2

0.52

0.98

g/l

0.59

364

Other epidermal thickening

613

1.56

4.00

2.1

2.7

0.55

1.31

g/l

1.86

527

Other otitis externa (chronic)

129

898

1.46

3.97

2.5

2.6

1.40

1.03

g/l

0.28

102

780

Other and unspecified injuries of wrist and hand

410

1.69

3.97

1.5

2.2

0.14

0.86

g/l

2.91

358

Secondary polycythaemia

284

1.84

3.97

3.0

2.9

0.67

1.18

g/l

0.72

254

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

473

3923

1.21

3.96

2.0

2.3

0.39

0.76

g/l

2.92

406

3449

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

352

2797

1.25

3.96

2.0

2.2

0.40

0.70

g/l

1.69

317

2455

Monocytic leukaemia

3.34

3.96

4.1

1.6

0.06

0.32

g/l

0.59

Contact with heat and hot substances

582

1.57

3.95

1.8

2.5

0.51

0.79

g/l

0.31

519

Encephalopathy

126

2.32

3.94

1.9

3.0

0.82

1.21

g/l

0.25

111

Benign neoplasm: Liver

263

1.87

3.93

2.3

2.2

0.14

0.86

g/l

1.98

239

Prolonged pregnancy

960

0.62

3.92

1.9

0.15

0.34

g/l

0.86

874

Benign neoplasm: Pancreas

445

1.66

3.90

2.9

3.0

0.84

1.46

g/l

1.05

385

Open wound of abdomen, lower back and pelvis

307

1.79

3.90

1.8

2.7

0.20

0.90

g/l

1.96

279

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

104

696

1.51

3.89

1.9

2.5

0.41

1.03

g/l

1.33

611

Benign neoplasm: Parotid gland

165

1205

1.39

3.89

2.1

2.5

0.59

1.03

g/l

1.23

143

1040

Polyp of the female genital tract

528

2494

1.21

3.86

2.2

2.3

0.55

0.71

g/l

0.50

441

2131

Pulmonary oedema

258

1.88

3.85

3.2

2.8

0.74

0.88

g/l

0.14

221

Episcleritis

602

1.55

3.85

2.6

2.3

0.81

1.03

g/l

0.22

539

Haemorrhagic disorder due to circulating anticoagulants

209

1.99

3.84

2.0

2.7

0.42

1.07

g/l

0.91

181

Dissection of aorta

462

1.64

3.83

2.4

2.9

0.30

1.59

g/l

4.51

401

Seborrhoeic dermatitis

190

1421

1.35

3.83

2.5

0.81

1.02

g/l

0.40

159

1218

Delivery

578

3600

0.84

3.81

2.4

2.2

0.73

0.66

g/l

0.21

505

3057

Brachial plexus disorders

133

938

1.43

3.80

2.2

2.5

0.85

0.83

g/l

0.02

121

844

Other congenital malformations of the digestive system, including avohilmo

520

1.59

3.80

1.5

2.6

0.40

1.19

g/l

2.44

458

Other and unspecified mononeuropathies of upper limb

325

1.76

3.79

2.3

2.6

0.42

1.08

g/l

1.00

294

Acute suppurative otitis media

304

2252

1.26

3.77

3.3

2.2

0.85

0.66

g/l

0.34

269

2007

Postpartum haemorrhage

167

1864

0.74

3.76

2.3

2.1

0.57

0.46

g/l

0.26

148

1678

Graves disease, strict definition

165

1211

1.38

3.75

2.3

0.14

0.73

g/l

5.92

144

1064

Malignant neoplasm of bladder

141

1009

1.41

3.73

1.8

1.5

0.48

0.42

g/l

0.10

122

851

Diseases of appendix

1397

11237

1.11

3.73

2.7

2.4

0.65

0.74

g/l

0.48

1207

9757

Other noninflammatory disorders of vagina

136

968

1.42

3.72

2.3

0.37

0.72

g/l

1.07

119

828

Disorders of sphingolipid metabolism and other lipid storage disorders

4.00

3.71

5.5

1.6

0.95

g/l

0.00

Septal defects

586

1.54

3.71

1.6

2.5

0.32

0.92

g/l

2.47

524

Colitis, primary sclerosing

116

2.30

3.70

2.5

2.4

0.00

0.81

g/l

2.03

108

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

537

1.58

3.70

3.2

2.6

0.65

1.30

g/l

1.51

473

Spasmodic torticollis

381

1.69

3.69

1.3

2.3

0.23

1.03

g/l

1.93

336

Benign neoplasm: Liver/bile ducts

306

1.77

3.67

2.4

2.1

0.12

0.84

g/l

2.36

278

Corneal scars and opacities

359

1.71

3.67

3.0

2.9

1.00

1.23

g/l

0.19

315

Other bullous disorders

352

1.72

3.65

3.0

2.6

0.55

1.41

g/l

1.65

311

Secondary parkinsonism, excluding more controls

299

1.78

3.65

3.2

1.8

0.59

1.11

g/l

0.62

253

Non-small cell lung cancer, including Hilmo

315

2374

1.26

3.65

2.1

1.5

1.04

0.37

g/l

1.95

270

2022

Other and unspecified follicular disorders

475

1.60

3.64

2.1

2.6

0.64

1.07

g/l

0.65

427

Patent foramen ovale

198

1.96

3.63

1.3

2.3

0.22

0.95

g/l

1.69

183

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

255

1999

1.28

3.62

2.4

2.2

0.84

0.56

g/l

0.65

227

1738

Nontoxic multinodular goitre

397

3274

1.22

3.62

2.3

2.5

1.10

0.91

g/l

0.24

332

2763

Impotence

116

808

1.46

3.62

2.2

2.6

0.80

0.84

g/l

0.06

101

695

Other and unspecified mononeuropathies of lower limb

353

1.71

3.61

1.8

2.3

0.58

1.24

g/l

0.87

304

Dystonia

102

693

1.49

3.61

1.3

2.6

0.19

0.98

g/l

3.91

608

Burns and corrosions of multiple and unspecified body regions

227

1.89

3.61

2.3

3.0

0.87

1.28

g/l

0.19

206

Other and unspecified pemphigoid

145

2.17

3.60

1.5

2.7

0.25

0.98

g/l

1.32

130

Third [oculomotor] nerve palsy

257

1.85

3.60

1.8

3.0

0.66

1.16

g/l

0.76

228

Malignant neoplasm of colon, including Hilmo

379

3100

1.23

3.58

2.7

1.5

1.04

0.35

g/l

2.67

322

2638

Foreign body entering into or through eye or natural orifice

135

967

1.41

3.58

3.0

2.5

0.43

1.15

g/l

3.08

119

856

Campylobacter enteritis

316

1.75

3.58

2.2

2.6

2.29

1.10

g/l

0.59

281

Convalescence

637

1.51

3.58

2.1

2.2

0.74

0.84

g/l

0.08

552

Other congenital malformations of upper alimentary tract

0.00

3.57

0.0

2.7

—

0.55

—

Localized skin eruption due to drugs and medicaments

125

2.23

3.55

2.9

2.4

0.00

1.07

g/l

1.99

108

Fibrosis of liver

2.58

3.55

1.7

2.1

0.39

1.13

g/l

0.55

Open wound of shoulder and upper arm

214

1.91

3.55

1.5

2.3

0.35

1.00

g/l

0.97

191

Disorder of external ear, unspecified

432

1.63

3.54

2.0

2.9

1.06

1.18

g/l

0.10

380

Other sexually transmitted chlamydial diseases, including avohilmo

516

1.56

3.54

1.2

1.6

0.12

0.36

g/l

1.05

476

ILD-related respiratory insufficiency

552

1.56

3.54

2.1

2.7

0.80

1.42

g/l

0.68

465

Superficial injury of neck

172

2.02

3.53

1.4

2.6

0.86

0.79

g/l

0.04

156

Malignant neoplasm, without specification of site, including Hilmo

655

1.50

3.53

2.8

1.4

1.33

0.43

g/l

1.72

557

Atopic conjunctivitis

432

1.62

3.51

1.6

2.1

0.26

0.87

g/l

1.37

384

Other specified disorders of muscle

326

1.72

3.48

1.6

2.4

0.12

1.82

g/l

5.05

269

Cholangitis (primary sclerosing, PSC)

127

906

1.42

3.48

1.8

2.5

0.33

1.01

g/l

3.74

110

774

Triptan medication for migraine, single purchase ok

1267

7700

1.12

3.47

2.3

2.4

0.52

0.64

g/l

0.97

1123

6719

Migraine, single triptan purchase ok & required. ICD-code if available is included

1267

7700

1.12

3.47

2.3

2.4

0.52

0.64

g/l

0.97

1123

6719

Acute alcohol intoxication, ICD10

352

2880

1.23

3.47

1.4

2.5

0.40

0.80

g/l

2.07

301

2535

Undefined dementia

165

2027

0.74

3.46

2.1

2.3

0.70

1.26

g/l

1.70

131

1642

Disorders of lacrimal system and orbit in diseases classified elsewhere

297

1.76

3.46

1.1

2.1

0.63

1.19

g/l

0.37

265

Additional codes for the location of defect, injury or illness

111

774

1.45

3.45

1.5

2.7

0.98

1.26

g/l

0.14

104

676

Other secondary coxarthrosis

459

1.60

3.45

1.8

2.5

0.54

1.36

g/l

1.60

404

Colorectal cancer, including Hilmo

545

4326

1.18

3.44

2.6

1.5

0.95

0.38

g/l

3.13

467

3675

Disorders of refraction and accommodation

440

3665

1.20

3.44

2.2

2.3

0.65

0.72

g/l

0.17

377

3203

Corns and callosities

129

925

1.41

3.43

2.1

2.5

0.81

0.94

g/l

0.16

114

805

Acute appendicitis

1277

10671

1.11

3.42

2.7

2.4

0.67

0.72

g/l

0.25

1108

9286

Other benign neoplasms of skin

772

6757

1.15

3.42

3.2

2.5

0.92

0.87

g/l

0.14

647

5759

Right side

0.00

3.41

0.0

2.0

—

0.23

—

Atrial septal defect

348

1.68

3.41

1.8

2.3

0.40

0.93

g/l

1.17

311

All dysplastic lesions of the cervix uteri

297

2350

1.25

3.41

2.2

2.1

0.52

0.51

g/l

0.04

262

2087

Acute appendicitis, no complications

945

8323

1.13

3.40

2.7

2.4

0.68

0.69

g/l

0.04

829

7306

Arterial embolism and thrombosis of lower extremity artery

524

1.56

3.40

1.7

2.8

0.64

1.47

g/l

1.71

444

Flat foot [pes planus] (acquired)

155

1146

1.37

3.40

2.1

2.7

0.81

1.06

g/l

0.37

132

981

Corneal degeneration

240

1.85

3.39

1.4

2.6

0.45

0.96

g/l

0.74

212

Benign neoplasm of middle ear and respiratory system

160

1191

1.36

3.39

2.9

2.5

0.72

1.14

g/l

1.11

138

1018

Benign neoplasm: Pituitary gland, craniopharyngeal duct

645

1.49

3.39

3.0

2.6

0.33

1.15

g/l

3.21

566

Contusion of toe(s) without damage to nail

239

1.83

3.39

1.3

2.8

0.07

0.86

g/l

2.31

216

Graves ophthalmopathy

299

1.75

3.39

1.1

2.1

0.63

0.88

g/l

0.15

268

Leiomyoma of uterus

1116

5581

1.13

3.38

2.3

2.4

0.67

0.68

g/l

0.02

928

4787

Appendicitis, broad definition

1375

11158

1.11

3.37

2.7

2.4

0.66

0.73

g/l

0.40

1189

9690

Oesophageal obstruction

502

1.56

3.36

3.5

2.9

0.50

1.50

g/l

2.73

431

Inguinal or femoral hernia, bilateral

229

1795

1.29

3.35

2.9

2.5

1.48

0.95

g/l

0.57

191

1537

Physiological and behavioural disorders associated with sexual development and orientation

9.29

3.33

1.0

6.4

0.00

g/l

—

Other maternal disorders predominantly related to pregnancy

645

4667

0.86

3.33

2.4

0.46

0.55

g/l

0.40

572

4083

Diphtheria

6.01

3.32

4.5

3.8

0.13

0.37

g/l

—

Appendectomy

1144

9769

1.12

3.31

2.5

2.4

0.69

g/l

0.01

995

8525

Perichondritis of external ear

242

1.83

3.31

2.3

2.7

0.65

1.18

g/l

0.71

205

HSIL lesion of the cervix uteri, vagina or vulva

238

1873

1.28

3.31

2.2

2.1

0.50

g/l

0.01

208

1644

Acute alcohol intoxication

474

4008

1.19

3.31

1.7

2.6

0.57

0.89

g/l

0.88

403

3499

Occupational exposure to risk-factors

464

0.47

3.30

2.4

2.8

0.98

1.37

g/l

0.22

411

Other diseases of spinal cord

370

1.65

3.30

4.1

3.0

0.50

1.36

g/l

1.56

328

Other puerperal infections

470

1.56

3.30

1.8

0.79

0.29

g/l

0.42

432

Excessive earwax

1380

11334

1.11

3.29

2.6

2.5

0.87

0.84

g/l

0.11

1133

9760

Chronic iridocyclitis

625

1.49

3.29

2.2

2.6

0.57

1.17

g/l

1.41

544

Other disorders of bone density and structure

264

1.78

3.28

1.9

2.3

0.89

g/l

0.00

238

Other other unspecified disorders of the circulatory system

497

1.56

3.27

2.3

2.7

1.39

1.23

g/l

0.09

426

Other disorders of the genitourinary system

267

2139

1.26

3.26

2.4

0.88

0.89

g/l

0.02

236

1818

Tongue abnormality

127

918

1.40

3.26

2.8

2.6

0.87

1.18

g/l

0.51

107

789

Sequelae of injuries of head

619

1.49

3.23

2.9

2.6

0.03

1.14

g/l

7.66

549

Manic episode

280

1.74

3.23

2.5

2.6

0.74

1.04

g/l

0.30

249

Trigeminal neuralgia

112

793

1.43

3.23

2.3

2.5

0.61

1.07

g/l

0.94

693

Unspecified dementia

163

1929

0.75

3.22

2.1

2.4

0.69

1.29

g/l

1.79

129

1589

Disorders of synovium and tendon in diseases classified elsewhere

229

1.83

3.21

1.8

2.3

0.20

1.25

g/l

2.21

196

Other misadventures during surgical and medical care

327

1.69

3.21

2.0

3.1

0.42

1.18

g/l

1.33

290

Use of disulfiram, acamprosate or naltrexone

139

1021

1.38

3.21

1.4

2.4

0.33

0.94

g/l

2.45

119

904

Maternal care related to the fetus and amniotic cavity and possible delivery problems

415

2906

0.83

3.19

2.9

2.1

0.57

0.48

g/l

0.32

373

2578

Type 1 diabetes, strict definition, subgroup 1

402

1.60

3.18

1.3

1.5

0.18

0.53

g/l

0.94

374

Amputation of ankle bones

305

1.71

3.18

2.5

2.7

1.52

1.29

g/l

0.09

267

Leisure time condition

337

2774

1.22

3.17

1.9

2.3

0.92

0.85

g/l

0.12

254

2394

Inguinal hernia, bilateral

224

1765

1.28

3.16

3.0

2.5

1.51

0.95

g/l

0.59

187

1511

Diphtheria, including avohilmo

5.53

3.16

4.5

3.6

0.13

0.34

g/l

—

Benign neoplasm of meninges

217

1704

1.29

3.16

2.0

2.4

0.43

0.96

g/l

3.11

186

1453

Spinal osteochondrosis

2.29

3.11

1.6

2.5

0.51

1.05

g/l

0.44

Dronedarone medication

424

1.59

3.11

2.1

2.7

0.78

1.62

g/l

1.10

357

Other drug-induced secondary parkinsonism

133

2.11

3.10

2.6

0.61

0.85

g/l

0.16

120

Benign neoplasm: Skin of ear and external auricular canal

577

1.50

3.10

2.2

2.7

1.29

1.41

g/l

0.07

498

Impetigo

407

1.59

3.09

3.3

2.5

1.52

0.78

g/l

0.50

364

Noninflammatory disorders of female genital tract

611

2640

1.17

3.09

2.2

2.3

0.71

0.67

g/l

0.09

516

2270

Crohn disease (strict definition, all UC cases excluded)

511

1.53

3.09

1.6

2.6

0.50

0.93

g/l

0.64

457

Macular cyst

498

1.54

3.06

2.3

2.9

0.69

1.42

g/l

1.05

429

Malignant neoplasm of liver and intrahepatic bile ducts

426

1.58

3.04

1.8

1.4

0.68

0.46

g/l

0.23

367

Abrasion of teeth

664

5808

1.15

3.02

2.7

2.5

0.71

0.77

g/l

0.20

571

5025

Malignant neoplasm of bronchus and lung, including Hilmo

444

3139

1.19

2.99

2.3

1.5

1.03

0.40

g/l

2.25

382

2673

Benign neoplasm of breast

216

1707

1.28

2.99

2.6

2.2

0.64

0.68

g/l

0.06

183

1451

Maternal care for known or suspected fetal abnormality and damage

154

980

1.34

2.99

1.8

1.9

0.18

0.37

g/l

0.99

148

889

Lateral epicondylitis

203

1591

1.28

2.98

2.1

2.3

0.58

0.98

g/l

1.23

175

1371

Intercostal neuropathy

2.41

2.98

5.2

3.0

0.30

1.53

g/l

1.19

Other and unspecified acute skin changes due to ultraviolet radiation

342

1.64

2.98

2.2

2.7

0.25

1.40

g/l

2.93

295

Congenital obstruction of the pelviureteric junction

2.40

2.97

3.6

2.8

0.50

0.69

g/l

0.15

Medial epicondylitis

388

1.59

2.97

2.0

2.3

0.70

1.30

g/l

0.86

338

Other disorders of cornea

188

1462

1.30

2.97

2.0

2.3

0.48

0.98

g/l

1.81

166

1262

Benign neoplasm: Skin of eyelid, including canthus

319

2634

1.22

2.96

3.4

2.4

0.89

0.87

g/l

0.03

269

2247

Inflammatory diseases of prostate (prostatitis)

248

1994

1.25

2.96

2.2

2.8

0.62

0.95

g/l

1.36

214

1730

Postinflammatory hyperpigmentation

5.92

2.96

2.1

4.0

4.71

0.08

g/l

—

Other problems related to primary support group, including family circumstances

125

889

1.38

2.96

1.8

2.3

0.34

0.67

g/l

1.11

113

791

Other disorders of choroid

192

1.88

2.95

1.8

3.3

0.14

0.80

g/l

2.45

168

Other acute skin changes due to ultraviolet radiation

462

1.54

2.93

2.1

2.5

0.64

1.19

g/l

0.71

402

Hypertrophy of tongue papillae

164

1.94

2.92

2.3

2.7

0.47

1.07

g/l

0.61

150

Other facial nerve disorders

328

1.64

2.91

2.2

2.3

1.38

1.09

g/l

0.13

285

Malignant neoplasm, without specification of site

431

1.56

2.89

2.5

1.4

1.64

0.50

g/l

1.42

361

Other specified/unspecified dorsopathies

407

1.57

2.89

4.7

2.4

0.82

1.37

g/l

0.63

350

Corneal ulcer

316

2612

1.22

2.89

2.4

2.3

0.58

0.80

g/l

0.87

274

2264

Benign neoplasm: Appendix

151

1.99

2.88

1.6

2.4

0.00

0.74

g/l

2.64

132

Benign neoplasm: Choroid

142

1069

1.35

2.87

2.0

2.6

1.03

1.09

g/l

0.06

117

916

Vulvovaginal ulceration/inflammation in other diseases

651

1.44

2.87

1.7

2.4

0.11

0.56

g/l

2.97

573

Asthma mixed form (mode)

528

1.49

2.86

2.2

1.8

0.84

0.96

g/l

0.09

443

Melanocytic naevi of upper limb, including shoulder

276

1.70

2.85

2.1

2.6

0.87

0.72

g/l

0.10

247

Burns classified according to extent of body surface involved

110

2.16

2.85

1.8

2.5

0.09

0.86

g/l

1.19

Pre-eclampsia or poor fetal growth

360

3001

1.20

2.84

2.1

2.2

0.45

0.50

g/l

0.15

320

2650

Follow-up care involving plastic surgery

449

1.54

2.84

1.7

2.2

0.27

0.68

g/l

1.08

388

Other sexually transmitted chlamydial diseases

329

1.62

2.83

1.3

1.5

0.18

0.50

g/l

0.84

304

Melanoma in situ of trunk

240

1.76

2.82

3.3

3.0

1.22

g/l

0.00

214

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

3.48

2.82

1.6

2.1

0.00

0.62

g/l

0.75

Moyamoya

9.12

2.81

1.2

1.0

0.00

1.67

g/l

—

Hereditary angioödema type 1

6.90

2.81

11.5

1.0

6.73

1.10

g/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

151

1151

1.33

2.81

2.8

2.4

0.51

1.02

g/l

1.69

134

984

Dissection of cerebral arteries, nonruptured

2.39

2.80

1.7

2.1

0.38

0.98

g/l

0.52

Hyperfunction of pituitary gland

450

1.53

2.79

3.7

2.2

0.60

0.83

g/l

0.28

403

Strabismus

435

3701

1.18

2.79

2.3

0.99

0.79

g/l

0.46

383

3197

Benign neoplasm: Spinal meninges

153

1.97

2.79

1.6

2.3

0.46

0.84

g/l

0.37

133

Other lesions of median nerve

372

1.59

2.78

1.3

2.6

0.11

1.20

g/l

4.00

313

Non-small cell lung cancer, adenocarcinoma

130

971

1.36

2.78

2.0

1.5

1.33

0.37

g/l

1.45

109

828

Disturbance of activity and attention

663

1.42

2.76

1.4

1.5

0.54

0.30

g/l

0.45

620

Focal epilepsy, strict definition

365

3072

1.20

2.76

2.0

2.3

0.73

0.87

g/l

0.32

305

2642

Hyperkinetic disorders

101

704

1.40

2.75

1.4

1.6

0.52

0.32

g/l

0.38

656

Focal brain injury

110

801

1.39

2.73

2.1

2.5

0.86

1.14

g/l

0.27

688

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

100

716

1.41

2.73

2.7

2.4

0.58

0.59

g/l

0.00

635

Respiratory tuberculosis, confirmed, including avohilmo

242

1.73

2.72

1.6

2.8

1.30

1.05

g/l

0.10

212

Chromophobe cell carcinoma of kidney

2.51

2.71

2.4

1.2

2.52

0.11

g/l

0.91

Ulcer of vagina/vulva

319

1.63

2.71

2.5

2.6

0.37

0.80

g/l

0.89

278

Prepatellar bursitis

544

1.47

2.70

2.4

2.3

0.60

1.40

g/l

1.41

460

Corticotropin deficiency

106

2.15

2.70

1.7

2.1

0.35

0.77

g/l

0.41

Viral encephalitis, not elsewhere classified/unspecified

243

1.72

2.69

3.9

2.7

1.76

1.16

g/l

0.31

217

Malignant neoplasm of respiratory system and intrathoracic organs

439

3116

1.18

2.68

2.3

1.5

1.06

0.40

g/l

2.35

373

2658

Assault by bodily force

660

1.42

2.68

2.1

2.3

0.52

0.60

g/l

0.08

602

Burn and corrosion of wrist and hand

367

1.57

2.67

1.4

2.5

0.20

0.90

g/l

2.16

331

Respiratory tuberculosis, confirmed

236

1.73

2.67

1.6

2.8

1.26

1.06

g/l

0.07

207

Presbycusis

360

3004

1.19

2.65

2.8

2.3

1.02

1.04

g/l

0.02

276

2515

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

155

1.90

2.64

2.9

2.4

0.33

1.04

g/l

0.90

143

Pediculosis, acariasis and other infestations

663

1.42

2.64

2.5

0.51

1.10

g/l

1.18

590

Other and unspecified injuries of ankle and foot

408

1.54

2.63

1.5

2.6

0.38

0.84

g/l

0.94

363

Other and unspecified disorders of skin and subcutaneous tissue

118

876

1.36

2.63

1.8

2.6

1.61

1.02

g/l

0.59

759

Hypertrophic disorders of skin

580

1.45

2.62

2.6

2.5

0.63

0.90

g/l

0.32

514

HSIL lesion of the cervix uteri

199

1583

1.26

2.62

2.1

0.51

0.48

g/l

0.04

177

1400

Ventricular septal defect, a heart condition

141

1.94

2.60

1.3

2.0

0.47

0.70

g/l

0.25

131

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

147

1129

1.32

2.60

2.4

2.5

0.77

1.08

g/l

0.43

121

971

Ingrowing nail

598

1.44

2.60

2.1

2.5

0.74

1.05

g/l

0.45

524

Osteochondrodysplasia with defects of growth of tubular bones and spine

5.84

2.60

1.0

1.2

0.00

0.41

g/l

—

Use of levodopa decarboxylase inhibitor

320

2683

1.20

2.60

2.1

2.4

0.59

1.03

g/l

2.11

267

2263

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

4.98

2.59

11.9

1.1

2.90

0.63

g/l

—

Other and unspecified disorders of adult personality and behaviour

2.96

2.59

1.4

1.2

0.00

0.75

g/l

0.98

Alzheimer’s disease (Atypical or mixed)

176

2193

0.78

2.58

1.8

2.4

1.24

1.17

g/l

0.07

136

1796

Abdominal aortic aneurysm (AAA)

210

1673

1.26

2.58

2.1

2.5

0.92

1.35

g/l

0.78

171

1392

Bitten or struck by other mammals

167

1305

1.29

2.57

2.7

2.5

0.75

0.91

g/l

0.26

152

1145

Malignant neoplasm of other and unspecified parts of tongue

172

1.85

2.55

1.7

1.2

0.60

0.37

g/l

0.26

156

Other diseases of gallbladder

677

1.41

2.55

3.1

2.6

0.96

1.17

g/l

0.20

578

Malignant neoplasm of small intestine, including Hilmo

405

1.53

2.53

2.3

1.4

0.73

0.34

g/l

0.58

347

Polypectomy (DHB20)

124

934

1.34

2.53

3.0

2.5

1.46

1.07

g/l

0.25

115

813

Amyloidosis of skin

5.90

2.53

3.8

1.1

2.40

0.08

g/l

—

Malignant neoplasm of small intestine

294

1.63

2.53

2.7

1.4

0.98

0.40

g/l

0.66

254

Congenital malformations of aortic and mitral valves

445

1.50

2.53

2.0

2.6

0.83

1.03

g/l

0.19

401

Pre-eclampsia or eclampsia

284

2358

1.21

2.52

2.2

2.3

0.54

0.57

g/l

0.06

251

2061

Ulcer of oesophagus

137

1048

1.32

2.52

2.1

2.7

0.46

1.25

g/l

3.13

117

889

Delivery, wide proxy

487

2981

0.86

2.51

2.4

2.2

0.83

0.67

g/l

0.43

416

2491

Macular hole

133

1015

1.33

2.51

2.4

2.6

0.43

0.98

g/l

1.43

107

871

Carcinoma in situ of skin, other sites/unspecified

257

1.68

2.50

2.3

2.8

0.83

1.23

g/l

0.40

217

Hepatocellular carcinoma

303

1.62

2.49

2.0

1.4

1.00

0.41

g/l

0.49

258

Foreign body in ear

203

1.76

2.48

1.4

3.0

0.09

0.79

g/l

2.22

184

Left side

0.00

2.46

0.0

2.4

—

0.51

—

Allergic contact dermatitis due to drugs in contact with skin

273

1.64

2.45

2.3

0.14

1.07

g/l

2.55

243

Other blood glucose lowering drugs, excl. Insulins

337

2855

1.19

2.44

2.0

2.5

0.57

1.00

g/l

1.90

293

2409

Benign neoplasm: Prostate

104

2.11

2.44

2.0

3.3

1.01

0.94

g/l

0.03

Other and unspecified primary disorders of muscles

2.29

2.43

1.4

2.9

0.29

1.09

g/l

0.66

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

144

1113

1.31

2.43

2.2

2.5

0.98

1.14

g/l

0.18

128

949

Pedestrian injured in transport accident

120

906

1.34

2.42

1.9

2.3

0.76

1.08

g/l

0.50

105

787

Ulcerative proctitis

683

1.39

2.42

1.5

2.3

0.35

0.94

g/l

1.62

599

Brain meningioma

667

1.40

2.41

2.5

1.4

0.53

0.34

g/l

0.43

560

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

251

1.67

2.41

3.9

2.7

1.76

1.13

g/l

0.33

223

Combinations of oral blood glucose lowering drugs

589

5203

1.14

2.41

1.8

2.7

0.58

0.96

g/l

2.77

514

4470

Myocardial infarction, with ST-elevation

374

3201

1.18

2.40

1.9

2.4

0.73

1.02

g/l

0.79

326

2703

Parkinson's disease, including avohilmo

358

3056

1.18

2.38

1.9

2.4

0.41

0.99

g/l

4.59

299

2582

Laparoscopic right hemicolectomy

130

999

1.32

2.36

2.3

2.6

0.83

1.21

g/l

0.50

107

852

Malignant neoplasm of head and neck, including Hilmo

179

1429

1.26

2.35

2.8

1.5

0.62

0.37

g/l

0.90

157

1225

Malignant neoplasm of digestive organs

771

5290

1.12

2.33

2.3

1.5

0.83

0.36

g/l

3.66

652

4524

Other strabismus

324

2734

1.19

2.33

2.3

0.89

0.77

g/l

0.23

288

2376

Malignant neoplasm of pancreas

1050

0.71

2.32

1.8

1.5

0.90

0.38

g/l

1.16

897

Tonsillectomy and adenotomy

579

4558

0.88

2.31

2.0

2.2

0.79

0.53

g/l

0.71

517

4070

Diabetic maculopathy

246

1924

1.22

2.29

1.5

2.2

0.15

0.67

g/l

7.94

213

1655

Respiratory tuberculosis, bacteriologically and histologically confirmed

247

1.65

2.29

1.6

2.8

1.26

1.10

g/l

0.06

215

Open wound of wrist and hand

785

6829

1.11

2.28

2.6

2.4

0.75

0.73

g/l

0.05

696

5966

Infective dermatitis

197

1597

1.24

2.27

2.2

2.5

0.70

0.97

g/l

0.48

157

1371

Otitis media, unspecified

128

904

1.31

2.27

2.7

2.2

0.96

0.86

g/l

0.08

115

799

Other noninflammatory disorders of uterus, except cervix

403

2316

1.17

2.26

2.5

2.4

1.16

0.76

g/l

1.08

340

1966

Other specified disorders of external ear

541

1.43

2.25

2.2

2.9

0.97

1.26

g/l

0.26

472

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

256

1.63

2.25

2.5

1.2

0.83

0.37

g/l

0.47

222

Parkinson's disease, strict definition

319

2713

1.19

2.25

1.9

2.4

0.45

1.02

g/l

3.75

268

2291

Malignant neoplasm of head and neck

150

1181

1.28

2.24

2.3

1.5

0.55

0.38

g/l

0.53

133

1016

Malignant neoplasm of colon

300

2539

1.19

2.22

2.9

1.5

1.08

0.36

g/l

2.16

255

2157

Brain meningioma, including Hilmo

686

1.37

2.22

2.5

1.4

0.53

0.35

g/l

0.43

576

Other disorders of Eustachian tube

377

1.51

2.21

1.8

2.5

0.67

1.08

g/l

0.33

333

Injury of other and unspecified intrathoracic organs

118

903

1.32

2.20

2.0

2.5

0.58

1.26

g/l

1.73

106

784

Focal epilepsy

380

3279

1.16

2.20

2.0

2.4

0.70

0.86

g/l

0.40

318

2824

Postpartum hemorraghe, all women as controls

167

2030

0.80

2.20

2.3

2.0

0.57

0.40

g/l

0.45

148

1826

Other and unspecified abdominal hernia

586

1.40

2.19

1.8

2.1

0.55

1.18

g/l

0.91

503

Glaucoma secondary to other eye disorders

586

1.40

2.19

2.7

1.40

1.28

g/l

0.07

502

Other degenerative diseases of the basal ganglia

299

1.58

2.17

2.8

0.89

1.75

g/l

0.95

261

Childhood allergy (age < 16)

438

1.42

2.17

1.1

1.3

0.00

0.11

g/l

2.03

410

Pedal cyclist injured in noncollision transport accidents

180

1454

1.25

2.16

1.9

2.4

0.30

0.92

g/l

3.72

159

1275

Lichen ruber planus, wide definition including periferal and oral lichen planus

435

3799

1.15

2.16

2.3

2.5

0.75

0.85

g/l

0.23

383

3262

Conductive and sensorineural hearing loss

1711

10591

1.07

2.15

2.7

2.5

1.00

0.81

g/l

0.88

1394

9167

Acute epiglottitis

152

1.81

2.15

5.5

2.6

2.18

1.26

g/l

0.32

138

Meningitis

579

1.40

2.15

3.4

2.5

1.23

0.89

g/l

0.25

513

Other congenital malformations of circulatory system

315

1.55

2.15

2.0

2.9

0.85

0.95

g/l

0.09

282

Inflammation of lacrimal passages (acute and unspecified)

205

1.69

2.15

2.7

2.0

0.56

1.24

g/l

0.75

179

Haemangioma and lymphangioma, any site

155

1233

1.27

2.14

2.9

2.5

1.12

0.97

g/l

0.15

133

1074

Other acquired deformities of musculoskeletal system and connective tissue

563

1.40

2.14

2.6

2.5

0.92

1.13

g/l

0.23

493

Acute nasopharyngitis (common cold)

168

1337

1.25

2.14

2.0

2.3

0.48

0.62

g/l

0.35

150

1201

Neovascular glaucoma

589

1.39

2.13

2.7

2.5

1.40

1.24

g/l

0.08

505

Benign neoplasm of male genital organs

292

1.57

2.13

2.1

2.9

1.03

1.60

g/l

0.50

260

Other intracranial haemorrhages

480

1.44

2.13

2.8

2.6

0.71

1.44

g/l

1.61

401

Car occupant injured in other and unspecified transport accidents

275

2320

1.19

2.12

2.4

2.3

0.73

0.81

g/l

0.11

241

2026

Glaucoma-related operations

128

998

1.30

2.12

2.7

2.6

1.05

1.23

g/l

0.19

110

837

Malignant neoplasm of tongue

237

1.63

2.11

2.1

1.2

0.50

0.35

g/l

0.20

213

Hypertrophic scar

530

1.41

2.11

2.8

2.4

0.71

0.82

g/l

0.11

468

Single delivery by caesarean section

135

984

0.78

2.11

2.1

1.7

0.28

0.21

g/l

0.17

123

902

Contact with other hot fluids

292

1.56

2.11

1.3

2.5

0.00

1.02

g/l

4.64

266

Ulcerative rectosigmoiditis

123

953

1.30

2.10

2.2

2.4

0.96

1.04

g/l

0.06

104

843

Thyroiditis, unspecified

176

1.74

2.10

1.3

2.0

0.00

1.04

g/l

2.22

154

Benign neoplasm: Cerebral meninges

192

1570

1.23

2.09

2.1

2.4

0.48

0.96

g/l

2.32

168

1348

All dysplastic lesions of the vagina

293

1.56

2.09

1.9

2.1

0.41

0.59

g/l

0.17

263

Other female pelvic inflammatory diseases

256

2151

1.20

2.08

1.7

2.6

0.72

0.67

g/l

0.09

199

1842

Scabies

473

1.43

2.08

2.7

2.4

0.71

0.91

g/l

0.21

426

Other congenital malformations of the digestive system

412

1.46

2.07

1.6

2.7

0.50

1.18

g/l

1.39

360

Lichen planus, including avohilmo

367

3178

1.16

2.07

2.3

2.5

0.80

0.84

g/l

0.08

322

2721

Outcome of delivery

158

769

1.27

2.07

1.9

2.1

0.10

0.32

g/l

1.58

149

698

Malignant neoplasm of oral cavity, including Hilmo

575

1.39

2.07

2.4

1.4

0.79

0.43

g/l

0.66

494

Congenital malformations of the respiratory system, including avohilmo

192

1.70

2.06

2.4

2.5

0.65

0.86

g/l

0.12

171

Familial hypercholesterolemia, with ischemic heart disease

206

1701

1.22

2.05

2.1

2.5

0.64

1.08

g/l

1.41

177

1422

Residual foreign body in soft tissue

542

1.40

2.04

2.2

2.4

0.27

1.46

g/l

4.24

473

Injury of nerves and spinal cord at neck level

287

1.56

2.04

3.0

3.1

0.92

1.04

g/l

0.09

255

Sequelae of injuries of upper limb

158

1268

1.26

2.04

2.8

2.5

1.13

1.02

g/l

0.11

133

1104

Chorioretinal inflammation

360

1.49

2.03

1.9

2.5

0.52

1.15

g/l

0.92

321

Pneumonitis due to solids and liquids

164

1323

1.25

2.03

2.3

0.82

1.12

g/l

0.46

131

1118

Glaucoma suspect

650

7214

0.90

2.02

2.4

2.6

1.05

0.89

g/l

0.43

516

6152

Injuries involving multiple body regions

426

1.45

2.02

3.0

2.6

0.16

0.96

g/l

2.98

376

Malignant neoplasm of oral cavity

443

1.44

2.02

2.0

1.4

0.73

0.38

g/l

0.64

381

110

1420

0.77

2.02

1.4

2.5

0.35

1.05

g/l

2.88

1220

Malignant neoplasm of testis, including Hilmo

133

1.83

2.01

1.8

1.2

0.26

0.28

g/l

0.03

115

Bicuspidal aortic valve syndrome

410

1.46

2.01

2.1

2.6

0.94

1.09

g/l

0.12

370

Benign neoplasm: Skin of trunk

553

1.39

2.01

3.3

2.6

0.59

1.10

g/l

0.84

489

Pilonidal cyst

102

775

1.32

2.01

2.2

0.38

0.75

g/l

0.94

707

Postpartum hemorraghe, parous women as controls

167

1723

0.81

2.01

2.3

2.2

0.57

0.46

g/l

0.26

148

1550

Use of glatiramer acetate

126

1.86

2.00

1.5

1.9

0.53

0.45

g/l

0.05

119

Other and unspecified injuries of shoulder and upper arm

378

1.47

1.99

2.7

2.8

0.69

1.19

g/l

0.67

333

Alcohol withdrawal state with delirium

122

953

1.29

1.99

1.3

2.5

0.52

1.03

g/l

0.83

836

Haemangioma, any site

145

1157

1.26

1.98

2.9

2.5

1.20

0.99

g/l

0.21

123

1006

Vascular dementia (subcortical)

624

1.37

1.98

3.5

2.4

1.55

1.41

g/l

0.10

514

Injury of intra-abdominal organs

249

1.59

1.98

2.2

2.6

0.75

0.97

g/l

0.18

220

Cerebral aneurysm, nonruptured

157

1265

1.25

1.98

1.8

2.5

0.44

0.94

g/l

1.74

131

1089

Other peripheral vertigo

179

1464

1.23

1.97

2.0

2.6

0.99

0.96

g/l

0.03

151

1258

Chromosomal abnormalities, not elsewhere classified

112

1.89

1.96

2.8

1.9

0.00

0.74

g/l

1.68

103

Other abnormal findings in urine

211

1.65

1.96

6.4

2.9

0.76

1.09

g/l

0.27

185

Paralytic strabismus

134

1062

1.27

1.95

2.3

2.5

1.77

1.16

g/l

0.57

116

913

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

720

1.33

1.94

1.7

1.5

0.50

0.47

g/l

0.04

610

Juvenile osteochondrosis

258

1.57

1.94

1.7

2.4

0.00

0.76

g/l

3.32

237

Parkinson's disease

337

2921

1.16

1.92

1.9

2.4

0.43

0.99

g/l

4.01

283

2474

Hypogonadotropic hypogonadism

275

1.55

1.91

4.8

2.3

0.31

0.96

g/l

1.50

251

Vascular dementia (sudden onset)

0.00

1.91

0.0

2.6

—

1.01

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

497

1.39

1.91

3.4

2.0

0.69

0.40

g/l

0.26

449

Conductive hearing loss, unspecified

145

1163

1.26

1.91

3.2

2.3

1.28

0.86

g/l

0.45

129

1010

Toxic colitis

2.52

1.91

2.2

1.8

2.32

0.37

g/l

0.59

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

3.91

1.91

3.8

1.1

2.40

0.06

g/l

—

Contraceptive management

446

3532

0.88

1.90

2.3

0.65

0.57

g/l

0.18

391

3161

Tracheo-bronchomalasia

3.26

1.90

1.9

3.7

0.00

3.30

g/l

—

Disorders of iron metabolism

190

1.66

1.87

1.4

2.1

0.29

1.46

g/l

1.84

168

Other disorders of conjunctiva

280

2398

1.18

1.87

2.6

2.3

0.73

0.88

g/l

0.34

247

2043

conjunctival haemorrhage

152

1230

1.25

1.87

2.2

2.3

0.36

1.01

g/l

3.17

136

1054

Malignant neoplasm of tongue, including Hilmo

318

1.50

1.86

2.7

1.2

0.73

0.37

g/l

0.41

274

Idiopathic hypercalciuria

2.20

1.86

2.4

0.79

1.02

g/l

—

Neuroendocrine tumor and carcinoma of small intestine

160

1.72

1.85

3.0

1.3

0.11

0.40

g/l

1.10

141

LSIL lesion of the cervix uteri, vagina or vulva

169

1382

1.23

1.85

2.4

2.2

0.49

0.59

g/l

0.21

146

1214

Radial styloid tenosynovitis [de Quervain]

570

1.36

1.84

2.8

2.3

0.73

1.11

g/l

0.41

499

Nontoxic single thyroid nodule

128

1018

1.27

1.83

2.5

2.3

1.00

0.92

g/l

0.09

114

879

Lung diseases due to external agents

281

2412

1.17

1.83

2.9

2.4

1.21

1.08

g/l

0.19

226

2050

Benign neoplasm of bone and articular cartilage

127

1010

1.27

1.81

2.1

2.5

0.57

1.03

g/l

0.97

886

Non-small cell lung cancer

203

1678

1.20

1.79

2.0

1.5

1.44

0.39

g/l

2.03

173

1421

Unattended death

135

0.36

1.79

6.2

2.0

0.30

0.86

g/l

—

117

Schizophrenia

165

2005

0.82

1.79

2.5

2.3

0.44

0.83

g/l

1.74

133

1760

Fall on and from ladder

141

1138

1.25

1.79

3.6

2.7

0.72

1.17

g/l

1.00

122

982

Diseases of middle ear and mastoid

917

6882

1.09

1.78

2.7

2.3

0.78

0.72

g/l

0.20

807

5988

Other disorders of breast

211

1773

1.20

1.77

2.5

2.3

0.53

0.64

g/l

0.21

177

1526

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

462

3985

1.13

1.77

3.0

1.5

0.87

0.36

g/l

1.91

392

3431

Lichen sclerosus et atrophicus

203

1701

1.20

1.77

2.0

2.3

0.30

0.80

g/l

3.35

173

1444

Suppurative and unspecified otitis media

469

3694

1.13

1.77

2.9

2.2

0.80

0.63

g/l

0.43

414

3246

Pregnancy with abortive outcome

1094

5267

1.08

1.76

2.1

2.5

0.68

0.72

g/l

0.16

927

4495

Erectile dysfunction

167

1376

1.23

1.76

2.4

2.5

1.12

1.11

g/l

0.01

148

1176

Other ulcerative colitis

619

1.34

1.74

1.5

2.6

0.71

0.97

g/l

0.19

545

Dentofacial anomalies [including malocclusion]

1161

8434

1.08

1.74

2.5

2.4

0.61

0.64

g/l

0.13

1005

7381

Schizoaffective disorder

102

794

1.29

1.74

2.0

2.4

0.39

0.78

g/l

1.07

709

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

109

856

1.28

1.74

2.8

1.4

1.13

0.39

g/l

1.49

736

Sixth [abducent] nerve palsy

475

1.39

1.73

3.1

2.8

2.17

1.34

g/l

0.40

405

Other and unspecified degenerative diseases of nervous system

450

1.40

1.73

2.2

2.7

1.26

1.43

g/l

0.08

384

Systemic sclerosis,strict definition

111

1.85

1.72

1.5

2.0

1.27

0.64

g/l

0.27

101

Vascular dementia (other)

104

1.89

1.72

1.8

2.6

1.24

0.93

g/l

0.12

Malignant neoplasm of endocrine gland, including Hilmo

126

1009

1.26

1.71

3.0

1.4

0.70

0.34

g/l

0.43

101

865

Unspecified mental disorder

630

5714

1.11

1.70

2.1

2.4

0.46

0.75

g/l

2.15

543

4978

Congenital iodine-deficiency syndrome/hypothyroidism

392

1.42

1.69

3.1

2.1

0.65

1.28

g/l

0.56

332

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

2.11

1.69

1.8

2.6

1.14

0.86

g/l

0.11

Defect, injury or illness of neck

2.16

1.69

1.2

2.2

0.00

0.36

g/l

1.05

Dislocation of lens

220

1.58

1.68

4.0

2.6

1.36

1.18

g/l

0.08

193

Blindness, monocular

127

1.78

1.68

5.0

2.3

1.24

0.85

g/l

0.17

111

Benign neoplasm: Parathyroid gland

150

1.71

1.67

1.5

2.3

0.38

0.99

g/l

0.82

136

Acute lymphadenitis

580

1.34

1.67

3.0

2.6

1.51

0.95

g/l

0.38

508

Nonspecific lymphadenitis

633

1.32

1.66

2.3

0.89

0.69

g/l

0.26

565

Left ventricular outflow tract obstruction, narrow definition

521

1.36

1.65

1.9

2.6

0.80

1.04

g/l

0.25

465

Alport

3.81

1.65

1.6

3.8

0.00

g/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

329

2881

1.15

1.65

2.1

2.4

0.74

0.87

g/l

0.29

271

2475

Varicose veins of other sites

104

820

1.28

1.63

2.5

1.07

1.00

g/l

0.05

714

Hereditary lymphedema, including avohilmo

2.86

1.62

1.0

1.5

0.00

0.88

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

107

1342

0.79

1.61

3.4

2.5

1.09

1.02

g/l

0.05

1164

Use of galantamine

123

1517

0.80

1.61

1.7

2.4

0.89

1.13

g/l

0.28

1252

Use of peginterferon beta-1a

2.77

1.60

2.1

1.3

1.73

1.27

g/l

—

Molar incisor enamel hypoplasia

144

1.67

1.60

1.6

1.9

0.05

0.49

g/l

1.25

138

Juvenile Open Angle Glaucoma

2.26

1.60

1.2

2.4

0.00

1.21

g/l

1.16

Unspecific neurodegenerative disorder

924

6829

0.92

1.59

2.0

2.6

1.16

1.04

g/l

0.38

718

5750

Colorectal cancer

461

3965

1.12

1.58

2.8

1.5

1.01

0.39

g/l

2.84

395

3363

Vertigo of central origin

224

1.55

1.58

2.2

3.1

1.38

0.89

g/l

0.26

192

Pleural plaque without asbestos

658

1.31

1.58

1.8

2.7

0.88

1.43

g/l

0.69

555

Calcification and ossification of muscle

2.55

1.57

2.5

2.3

1.11

1.69

g/l

—

Ménière disease

175

1466

1.20

1.57

1.8

2.5

0.94

1.01

g/l

0.08

148

1258

Other and unspecified corneal deformities and disorders

398

1.40

1.57

2.1

2.6

0.58

1.09

g/l

0.65

350

Cysts of oral region, not elsewhere classified

755

1.28

1.55

3.2

2.6

0.45

1.21

g/l

2.89

661

Disturbances of smell and taste

571

1.33

1.55

3.6

3.1

0.46

1.16

g/l

1.87

499

Frontotemporal dementia

1.93

1.55

2.1

2.3

1.83

0.51

g/l

0.50

Benign neoplasm of brain and other parts of central nervous system

110

880

1.26

1.55

2.8

2.6

1.12

1.11

g/l

0.02

766

Dementia in other diseases classified elsewhere

774

1.28

1.55

1.7

2.6

0.62

1.41

g/l

1.58

656

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

100

790

1.27

1.55

2.7

2.3

0.58

0.63

g/l

0.05

701

Hypoplasia of dental enamel , including avohilmo

139

1.67

1.55

1.6

1.9

0.05

0.51

g/l

1.25

134

Any dementia, excluding more controls

864

5478

1.09

1.55

2.1

2.6

1.07

1.02

g/l

0.13

700

4608

Other disorders of skin and subcutaneous tissue related to radiation

3.05

1.54

1.2

0.12

0.00

g/l

—

Dysplasia of cervi uteri

307

1888

1.15

1.52

2.3

2.1

0.67

0.53

g/l

0.38

260

1635

Diabetes insipidus

101

1.82

1.52

2.2

2.4

1.23

0.72

g/l

0.24

Gonococcal infection, including avohilmo

375

1.40

1.52

2.3

2.1

0.86

g/l

0.00

337

Disorders of globe

359

1.41

1.51

2.0

2.9

1.10

1.11

g/l

0.01

311

Maternal care for known or suspected abnormality of pelvic organs

194

1543

0.85

1.49

3.1

2.1

0.44

0.48

g/l

0.08

176

1380

Maternal care for other known or suspected fetal problems

142

1080

0.82

1.49

1.7

1.9

0.16

0.29

g/l

0.47

129

987

LSIL lesion of the cervix uteri

121

983

1.24

1.48

2.6

2.3

0.64

0.56

g/l

0.12

103

881

Felty syndrome

1.99

1.48

1.6

2.6

0.67

0.36

g/l

0.28

Myopia

158

1319

1.20

1.47

2.2

2.4

0.55

0.82

g/l

0.38

138

1164

Nontoxic diffuse goitre

429

1.37

1.47

3.1

2.3

0.38

0.94

g/l

0.86

367

All dysplastic lesions of the vulva

515

1.33

1.47

2.2

2.5

0.63

0.82

g/l

0.20

452

Pre-eclampsia

244

2113

1.16

1.47

2.4

2.2

0.58

0.57

g/l

0.02

213

1847

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

404

1.38

1.45

1.6

2.5

0.42

0.98

g/l

0.97

361

Status epilepticus

439

1.36

1.44

1.5

2.8

0.51

1.24

g/l

1.23

370

Calcaneal spur

141

1.66

1.44

1.9

2.0

0.50

1.94

g/l

1.14

116

Peripheral retinal degeneration

405

1.37

1.44

3.7

2.8

0.80

0.96

g/l

0.14

359

Other and unspecified intracranial injuries

371

1.39

1.43

1.8

2.8

1.71

1.29

g/l

0.16

324

Other specified disorders of kidney and ureter

423

1.36

1.42

3.1

2.9

0.82

1.13

g/l

0.29

373

Pyoderma

222

1.51

1.41

2.0

2.6

0.29

1.24

g/l

1.61

196

Other disorders affecting eyelid function

121

0.40

1.40

5.0

2.5

0.70

1.03

g/l

—

107

Lesion of radial nerve

450

1.35

1.40

2.3

2.5

1.51

1.42

g/l

0.04

396

Other specified and unspecified disorders of lens

151

1.63

1.39

1.6

2.6

0.00

0.98

g/l

2.89

130

Vascular dementia (mixed)

323

1.42

1.39

2.5

2.4

1.99

1.22

g/l

0.41

268

Pleural plaque

205

1765

1.17

1.38

2.2

2.5

1.07

1.18

g/l

0.15

168

1488

Foreign body in alimentary tract

715

1.27

1.38

1.6

2.6

0.72

1.19

g/l

0.67

621

Contact with machinery

135

1620

0.83

1.37

2.4

1.38

0.92

g/l

0.44

114

1416

Otorrhagia

105

1.76

1.37

3.1

2.8

1.18

1.39

g/l

0.10

Gonococcal infection

366

1.38

1.36

2.4

2.1

0.90

0.88

g/l

0.01

329

Secondary parkinsonism+Parkinsonism in other disease

401

1.36

3.2

2.8

0.59

1.53

g/l

1.52

347

Malignant neoplasm of bronchus and lung

369

2760

1.12

1.35

2.1

1.5

1.16

0.37

g/l

2.40

311

2353

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1067

0.79

1.34

3.2

2.4

1.10

1.00

g/l

0.05

937

Renal cell carcinoma of kidney

419

1.35

1.34

2.3

1.5

1.81

0.49

g/l

1.33

356

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

575

1.29

1.34

1.7

2.3

0.19

0.48

g/l

0.79

520

Congenital malformations of genital organs

766

1.25

1.33

2.0

2.1

0.36

0.52

g/l

0.41

684

Vertical strabismus

420

1.35

1.32

2.0

2.7

1.36

1.08

g/l

0.16

372

Bacterial meningitis

412

1.35

1.31

4.1

2.8

1.49

0.90

g/l

0.31

362

Non-small cell lung cancer, squamous, helper endpoint

828

0.77

1.31

1.9

2.6

1.91

1.34

g/l

0.28

699

Alzheimer disease

713

5505

0.92

1.31

1.9

2.5

1.25

1.07

g/l

0.45

566

4584

Frontotemporal dementia, wide, incl. Pick's disease

1.77

1.31

2.1

2.2

1.68

0.44

g/l

0.52

Vascular dementia

212

1773

1.16

1.30

2.6

2.3

1.23

1.26

g/l

0.04

169

1463

Neuroendocrine tumor and carcinoma of rectum

2.12

1.29

5.2

1.1

1.60

0.00

g/l

—

Embedded teeth, including avohilmo

667

1.26

1.29

2.8

2.0

0.47

0.69

g/l

0.40

600

521

4446

1.10

1.29

2.4

2.3

1.09

1.02

g/l

0.13

406

3717

Small cell lung cancer, helper endpoint

400

0.67

1.28

1.7

2.6

0.48

1.35

g/l

1.24

344

Chondromalacia

328

1.39

1.28

1.8

2.3

1.09

0.92

g/l

0.08

302

Other or unspecified paralytic strabismus

1.86

1.28

1.0

3.0

0.00

0.70

g/l

1.20

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

457

1.32

1.28

1.3

2.3

0.35

1.34

g/l

2.21

397

Severe visual impairment, monocular

131

1.64

1.26

1.2

2.9

0.09

0.56

g/l

1.22

117

Malignant neoplasm of thyroid gland, including Hilmo

109

895

1.23

1.26

3.0

1.4

0.80

0.33

g/l

0.51

765

Other appendicitis

129

1077

1.20

1.26

3.0

2.5

0.46

1.07

g/l

2.25

107

943

Rheumatic fever incl heart disease

424

1.34

1.26

2.9

2.7

0.24

1.19

g/l

3.82

363

Alopecia areata

278

1.42

1.26

2.1

0.29

0.83

g/l

0.96

247

Fitting and adjustment of other devices

751

6144

1.08

1.25

2.6

2.3

1.26

0.89

g/l

1.22

618

5165

Dislocation, sprain and strain of joints and ligaments of head

381

1.35

1.24

2.0

1.27

0.76

g/l

0.34

341

Chalazion

180

1549

1.17

1.24

3.3

2.4

0.67

0.94

g/l

0.67

156

1339

Postpartum care and examination

602

0.79

1.22

2.0

1.9

0.25

0.26

g/l

0.03

544

Peritonsillar abscess

280

2486

1.13

1.22

3.2

2.3

0.61

0.75

g/l

0.41

249

2169

Endometriosis of pelvic peritoneum

206

1628

1.15

1.22

1.8

2.3

0.81

0.57

g/l

0.44

179

1418

Secondary parkinsonism

392

1.34

1.21

3.2

2.8

0.59

1.50

g/l

1.40

339

Benign neoplasm: Larynx

436

1.32

1.21

2.9

2.8

0.82

1.33

g/l

0.54

382

Benign neoplasm of ovary

291

2595

1.13

1.20

2.3

2.4

1.29

0.71

g/l

0.86

250

2197

Small plaque parapsoriasis

2.14

1.18

2.0

2.2

0.00

0.47

g/l

—

Infliximab

141

1.57

1.18

1.1

2.0

0.00

0.52

g/l

1.53

129

Rubella [German measles]

352

1.35

1.15

2.6

2.3

1.13

0.81

g/l

0.27

321

Rubella [German measles], including avohilmo

352

1.35

1.15

2.6

2.3

1.13

0.81

g/l

0.27

321

Malignant neoplasm of ureter, including Hilmo

111

1.66

1.15

3.9

1.4

1.67

0.42

g/l

0.69

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

597

0.75

1.14

2.5

2.7

1.66

1.19

g/l

0.20

520

Alcohol abuse counselling and surveillance

159

1.53

1.13

1.3

2.3

0.67

1.31

g/l

0.54

148

Vasomotor rhinitis (mode)

120

1008

1.20

1.13

2.2

2.7

0.43

1.06

g/l

2.73

870

Laparoscopic left hemicolectomy

260

1.41

1.12

2.4

2.6

1.65

1.13

g/l

0.18

229

Inflammatory disorders of breast

619

1.25

1.11

1.9

2.4

0.50

0.66

g/l

0.19

542

Eustachian salpingitis and obstruction

700

1.23

1.11

2.3

1.00

0.67

g/l

0.25

631

Aneurysms, operations, SAH

301

2706

1.12

1.10

2.2

2.3

0.45

0.87

g/l

2.40

248

2317

Abnormal findings in secretions and smears from cervix uteri vagina vulva

671

4591

1.08

1.10

2.2

2.3

0.43

0.57

g/l

0.69

593

3994

Lichen planus

240

2131

1.13

1.09

2.6

2.3

0.80

0.90

g/l

0.16

212

1819

Dislocation, sprain and strain of joints and ligaments of knee

978

8332

1.06

1.09

2.0

2.5

0.42

0.71

g/l

3.81

850

7295

HSIL lesion of the vulva

219

1.44

1.09

3.3

2.3

1.23

0.67

g/l

0.30

195

Adrenogenital disorders

1.98

1.08

8.3

3.5

0.00

0.98

g/l

—

Non-invasive ventilation

299

2317

1.12

1.08

3.3

2.5

2.11

0.75

g/l

3.57

243

2016

Ovarian dysfunction

496

1.27

1.08

2.1

1.9

0.42

0.31

g/l

0.13

449

Intermittent heterotropia

497

1.27

1.06

2.1

2.3

0.32

0.81

g/l

1.41

437

Exposure to other specified electric current

191

0.57

1.05

3.3

2.3

0.95

1.08

g/l

0.09

175

Respiratory conditions due to other external agents

298

1.36

1.04

6.8

2.2

1.97

0.99

g/l

0.45

255

Chorioretinal scars

1.98

1.04

1.9

2.4

0.00

0.49

g/l

—

Antepartum haemorrhage, not elsewhere classified

624

1.24

1.04

2.6

2.0

0.44

0.38

g/l

0.08

564

L02BA Anti-estrogens

275

2469

1.12

1.04

2.0

2.4

0.60

0.74

g/l

0.27

233

2112

Hypertrophy of breast in women and men

276

2478

1.12

1.04

2.1

2.4

0.41

0.73

g/l

1.41

244

2165

LSIL lesion of the vulva

298

1.35

1.03

2.0

2.4

0.17

0.62

g/l

1.15

267

Other osteochondropathies

752

1.22

1.03

2.8

2.3

1.01

0.89

g/l

0.11

664

Benign lipomatous neoplasm of of intra-abdominal organs

1.95

1.03

1.6

2.5

0.12

0.28

g/l

—

Heterophoria

105

880

1.20

1.03

2.8

2.5

0.84

0.97

g/l

0.11

771

Transient global amnesia

139

1612

0.86

1.02

2.7

2.4

1.31

0.98

g/l

0.34

111

1394

Maternal care for known or suspected malpresentation of fetus

112

946

0.84

1.02

2.2

1.9

0.37

0.31

g/l

0.12

106

861

Sensorineural hearing loss

1619

10321

1.05

1.02

2.6

2.5

1.03

0.83

g/l

0.92

1317

8913

Embolic stroke with flimmer

387

1.30

1.01

2.2

2.1

1.18

1.58

g/l

0.19

323

Erythema intertrigo

326

1.33

1.00

2.3

3.1

0.03

1.25

g/l

4.58

286

Calculus of lower urinary tract

101

848

1.20

1.00

3.1

2.6

0.63

1.19

g/l

1.12

723

Certain zoonotic bacterial diseases, including avohilmo

379

1.31

0.99

2.0

2.8

0.96

1.27

g/l

0.18

331

Carcinoma in situ, bladder

630

1.24

0.99

3.7

2.6

1.39

1.33

g/l

0.04

546

Endometriosis ASRM stages 1,2

214

1900

1.13

0.99

1.7

2.1

0.79

0.54

g/l

0.50

183

1664

Other diseases of biliary tract

166

1451

1.15

0.99

2.8

2.5

0.49

0.93

g/l

1.59

138

1223

Other diseases of peritoneum

621

1.23

0.99

1.7

2.6

0.63

1.16

g/l

0.88

538

Burns and corrosions of multiple body regions

1.66

0.98

1.5

2.1

0.00

1.24

g/l

—

Other chromosome abnormalities, not elsewhere classified

2.21

0.98

1.2

3.0

0.00

1.47

g/l

—

Benign neoplasm: Scrotum

1.85

0.98

1.4

1.19

1.55

g/l

—

Malignant neoplasm of ovary

627

0.78

0.98

3.4

1.4

0.28

0.29

g/l

0.02

530

Amblyopia ex anopsia

397

1.29

0.98

1.4

2.3

0.23

0.92

g/l

1.85

354

Benign neoplasm: Conjunctiva

433

1.28

0.98

2.0

2.9

0.56

1.08

g/l

1.04

382

Acute appendicitis, with complications

332

3022

1.10

0.98

2.9

2.4

0.65

0.87

g/l

0.80

279

2617

Hypertrophy of breast

231

2064

1.12

0.97

1.6

2.3

0.42

0.59

g/l

0.49

202

1801

Effects of foreign body entering through natural orifice

385

3532

1.09

0.96

2.1

2.4

0.63

0.80

g/l

0.55

332

3092

Benign neoplasm: Endocrine pancreas

1.66

0.96

1.9

2.8

0.83

0.75

g/l

0.05

Other complications of labour and delivery, not elsewhere classified

595

0.79

0.96

1.5

1.7

0.20

0.23

g/l

0.04

547

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

200

1.42

0.95

2.7

2.8

1.37

0.95

g/l

0.30

174

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

226

2020

1.12

0.95

3.0

2.4

1.07

0.88

g/l

0.36

191

1755

Complications following abortion and ectopic and molar pregnancy

471

1.26

0.95

1.7

2.6

1.35

0.67

g/l

0.56

407

Benign neoplasm: Long bones of lower limb

338

1.31

0.94

1.7

2.2

0.82

0.89

g/l

0.04

309

Obstructed labour due to malposition and malpresentation of fetus

171

1800

0.88

0.94

1.8

2.1

0.20

0.36

g/l

0.91

159

1631

Status post-ami

557

3933

1.08

0.94

1.7

2.6

0.64

1.10

g/l

2.88

473

3291

Malignant neoplasm of stomach, including Hilmo

834

1.19

0.94

1.3

1.5

0.25

0.42

g/l

0.62

708

Malignant neoplasm of ovary, including Hilmo

833

0.81

0.94

3.5

1.4

0.87

0.31

g/l

0.83

704

Malignant neoplasm of hypopharynx, including Hilmo

1.75

0.94

1.5

1.2

0.92

0.18

g/l

0.47

Long labour

198

1890

0.89

0.94

2.4

2.1

0.53

0.51

g/l

0.03

180

1696

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

254

1.35

0.94

1.7

1.8

0.44

0.43

g/l

0.01

237

Other disorders of male genital organs

427

1.27

0.93

1.6

2.6

0.27

0.83

g/l

1.52

369

Burn and corrosion confined to eye and adnexa

218

1.39

0.92

1.8

2.6

0.37

1.04

g/l

1.06

205

Carcinoma in situ of other and unspecified sites

691

1.21

0.92

3.5

2.6

1.27

1.25

g/l

0.01

594

Dengue, including avohilmo

2.16

0.91

4.8

1.6

0.92

0.14

g/l

—

Endocrine disorders, other/unspecified

219

0.63

0.91

2.6

2.5

0.00

1.14

g/l

—

199

Foreign body in respiratory tract

619

1.22

0.90

2.8

2.5

0.38

1.25

g/l

2.92

543

Blood alcohol or alcohol intoxication level

211

1.39

0.89

1.2

2.3

0.00

1.17

g/l

3.64

197

Measles

1.67

0.89

1.3

1.4

0.22

0.84

g/l

0.76

Measles, including avohilmo

1.67

0.89

1.3

1.4

0.22

0.84

g/l

0.76

Sequelae of other and unspecified infectious and parasitic diseases

557

1.23

0.88

2.6

2.3

0.31

0.74

g/l

1.18

496

Schizophrenia or delusion

463

4301

1.08

0.88

2.1

2.3

0.58

0.71

g/l

0.32

390

3750

Ill-defined and unknown causes of mortality

157

1780

0.88

0.87

2.5

1.38

1.17

g/l

0.19

123

1503

Glaucoma

1246

10115

1.05

0.87

2.4

2.5

1.10

0.92

g/l

0.83

1006

8637

Other benign neoplasms of connective and other soft tissue

155

1364

1.14

0.86

3.1

2.4

0.87

0.94

g/l

0.07

128

1179

Use of amantadine

204

1.39

0.86

1.5

2.5

0.08

1.01

g/l

2.20

182

Problems related to social environment

333

0.72

0.86

3.1

2.7

0.90

0.95

g/l

0.03

288

Abscess of Bartholin gland

247

1.35

0.86

2.8

2.4

2.73

0.39

g/l

0.83

223

Unknown and unspecified causes of morbidity

732

1.19

0.86

2.1

2.3

0.42

1.08

g/l

2.29

621

Separation of retinal layers (serosa)

532

1.23

0.86

2.5

2.7

0.46

1.14

g/l

1.50

473

Other acquired deformities of ankle and foot

1.62

0.86

1.7

2.3

0.29

1.86

g/l

—

Other benign neoplasm of uterus: Other parts/unspecified

688

1.20

0.85

3.3

2.3

0.89

1.08

g/l

0.18

559

Pregnancy, childbirth and the puerperium

452

2544

0.93

0.85

1.9

2.3

0.87

0.76

g/l

0.23

381

2108

Metabolic disorder, other/unspecified

1.99

0.85

6.0

1.6

1.30

0.48

g/l

—

Perforation of tympanic membrane

158

1395

1.14

0.84

2.5

2.3

0.70

0.86

g/l

0.30

135

1199

Retained placenta and membranes, without haemorrhage

120

1381

0.87

0.83

3.1

2.2

1.11

0.64

g/l

0.71

105

1207

Benign mammary dysplasia

240

2174

1.11

0.83

2.8

2.3

0.65

0.70

g/l

0.09

209

1839

Schizophrenia, schizotypal and delusional disorders

465

4338

1.07

0.81

2.1

2.3

0.58

0.71

g/l

0.32

392

3782

Malignant neoplasm of nasopharynx

1.86

0.80

1.0

1.1

0.00

0.02

g/l

—

Malignant neoplasm of hypopharynx

1.70

0.80

1.0

1.1

0.00

0.18

g/l

—

Oligomenorrhoea

303

1.29

0.80

2.1

2.5

0.38

0.82

g/l

0.64

267

Colon adenocarcinoma

224

2027

1.11

0.80

2.9

1.5

1.11

0.39

g/l

1.64

190

1728

Multiple delivery

967

0.84

0.79

2.5

2.0

0.35

0.44

g/l

0.23

852

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

565

1.21

0.79

2.6

2.4

0.31

0.81

g/l

1.40

501

Familial benign pemphigus (Hailey-Hailey disease)

0.00

0.79

0.0

1.6

—

1.04

—

Benign neoplasm: Lip

287

1.30

0.78

3.0

2.5

2.07

0.93

g/l

0.49

252

Endometriosis diagnosis and infertility diagnosis occurring together

110

953

1.16

0.78

1.4

2.3

0.33

0.55

g/l

0.51

849

Other and unspecified disease of Bartholin gland

385

1.26

0.78

2.0

2.6

0.51

0.84

g/l

0.41

335

Use of rivastigmine

306

3313

0.92

0.78

2.5

2.4

0.96

1.03

g/l

0.12

244

2736

Medical treatment for female infertility

139

1560

0.88

0.78

1.7

2.0

0.44

0.32

g/l

0.27

125

1410

Malignant neoplasm of endocrine gland

101

871

1.16

0.77

2.5

1.4

0.83

0.32

g/l

0.52

748

Pityriasis lichenoides chronica

1.74

0.77

2.9

3.1

0.00

1.18

g/l

—

Oral lichen planus, including avohilmo , including avohilmo

120

1049

1.15

0.77

2.2

2.6

0.87

0.94

g/l

0.06

106

909

Malignant neoplasm of breast, ER-negative, including Hilmo

341

2948

1.08

0.76

2.2

1.5

0.56

0.33

g/l

0.96

280

2481

Deep endometriosis

103

1188

0.86

0.76

1.5

2.3

0.65

0.68

g/l

0.03

1021

Infections of genitourinary tract in pregnancy

1016

0.85

0.75

2.9

2.2

0.24

0.61

g/l

1.98

883

Gastrointestinal stromal tumor and sarcoma

150

1.42

0.75

1.3

1.4

0.44

0.32

g/l

0.16

130

Other congenital malformations of respiratory system

2.08

0.74

1.0

1.4

0.00

1.14

g/l

—

Abnormalities of forces of labour

103

893

1.16

0.74

1.8

2.2

0.18

0.52

g/l

1.75

811

Presbyopia

110

959

1.15

0.74

1.8

2.5

0.73

0.91

g/l

0.22

857

Disorders of adrenal gland, other and/or unspecified

1.70

0.73

1.6

2.3

0.16

0.99

g/l

—

Defect, injury or illness of lumbar spine

2.04

0.73

1.2

1.4

0.00

1.36

g/l

—

Other vitreous opacities

581

1.20

0.72

3.3

2.7

1.46

1.11

g/l

0.22

509

Circumscribed brain atrophy

327

1.27

0.72

1.8

3.0

1.07

1.32

g/l

0.15

283

Toxic effects of substances chiefly nonmedicinal as to source

125

1415

0.88

0.72

1.7

2.4

0.16

0.94

g/l

5.22

105

1239

Hereditary corneal dystrophies

545

1.20

0.71

2.0

2.7

0.50

1.38

g/l

1.53

473

Other contact dermatitis

110

962

1.15

0.71

2.0

2.5

1.12

1.00

g/l

0.09

836

Poor fetal growth

775

1.16

0.71

1.8

2.0

0.11

0.36

g/l

1.19

703

Other fall from one level to another

346

3212

1.08

0.71

2.2

2.4

0.74

0.85

g/l

0.24

300

2792

Melanoma of uvea

135

1.43

0.70

5.3

2.6

2.52

0.86

g/l

0.67

118

Benign neoplasm: other/unspecified salivary gland

382

1.24

0.70

1.6

2.6

0.30

1.31

g/l

2.33

331

Papillary adenocarcinoma of thyroid gland

601

1.19

0.70

1.7

1.4

1.09

0.32

g/l

0.59

522

Malignant neoplasm of nasal cavity and sinuses

1.59

0.70

6.9

1.2

0.93

0.33

g/l

0.47

Gestational diabetes (for exclusion)

284

2118

0.92

0.69

1.8

2.0

0.41

0.38

g/l

0.07

256

1921

Vestibular neuronitis

148

1324

1.12

0.68

2.8

2.6

1.00

1.07

g/l

0.08

128

1140

Right hemicolectomy

108

948

1.15

0.68

3.7

2.6

0.95

1.29

g/l

0.43

100

802

Other menopausal disorders

433

2258

1.07

0.68

2.3

2.4

0.43

0.68

g/l

1.37

384

1945

Other and unspecified disorders of globe

1.84

0.67

2.6

1.3

0.00

0.04

g/l

—

Morphin

285

1.27

0.67

1.8

1.7

1.38

1.24

g/l

0.05

240

Kela-code for behavioural disturbances in mental retardation

0.52

0.67

1.8

2.0

2.68

0.80

g/l

—

Tooth eruption problems

109

924

1.14

0.67

2.5

1.9

0.40

0.57

g/l

0.39

102

837

Polyhydramnios

306

0.75

0.67

1.3

2.1

0.00

0.26

g/l

1.89

279

Disorders of eyelid in diseases classified elsewhere

403

1.22

0.66

1.2

2.8

0.00

1.01

g/l

6.05

351

Alzheimer disease, including avohilmo

836

6051

0.95

0.66

2.0

2.5

1.31

1.04

g/l

0.85

665

5058

Glaucoma, exfoliation

193

2118

0.91

0.66

2.7

2.4

1.35

1.01

g/l

0.50

152

1770

Labour and delivery complicated by fetal stress [distress]

153

1109

0.90

0.66

1.8

0.15

0.26

g/l

0.63

141

1011

Other benign neoplasms of uterus

100

876

1.15

0.66

3.1

2.2

1.04

0.87

g/l

0.15

726

Mixed conductive and sensorineural hearing loss

239

2197

1.09

0.66

2.5

2.3

1.22

0.81

g/l

0.58

192

1883

Complications predominantly related to the puerperium

294

2724

1.08

0.66

2.3

2.2

0.57

0.56

g/l

0.01

263

2397

Anisometropia and aniseikonia

386

1.23

0.65

2.7

0.98

1.28

g/l

0.23

337

Myocardial infarction, unclassifiable

410

3899

0.94

0.64

1.8

2.4

0.79

1.14

g/l

0.72

347

3244

Colon adenocarcinoma, helper endpoint

224

2437

0.92

0.64

2.9

2.4

1.11

0.99

g/l

0.14

190

2069

Tuberculosis, IBD comorbidity

124

1104

1.13

0.64

2.1

2.3

1.20

1.12

g/l

0.06

102

921

Respiratory tuberculosis, not confirmed

611

0.83

0.63

2.5

2.7

1.69

1.29

g/l

0.18

515

Dementia, including avohilmo

1119

7344

1.04

0.63

2.1

2.6

1.05

1.01

g/l

0.10

884

6208

Polycystic ovarian syndrome, broad definition

677

0.84

0.63

1.2

1.7

0.02

0.24

g/l

2.84

613

Calcific tendinitis

104

1.46

0.63

2.5

2.8

0.64

1.73

g/l

—

Pedal cyclist injured in transport accident

338

3155

1.07

0.63

2.1

2.3

0.56

0.78

g/l

0.87

293

2762

Congenital malformations of eye, ear, face and neck

589

1.18

0.63

2.9

2.3

0.44

0.99

g/l

0.96

519

Postmenopausal atrophic vaginitis

453

2321

1.07

0.63

2.6

2.4

0.73

0.74

g/l

0.02

386

1983

Presence of other devices

450

4692

0.94

0.62

2.5

2.4

1.34

0.96

g/l

0.91

381

4007

Cyst of spleen

0.00

0.61

0.0

3.3

—

0.80

—

Tuberculosis, wide, including avohilmo

131

1175

1.12

0.60

2.1

2.5

1.16

1.19

g/l

0.02

108

985

Communicating hydrocephalus

290

1.25

0.60

2.3

3.0

0.32

1.35

g/l

2.43

253

False labour

228

1537

0.92

0.60

2.0

0.40

0.38

g/l

0.04

212

1394

Other melanin hyperpigmentation

327

1.23

0.59

1.7

2.5

0.24

1.23

g/l

2.60

278

Non-small cell lung cancer, adenocarcinoma, helper endpoint

130

1168

1.12

0.59

2.0

2.6

1.33

1.15

g/l

0.15

109

993

Malignant neoplasm of stomach

724

1.15

0.59

1.2

1.5

0.31

0.44

g/l

0.39

617

Caught, crushed, jammed or pinched in or between objects

547

1.17

0.59

1.5

2.6

0.29

1.15

g/l

2.91

488

Malignant neoplasm of pancreas, including Hilmo

119

1329

0.89

0.59

2.3

1.5

0.64

0.37

g/l

0.84

103

1138

Respiratory tuberculosis, not confirmed, including avohilmo

616

0.84

0.59

2.5

2.7

1.65

1.31

g/l

0.15

519

Haemorrhage in early pregnancy

292

3041

0.93

0.58

2.5

2.3

0.41

0.56

g/l

0.63

260

2667

Exposure to smoke, fire and flames

276

0.76

0.58

1.2

2.8

0.02

1.13

g/l

4.16

244

Female infertility, tubal origin

437

1.19

0.58

1.4

2.1

0.58

0.51

g/l

0.06

395

Acute otitis externa, noninfective

193

1.31

0.58

2.6

2.7

0.93

1.24

g/l

0.15

171

Lesion of sciatic nerve

669

0.85

0.58

1.6

2.4

2.21

1.30

g/l

0.37

555

Kela-code for severe mental illness

540

5132

1.05

0.58

2.2

2.3

0.47

0.77

g/l

1.99

459

4464

Chronic mastoiditis

374

1.21

0.57

1.8

2.6

0.21

1.51

g/l

3.84

321

Endometriosis of fallopian tube

1.53

0.57

1.1

2.6

0.00

0.24

g/l

—

Bradycardia, unspecified, drug-induced

1.66

0.56

1.3

2.8

0.48

0.54

g/l

—

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

1.47

0.56

1.1

1.2

0.05

0.31

g/l

—

Benign lipomatous neoplasm of other sites/unspecified

150

1363

1.10

0.56

3.1

2.4

0.67

1.07

g/l

1.01

138

1169

Excessive vomiting in pregnancy

709

1.15

0.56

1.7

2.3

0.20

0.69

g/l

2.43

634

Benign neoplasm of other and unspecified sites

431

1.19

0.55

2.7

2.4

0.39

1.11

g/l

1.45

373

Tuberculosis, wide

128

1155

1.11

0.55

2.1

2.5

1.17

1.20

g/l

0.02

105

968

Injury of muscle and tendon at shoulder and upper arm level

691

6620

1.05

0.55

2.5

0.56

0.87

g/l

1.99

591

5749

Spermatocele

130

1175

1.11

0.54

2.8

2.6

1.36

0.96

g/l

0.47

120

1012

Other obstructed labour

781

0.87

0.53

2.5

2.3

0.44

0.64

g/l

0.37

696

Malignant neoplasm of thyroid gland

807

1.13

0.53

2.5

1.4

0.92

0.32

g/l

0.56

696

Vascular dementia (undefined)

697

1.14

0.53

1.6

2.2

0.91

1.27

g/l

0.33

573

Hydatidiform mole

132

0.68

0.52

2.4

2.2

4.30

0.36

g/l

—

118

Oral lichen planus

397

1.19

0.52

1.6

2.6

0.72

1.23

g/l

0.61

348

Dysplastic lesion of unknown severity of the cervix uteri

1.46

0.52

1.6

1.9

0.00

0.51

g/l

0.93

Acute and transient psychotic disorders

150

1369

1.10

0.52

2.4

2.3

0.81

0.78

g/l

0.02

124

1216

Embolic stroke

733

1.14

0.51

1.8

2.6

0.77

1.44

g/l

0.66

618

Benign leiomyoma with endometriosis

262

2450

1.07

0.51

2.3

2.4

1.12

0.76

g/l

0.41

222

2080

Von Willebrand disease

118

1.37

0.50

2.8

2.5

1.06

0.61

g/l

0.34

108

Other ill-defined and unspecified causes of mortality

149

1627

0.91

0.50

2.4

2.5

1.44

1.19

g/l

0.22

117

1368

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

102

915

1.12

0.50

1.5

2.5

0.28

0.90

g/l

3.13

785

L02BB Anti-androgens

161

1751

0.92

0.50

2.1

2.5

1.03

1.21

g/l

0.23

134

1478

Maltreatment syndromes

389

1.19

0.50

2.3

2.0

1.85

0.71

g/l

0.59

352

Foreign body on external eye

179

1939

0.92

0.50

2.3

2.4

0.86

0.82

g/l

0.06

154

1721

Endometriosis of ovary

231

2027

1.07

0.49

1.8

2.3

0.85

0.63

g/l

0.40

197

1744

Universal erythroderma, KELA reimbursement

163

1.30

0.49

1.5

2.6

1.32

1.27

g/l

0.02

146

Supervision of high-risk pregnancy

181

1002

1.09

0.49

1.7

2.1

0.37

0.36

g/l

0.02

164

909

Lymphangioma, anys site

1.46

0.48

1.7

3.0

0.12

1.04

g/l

1.35

Use of rasagiline

401

1.18

0.48

1.5

3.1

0.19

1.46

g/l

3.92

349

Injury of muscle and tendon at wrist and hand level

207

1925

1.08

0.48

2.2

2.5

0.82

0.87

g/l

0.06

186

1682

Disorders of plasma-protein metabolism, not elsewhere classified

1.49

0.47

4.5

1.7

3.19

0.58

g/l

—

Valgus deformity, not elsewhere classified

1.49

0.47

1.1

1.9

0.00

2.22

g/l

—

Endometriosis of rectovaginal septum and vagina

1004

0.89

0.47

1.6

2.2

0.75

0.69

g/l

0.06

859

Benign lipomatous neoplasm

518

4955

1.05

0.47

2.8

2.5

0.79

0.85

g/l

0.17

452

4254

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

116

1053

1.10

0.47

1.9

2.3

0.31

0.64

g/l

1.39

107

912

Malignant neoplasm of other and ill-defined digestive organs

1.40

0.46

1.3

0.72

0.45

g/l

0.20

malignant neoplasm of female genital organs, including Hilmo

276

2474

1.06

0.46

2.5

1.5

0.67

0.32

g/l

1.28

229

2069

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

1.42

0.46

3.7

1.4

0.89

0.16

g/l

—

Kyphosis

165

1.28

0.45

3.2

1.8

0.88

1.26

g/l

0.17

143

Twin gestation

694

1.13

0.45

1.7

2.1

0.15

0.43

g/l

1.71

624

Benign neoplasm of other and unspecified female genital organs

588

0.86

0.45

1.7

2.4

0.41

0.84

g/l

0.54

501

Antenatal screening

204

1062

1.08

0.44

2.0

2.1

0.32

0.35

g/l

0.08

194

967

Pterygium

442

1.16

0.44

2.4

2.7

0.59

1.46

g/l

1.32

390

Mild mental retardation

208

0.77

0.44

2.1

2.4

0.41

1.02

g/l

0.65

194

Otosclerosis

121

1106

1.10

0.44

1.9

2.6

0.59

1.03

g/l

0.66

102

955

Diabetes mellitus in pregnancy

244

1652

0.94

0.44

1.5

2.1

0.12

0.34

g/l

2.70

221

1498

Melanocytic naevi of other and unspecified parts of face

725

1.12

0.43

3.7

2.5

1.06

0.99

g/l

0.05

633

Erosion and ectropion of cervix uteri

396

1.17

0.43

3.6

2.3

0.53

0.73

g/l

0.20

341

Transient acantholytic dermatosis [Grover]

1.60

0.43

1.2

2.5

0.80

0.47

g/l

—

Serous carcinoma of ovary

0.64

0.43

1.8

1.6

1.68

0.50

g/l

—

Specific developmental disorder of motor function

1.62

0.43

1.0

2.4

0.00

0.15

g/l

—

Oral leukoplakia, including avohilmo

378

1.17

0.43

1.6

2.6

0.46

1.23

g/l

1.05

337

Obstetric embolism

0.00

0.42

0.0

1.1

—

0.00

—

Pedestrian injured in collision with car, pick-up truck or van

286

1.20

0.42

1.9

2.5

1.14

0.95

g/l

0.09

250

Need for immunization against certain single viral diseases

0.00

0.41

0.0

1.3

—

1.11

—

Syndactyly

0.00

0.41

0.0

3.5

—

0.67

—

Defect, injury or illness of face

0.00

0.41

0.0

3.8

—

0.43

—

Chondrosarcoma, including Hilmo

1.37

0.41

2.5

1.2

0.62

0.50

g/l

—

Dementia due to Parkinson's disease

444

0.85

0.41

1.4

2.6

0.91

1.46

g/l

0.36

376

Malignant neoplasm of eye, brain and central nervous system

501

1.14

0.41

1.7

1.4

0.98

0.35

g/l

0.71

437

Carcinoma in situ of breast, other/unspecified

195

1.24

0.41

2.8

2.5

0.18

0.85

g/l

1.24

169

Benign neoplasm: Pineal gland

0.00

0.41

0.0

1.6

—

2.20

—

Choroidal detachment

1.50

0.41

1.2

3.0

0.00

0.38

g/l

—

Malignant neoplasm of nasal cavity and middle ear

1.33

0.40

7.0

1.2

0.43

0.32

g/l

—

Fistulae involving female genital tract

214

1.22

0.40

2.3

2.6

0.94

1.04

g/l

0.05

183

Pathological resorption of teeth

456

1.15

0.39

1.2

2.7

1.10

1.08

g/l

0.01

409

Examination and encounter for administrative purposes

120

1104

1.09

0.39

2.9

2.6

0.88

0.98

g/l

0.12

104

921

Mental and behavioural disorders due to use of volatile solvents

0.00

0.39

0.0

3.2

—

0.82

—

Motor disorders

1.42

0.39

1.0

2.2

0.00

0.13

g/l

—

Androgenic alopecia

1.36

0.38

1.1

2.5

0.00

0.55

g/l

1.10

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

956

0.91

0.37

3.3

2.6

0.31

1.10

g/l

3.74

825

Sequelae of infectious and parasitic diseases

102

934

1.09

0.37

2.9

2.4

0.82

1.11

g/l

0.28

808

Normotensive glaucoma

174

1631

1.07

0.37

2.4

2.5

1.45

0.96

g/l

0.71

138

1392

Colorectal adenocarcinoma

365

3449

1.05

0.36

2.8

1.5

0.96

0.38

g/l

2.18

309

2927

Superficial injuries involving multiple body regions

291

1.17

0.36

4.4

2.5

0.23

0.83

g/l

1.38

260

Congenital malformations of spine and bony thorax

1.44

0.36

1.2

2.3

0.00

0.17

g/l

—

Evidence of alcohol involvement determined by blood alcohol level

144

1.26

0.35

1.2

2.1

0.00

1.31

g/l

2.55

134

Small cell lung cancer

320

0.84

0.35

1.7

1.4

0.48

0.45

g/l

0.02

275

Small cell lung cancer, including Hilmo

320

0.84

0.35

1.7

1.4

0.48

0.45

g/l

0.02

275

Benign neoplasm of thyroid gland

448

0.87

0.35

1.6

2.5

0.33

1.16

g/l

1.87

391

Dementia due to Parkinsons disease, excluding more controls

329

1.16

0.35

1.4

2.5

0.91

1.62

g/l

0.48

277

Pregnancy hypertension

496

4270

1.04

0.35

2.3

0.61

0.53

g/l

0.17

445

3733

Multiple gestation

717

1.10

0.35

1.7

2.1

0.15

0.42

g/l

1.70

646

Autoimmune thyroiditis

190

1.22

0.35

1.9

2.1

0.62

0.57

g/l

0.04

172

Malignant neoplasm of nasopharynx, including Hilmo

1.38

0.35

1.0

1.2

0.00

0.27

g/l

—

Malignant neoplasm of oropharynx, including Hilmo

246

1.19

0.34

7.0

1.3

1.36

0.40

g/l

0.89

215

Clubfoot

1.35

0.34

1.7

1.9

2.30

0.67

g/l

0.34

Mental retardation, excluding more controls

264

1.17

0.34

1.9

2.6

0.92

1.07

g/l

0.09

236

Melanocytic naevi, other sites/unspecified

1054

0.92

0.34

2.4

1.22

1.04

g/l

0.13

928

Bullous keratopathy

109

1.30

0.34

1.0

2.6

0.00

0.62

g/l

1.82

Primary open-angle glaucoma

657

6511

0.97

0.33

2.5

1.14

0.95

g/l

0.55

524

5483

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

126

1173

1.08

0.33

2.0

2.5

1.01

1.00

g/l

0.02

110

1020

Malignant neoplasm of breast, HER-negative

308

2828

1.05

0.33

2.2

1.5

0.54

0.34

g/l

0.71

251

2375

Thromboangiitis obliterans

1.29

0.32

1.2

3.0

0.57

0.16

g/l

—

Vascular syndromes of brain in cerebrovascular disorders

728

0.90

0.32

2.4

2.6

2.13

1.40

g/l

0.39

621

Female infertility

340

1951

1.05

0.32

2.1

2.2

0.29

0.52

g/l

1.49

300

1705

Malignant neoplasm of lip, including Hilmo

132

0.75

0.32

1.1

1.3

0.00

0.35

g/l

—

113

Postpartum haemorrhage due to retained placenta

863

0.91

0.32

2.2

2.0

0.50

0.41

g/l

0.18

777

Persistent delusional disorders

1049

0.92

0.31

2.1

2.4

0.50

0.97

g/l

0.86

901

Malignant neoplasm of corpus uteri, including Hilmo

147

1380

1.07

0.31

1.7

1.5

0.42

0.33

g/l

0.25

113

1154

Male infertility

337

0.86

0.31

2.0

2.3

0.99

0.71

g/l

0.18

311

Open bite

361

1.14

0.31

1.2

1.9

0.08

0.48

g/l

1.66

327

Toxic effect of contact with venomous animals

506

0.89

0.31

2.4

2.7

0.40

1.09

g/l

1.13

446

Complications associated with artificial fertilization

0.72

0.31

2.0

2.4

0.56

0.29

g/l

—

Ovarian hyperstimulation (induction)

100

0.70

0.30

2.0

1.5

0.56

g/l

—

Impacted teeth

126

1156

0.93

0.30

1.7

1.9

0.59

0.51

g/l

0.12

121

1050

Tooth agenesis EXCLUDE clefts and syndromes

206

0.82

0.29

1.3

1.8

0.12

0.37

g/l

0.66

196

Stenosis and insufficiency of lacrimal passages

154

1453

1.06

0.29

2.1

2.5

0.80

1.02

g/l

0.41

128

1246

Cervical polyps

139

1307

1.07

0.29

2.3

0.96

0.65

g/l

0.46

124

1121

Protein-energy malnutrition of moderate and mild degree

121

1.25

0.29

1.3

1.9

1.00

0.49

g/l

—

107

Adenocarcinoma and papillary adenocarcinoma of stomach

355

0.87

0.28

1.2

1.4

0.55

0.50

g/l

0.04

303

Divergent concomitant strabismus

853

1.08

0.28

2.2

2.4

0.68

1.01

g/l

0.50

740

Contact with other specified venomous animals

1.31

0.28

1.1

2.9

0.00

0.74

g/l

1.81

Beningn neoplasm: Meninges, unspecified

214

1.18

0.28

1.3

2.5

0.37

1.20

g/l

0.97

182

Mandibular prognathia

116

0.77

0.27

1.2

2.2

0.14

0.47

g/l

—

108

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

897

7119

0.98

0.27

2.4

0.73

0.71

g/l

0.06

756

6184

Chronic suppurative otitis media, including avohilmo

108

1010

1.07

0.27

1.5

2.5

0.69

1.13

g/l

1.06

871

Congenital malformations of breast, including avohilmo

122

1.23

0.27

1.0

2.1

0.00

0.49

g/l

1.39

114

Non-allergic asthma

121

1136

1.07

0.27

2.4

0.84

1.01

g/l

0.16

104

972

Unspecified jaundice

731

1.08

0.26

2.2

2.5

0.91

1.13

g/l

0.19

619

Carcinoma in situ of cervix uteri

818

1.08

0.26

2.3

2.2

0.54

0.61

g/l

0.10

728

Chronic diseases of tonsils and adenoids

1222

7847

0.98

0.26

2.1

2.5

0.66

0.70

g/l

0.17

1098

6817

Cyst of Bartholin Gland

386

1.12

0.26

2.2

2.3

1.56

0.66

g/l

0.59

344

Sequelae of infectious and parasitic diseases, including avohilmo

103

964

1.07

0.26

2.9

2.3

0.81

1.10

g/l

0.27

830

Pregnancy examination and test

107

708

0.94

0.25

1.8

2.0

0.16

0.26

g/l

0.51

102

645

Alzheimer’s disease, strict definition

563

4664

0.97

0.25

1.9

2.4

1.27

1.12

g/l

0.31

462

3868

Malignant neoplasm of gallbladder, including Hilmo

0.73

0.24

1.3

1.2

0.00

0.19

g/l

—

Other and unspecified nonscarring hair loss

1.29

0.24

1.4

2.7

0.00

0.79

g/l

—

Prolapse and hernia of ovary and fallopian tube

594

1.09

0.24

2.4

2.1

1.69

0.84

g/l

0.73

476

Failed attempted abortion

0.70

0.24

3.2

1.6

0.63

0.56

g/l

—

Congenital malformations of breast

115

1.22

0.23

1.0

1.8

0.00

0.46

g/l

1.21

107

Other and unspecified hydrocephalus

237

1.14

0.23

3.4

2.6

0.64

0.72

g/l

0.07

204

Other congenital malformations of limb(s)

1.32

0.23

1.0

2.0

0.00

0.29

g/l

—

malignant neoplasm of female genital organs

222

2259

0.96

0.23

2.2

1.5

0.46

0.33

g/l

0.47

183

1890

Other mental disorders due to brain damage and dysfunction and to physical disease

231

2222

1.04

0.23

2.9

2.4

0.77

0.97

g/l

0.50

188

1883

Non-seminoma of testis, including Hilmo

1.29

0.23

1.6

1.2

0.00

0.13

g/l

—

Unspecified chronic bronchitis

486

1.09

0.23

2.4

2.8

1.93

1.60

g/l

0.17

416

Family history of malignant neoplasm

137

1302

1.05

0.22

3.4

2.2

0.77

0.67

g/l

0.13

123

1140

Other endocrine disorders

413

0.90

0.22

2.9

2.6

0.27

1.15

g/l

2.47

367

Benign neoplasm: Short bones of upper limb

172

1.17

0.22

1.8

2.7

0.85

0.56

g/l

0.15

153

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

152

1592

0.95

0.22

3.1

1.5

0.96

0.36

g/l

1.50

130

1376

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

305

1.12

0.22

3.8

2.8

0.97

1.04

g/l

0.03

274

Myiasis

0.00

0.22

0.0

5.0

—

0.54

—

Melanoma in situ of eyelid, including canthus

0.00

0.22

0.0

5.0

—

0.54

—

Induced delusional disorder

0.00

0.22

0.0

4.5

—

0.91

—

Medullary carcinoma of thyroid gland

0.00

0.22

0.0

1.1

—

0.00

—

Crushing injury of hip and thigh

0.00

0.22

0.0

1.1

—

0.91

—

Congenital heart conduction disorder

0.00

0.21

0.0

1.0

—

0.00

—

Supernumerary ureter

0.00

0.21

0.0

1.0

—

0.00

—

Calculus of urinary tract in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

0.08

—

Ascariasis, including avohilmo

0.00

0.21

0.0

1.3

—

0.38

—

Other congenital musculoskeletal deformities

0.00

0.21

0.0

1.0

—

1.00

—

Thyrotoxicosis with toxic single thyroid nodule

101

0.79

0.21

6.1

2.5

4.08

0.53

g/l

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

0.21

0.0

1.0

—

0.00

—

Female infertility, cervical, vaginal, other or unspecified origin

307

1900

1.03

0.21

2.2

0.24

0.54

g/l

2.53

270

1662

Burn and corrosion of trunk

344

1.11

0.21

1.7

2.9

0.07

1.21

g/l

5.16

309

Intracerebral haemorrhage

223

2313

0.96

0.21

2.5

2.4

0.88

1.16

g/l

0.48

189

1936

Other and unspecified epidermal thickening

325

1.11

0.21

2.1

2.7

0.41

1.29

g/l

1.66

291

Medicines for HER+ breast cancer

634

5779

1.02

0.21

2.2

2.5

0.62

0.77

g/l

0.51

528

4901

Unicornuate uterus

0.00

0.21

0.0

1.0

—

0.77

—

Birth injury to peripheral nervous system

0.00

0.21

0.0

4.5

—

2.61

—

Other congenital musculoskeletal deformities, including avohilmo

0.00

0.21

0.0

1.0

—

0.85

—

Constitutional tall stature

0.00

0.21

0.0

1.0

—

0.00

—

Endovascular or surgical operations to intracerebral aneurysms

852

0.94

0.20

2.0

2.7

0.28

1.13

g/l

3.33

737

Anxious personality disorder

134

0.82

0.20

4.1

2.2

0.17

0.84

g/l

1.01

123

Disorder of amino-acid metabolism, other/unspecified

0.00

0.20

0.0

1.9

—

1.92

—

Other congenital malformations of spinal cord

0.00

0.20

0.0

1.1

—

1.04

—

Certain zoonotic bacterial diseases

221

1.14

0.20

1.2

2.6

1.32

1.01

g/l

0.09

195

Benign neoplasm: Rectum/anal canal icd-9

133

0.82

0.19

2.5

2.0

0.00

0.76

g/l

—

108

Deep bite

117

977

1.05

0.19

3.2

2.4

0.71

0.84

g/l

0.19

100

871

Contact with sharp glass

356

1.10

0.19

2.0

2.2

0.00

0.77

g/l

4.11

323

Use of levodopa decarbox-comt-inhibitor

529

0.92

0.19

1.1

2.9

0.14

1.43

g/l

5.38

458

Open wound of thorax

156

1.16

0.18

2.2

2.5

1.40

1.35

g/l

0.01

143

Primary open-angle glaucoma, strict

536

5457

0.98

0.18

2.5

1.15

0.93

g/l

0.58

429

4589

Malignant neoplasm of corpus uteri

133

1273

1.05

0.18

1.7

1.5

0.47

0.34

g/l

0.32

102

1070

Psoas tendinitis

1.19

0.18

1.3

1.7

0.00

0.40

g/l

—

Necrobiosis lipoidica, not elsewhere classified

1.17

0.18

5.9

2.7

3.17

0.29

g/l

—

Contact with nonpowered hand tool

474

1.08

0.17

1.7

2.8

0.52

1.37

g/l

1.15

426

Other specified/unspecified deforming dorsopathies

176

1.14

0.17

2.0

2.1

1.36

1.27

g/l

0.03

151

Tuberculosis of other organs

291

1.10

0.17

2.3

2.7

1.44

1.25

g/l

0.06

250

Struck by thrown, projected or falling objec

552

1.07

0.17

3.1

2.6

0.20

0.96

g/l

2.81

492

Malignant neoplasm of floor of mouth

0.74

0.17

2.0

1.1

1.48

0.11

g/l

—

Other and unspecified injuries of neck

1.11

0.17

12.9

2.8

0.27

1.17

g/l

—

Family history of certain disabilities and chronic diseases leading to disablement

413

0.92

0.17

1.7

2.1

0.22

0.79

g/l

2.00

366

Other congenital malformations of tongue, mouth and pharynx

0.75

0.17

1.6

2.6

0.00

0.57

g/l

—

Any dementia

936

6376

1.02

0.16

2.1

2.5

1.08

1.04

g/l

0.12

753

5353

Tuberculosis of other organs, strict, including avohilmo

350

1.09

0.16

2.2

2.7

1.21

1.12

g/l

0.03

300

Benign neoplasm: Skin of other and unspecified parts of face

164

1699

0.96

0.16

3.8

2.4

0.68

0.96

g/l

0.47

137

1453

Unspecified renal colic

1.13

0.16

2.6

1.3

0.93

0.67

g/l

—

Pneumoconiosis due to asbestos and other mineral fibres

331

1.09

0.16

2.1

2.5

1.41

1.59

g/l

0.09

283

Other specified/unspecified diseases of inner ear

1.12

0.16

1.9

2.0

0.11

0.35

g/l

—

Ethmoidectomy

179

1731

1.04

0.16

2.9

2.4

0.96

0.85

g/l

0.08

152

1511

Femoral hernia

658

0.94

0.16

3.1

2.3

0.86

1.15

g/l

0.25

561

Retinoschisis and retinal cysts

341

1.09

0.16

4.2

2.9

0.20

1.32

g/l

3.72

296

Coarctation of the aorta

1.10

0.16

9.5

2.2

1.44

1.14

g/l

—

L02BG Aromatase inhibitors

532

5158

1.02

0.15

2.3

2.6

0.49

0.80

g/l

1.68

443

4355

Nontraumatic intracranial haemmorrhage

360

3678

0.98

0.15

2.6

2.3

0.74

0.98

g/l

0.70

302

3085

Open wound of neck

1.11

0.15

1.4

2.8

0.00

1.03

g/l

—

Urticaria due to cold and heat

1.11

0.15

1.6

2.0

0.12

0.55

g/l

—

Obstructed labour due to maternal pelvic abnormality

184

1897

0.97

0.14

2.7

2.4

0.61

0.72

g/l

0.17

157

1649

Thyrotropin deficiency

112

1.17

0.14

1.2

2.1

0.33

0.53

g/l

0.19

104

Tuberculosis of other organs, strict

343

1.08

0.14

2.2

2.8

1.25

1.14

g/l

0.04

294

Malignant neoplasm of rectosigmoid junction

212

0.89

0.14

4.6

1.3

1.57

0.38

g/l

0.48

181

Atrial septal defect, secundum type

236

1.10

0.14

1.3

2.2

0.21

1.04

g/l

1.47

212

L01XE Protein kinase inhibitors

832

1.05

0.14

3.6

2.7

0.87

1.26

g/l

0.59

726

Endometriosis of intestine

103

1.17

0.14

1.0

3.0

0.00

0.39

g/l

1.60

Foreign body or object entering through skin

695

1.05

0.13

3.4

2.5

0.75

1.05

g/l

0.43

618

Endometriosis ASRM stages 3,4

295

3016

0.98

0.13

1.8

2.3

0.84

0.66

g/l

0.37

252

2573

Other specified and unspecified strabismus

113

1.15

0.13

2.1

2.7

2.29

0.73

g/l

0.31

101

Other disorders of amniotic fluid and membranes

984

0.96

0.13

2.2

1.9

0.38

0.34

g/l

0.09

891

Carcinoma in situ of breast, intraductal

133

1287

1.03

0.13

2.5

2.2

0.39

0.66

g/l

0.79

110

1104

Alzheimer’s disease (Late onset)

543

4401

1.02

0.12

1.9

2.4

1.28

1.12

g/l

0.33

443

3639

Non-small cell lung cancer, squamous

672

0.95

0.12

1.9

1.5

1.91

0.45

g/l

0.96

568

Adenocarcinoma and papilloma adenocarcinoma of rectum

147

1514

0.97

0.12

3.2

1.5

0.83

0.35

g/l

1.32

125

1306

Other noninflammatory disorders of cervix uteri

698

1.05

0.12

3.0

2.3

0.57

0.78

g/l

0.29

591

Respiratory tuberculosis, confirmed and not-confirmed

816

1.04

0.12

2.1

2.6

1.52

1.35

g/l

0.09

682

Respiratory tuberculosis

816

1.04

0.12

2.1

2.6

1.52

1.35

g/l

0.09

682

Motorcycle rider injured in noncollision transport accidents

249

1.09

0.12

1.8

2.1

0.91

0.97

g/l

0.03

229

Malignant neoplasm of rectum, including Hilmo

193

1882

1.03

0.12

3.0

1.5

0.85

0.38

g/l

1.45

169

1614

Other abnormal products of conception

291

1870

1.02

0.11

2.0

2.2

0.38

0.34

g/l

0.10

266

1681

Malignant neoplasm of rectosigmoid junction, including Hilmo

386

1.06

0.11

2.9

1.4

0.94

0.39

g/l

0.54

335

Preterm labour and delivery

305

2992

1.02

0.11

2.9

2.3

0.78

0.59

g/l

0.54

268

2635

Gestational [pregnancy-induced] hypertension

246

2507

0.98

0.11

2.5

2.1

0.60

0.49

g/l

0.14

229

2192

Malignant neoplasm of brain, including Hilmo

573

1.05

0.11

2.5

1.4

1.26

0.35

g/l

1.18

495

Dental pulpitis, including avohilmo

1522

9816

0.99

0.10

2.2

2.5

0.54

0.70

g/l

1.32

1340

8594

Frostbite

115

1.13

0.10

1.1

2.2

0.00

1.12

g/l

2.00

107

Dislocation, sprain and strain of joints and ligaments of elbow

662

1.04

0.10

2.4

2.3

0.14

0.91

g/l

4.24

588

Benign neoplasm: Cranial nerves

407

1.06

0.10

4.3

2.6

0.80

1.30

g/l

0.51

353

Unspecified abortion

515

1.05

0.10

1.6

2.6

1.12

0.52

g/l

0.42

455

L02BX Other hormone antagonists and related agents

103

1063

0.97

0.10

1.8

2.7

1.01

1.23

g/l

0.19

909

Normal-pressure hydrocephalus

840

1.04

0.10

3.1

2.5

0.64

1.31

g/l

2.08

708

Helminthiases

183

1.10

0.10

3.5

2.4

0.23

0.76

g/l

1.46

162

Primary angle-closure glaucoma

707

0.96

0.10

2.4

2.7

0.73

1.17

g/l

0.66

601

Dementia

1025

6945

1.01

0.09

2.2

2.6

1.07

1.01

g/l

0.17

811

5862

Subarachnoid haemorrhage

164

1678

0.98

0.09

2.5

2.4

0.44

1.07

g/l

2.85

135

1421

Pedal cyclist injured in collision with motor vehicle

330

0.94

0.09

1.2

2.3

0.23

0.84

g/l

1.31

300

Mental retardation

298

1.07

0.09

1.9

2.3

0.92

0.89

g/l

0.02

270

Assault by sharp object

126

1.11

0.09

1.1

1.8

0.00

0.56

g/l

1.82

115

Moderate visual impairment, monocular

0.81

0.08

1.6

2.1

0.52

1.16

g/l

—

Other/unspecified mastoiditis and related conditions

0.83

0.08

1.8

2.3

0.10

0.75

g/l

—

Mucinous and mucinous cystic tumor of rectum

0.80

0.08

1.6

1.2

4.18

0.21

g/l

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS